Chmp1 negatively regulates Epidermal Growth Factor signaling in the Drosophila wing by Valentine, Meagan Elisabeth
Marshall University
Marshall Digital Scholar
Theses, Dissertations and Capstones
2014
Chmp1 negatively regulates Epidermal Growth
Factor signaling in the Drosophila wing
Meagan Elisabeth Valentine
lester64@marshall.edu
Follow this and additional works at: http://mds.marshall.edu/etd
Part of the Biological Phenomena, Cell Phenomena, and Immunity Commons, Cell and
Developmental Biology Commons, and the Genetic Processes Commons
This Dissertation is brought to you for free and open access by Marshall Digital Scholar. It has been accepted for inclusion in Theses, Dissertations and
Capstones by an authorized administrator of Marshall Digital Scholar. For more information, please contact zhangj@marshall.edu.
Recommended Citation
Valentine, Meagan Elisabeth, "Chmp1 negatively regulates Epidermal Growth Factor signaling in the Drosophila wing" (2014). Theses,
Dissertations and Capstones. Paper 802.
CHMP1 NEGATIVELY REGULATES EPIDERMAL GROWTH FACTOR SIGNALING IN 
THE DROSOPHILA WING 
 
A dissertation submitted to 
the Graduate College of 
Marshall University 
 
In partial fulfillment of 
the requirements for the degree of Doctor of Philosophy 
 
in  
 
Biomedical Sciences 
 
by 
Meagan Elisabeth Valentine 
 
Approved by 
Dr. Simon Collier, Committee Chairperson 
Dr. Beverly Delidow 
Dr. Richard Egleton 
Dr. Todd Green 
Dr. Guo-Zhang Zhu 
 
Marshall University 
May 2014 
  
ii 
 
ACKNOWLEDGEMENTS 
Thanks to the Biomedical Sciences program for not only funding my education, but for 
providing the outstanding resources and teachers to promote my education and scientific 
training. Within this program there are numerous faculty and staff members who are friendly and 
willing to help wherever they can. 
I especially extend my gratitude to my committee, Drs. Beverly Delidow, Todd Green, 
Richard Egleton, and Guo-Zhang Zhu. They were consistently supportive and encouraging. Their 
advice was invaluable and when I needed help, be it teaching a class in which I was the only 
student, or writing last minute recommendation letters, they were reliable and always came 
through. I thank my committee for listening to me talk during meetings and seminars, for being 
approachable, and for being critical without being harsh. 
Special thanks to my advisor, Dr. Simon Collier. Without his guidance my educational 
career would have taken a different route. As an undergraduate, he encouraged me to pursue a 
Master’s degree, and then as a Master’s student, he encouraged me to pursue a PhD. He has 
supported me academically, financially, and personally throughout my scientific training. I thank 
him for giving me my space, for weekly meetings, for weekend conferences, for being interested 
in my ideas, and for editing numerous powerpoints, lots of posters, a few grant applications, 
multiple papers, and my dissertation. I especially appreciate his not abandoning me when he got 
a job at the University of Cambridge. He worked with me, Marshall University, and the 
University of Cambridge to get me to England for the incredible experience of working overseas 
for 6 months to finish my PhD. I would also like to thank the University of Cambridge, 
especially Drs. Cahir O’Kane and Steven Russell, for inviting me to Cambridge to finish up my 
PhD work with Simon, and for also providing resources and space for my research and writing.   
iii 
 
I would like to thank all who have been through the Collier lab, especially Justin Hogan, 
Andrea Belalcazar, Shaimar Gonzalez, David Neff, and Jared Galloway, for being such great 
listeners and for all of their help and advice in the lab. 
Last but certainly not least, I would like to thank my family and friends – they made this 
possible, supporting me throughout my entire education. Thanks to my father, Jim Lester, for 
sparking my interest in science as a kid. Thanks to my mother, Dreama Lester, for being a friend 
and work-out partner when I needed to get away from the lab. Thanks to my brothers, J.R. and 
Cameron Lester, for being good friends and for listening to me ramble about science that they 
didn’t care a thing about. Thanks especially to my wonderful husband, Michael. He has been my 
rock. He brings me joy. He listens when I am frustrated, encourages me when I am insecure, 
gives me perspective when I’m bogged down in the details, and is patient when I’m stressed and 
irritable. Thanks to Michael’s family too, who make me laugh so hard, and have shown a 
genuine interest in me and my research. 
  
iv 
 
TABLE OF CONTENTS 
Acknowledgements .................................................................................................................................... ii 
List of Figures .......................................................................................................................................... viii 
List of Tables ............................................................................................................................................. xi 
List of Abbreviations ............................................................................................................................... xii 
Abstract ..................................................................................................................................................... xvi 
Chapter 1. Background and Introduction .......................................................................................... 1 
I. Fly development ....................................................................................................................... 2 
A. Life cycle ........................................................................................................................... 2 
B. Wing development ........................................................................................................... 3 
C.  Eye development .............................................................................................................. 6 
II. Fly genetics ............................................................................................................................... 7 
A. Balancer chromosomes .................................................................................................... 8 
B. UAS-Gal4 .......................................................................................................................... 9 
C. RNAi in flies ................................................................................................................... 11 
D. FLP/FRT .......................................................................................................................... 12 
E. Variations of FLP/FRT .................................................................................................. 14 
F.  Fly crosses ....................................................................................................................... 15 
III. The DER pathway .................................................................................................................. 18 
IV. The ESCRT machinery .......................................................................................................... 21 
V. Structure and function of Chmp1 ......................................................................................... 24 
A. Chmp1 structure ............................................................................................................. 24 
B. Chmp1 and survival ....................................................................................................... 25 
v 
 
C. Control of growth ........................................................................................................... 26 
D. Chmp1 in the nucleus .................................................................................................... 28 
E. Chmp1 in the cytoplasm ................................................................................................ 30 
F. Chmp1 and mitosis......................................................................................................... 31 
G. Conserved binding partners of Chmp1 ........................................................................ 31 
H. Binding partners of Drosophila Chmp1 ...................................................................... 33 
Chapter 2: Rationale, Specific Aims, and Hypotheses .................................................................. 35 
I. Rationale .................................................................................................................................. 35 
II. Specific Aims and Experimental Design ............................................................................ 37 
III. Hypotheses .............................................................................................................................. 40 
Chapter 3: Materials and Methods .................................................................................................... 42 
I. Alignment of Chmp1 sequences ........................................................................................... 42 
II. Generation of transgenic fly lines ........................................................................................ 42 
III. Fly stocks and genetics .......................................................................................................... 43 
IV. Mounting fly wings ................................................................................................................ 45 
V. Measurements and statistics .................................................................................................. 45 
VI. Immunohistochemistry of embryos ..................................................................................... 46 
VII. Immunohistochemistry of imaginal discs ........................................................................... 47 
VIII. Antibodies used ...................................................................................................................... 49 
IX. Eye preparation and sectioning ............................................................................................ 49 
Chapter 4: Results .................................................................................................................................. 51 
I.  Chmp1 is conserved and essential ........................................................................................ 51 
II.  Chmp1 knockdown produces a cell fate change in the wing ............................................ 55 
vi 
 
III.  Chmp1 interacts with regulators of DER signaling ........................................................... 71 
IV.  Chmp1 negatively regulates DER signaling ....................................................................... 78 
V.  Over-expression of Chmp1 ................................................................................................... 85 
VI.  Investigation into Chmp1 regulation of Notch-Delta signaling ....................................... 91 
VII.  Testing for interactions between Chmp1 and regulators of the DER using Chmp1 over-
expression fly lines ............................................................................................................... 104 
VIII.  Chmp1 knockdown in the eye disrupts ommatidia .......................................................... 107 
IX.  Drosophila Chmp1 localizes apically and to the cell membrane ................................... 111 
X.  Chmp1 localizes to the late endosome .............................................................................. 115 
Chapter 5: Discussion .......................................................................................................................... 118 
I.  Chmp1 is essential ................................................................................................................ 119 
II.  Chmp1 regulates wing vein cell fate decision .................................................................. 120 
III.  Chmp1 and DER signaling ................................................................................................. 121 
IV.  Clones of Chmp1 knockdown in the wing ........................................................................ 125 
V.  Chmp1 and Notch signaling ................................................................................................ 127 
VI.  HM-Chmp1 localization ...................................................................................................... 128 
VII.  Concluding remarks ............................................................................................................. 131 
X. Possible future studies ......................................................................................................... 132 
Chapter 6: Projects investigating Frizzled Planar Cell Polarity Signaling in Drosophila .. 136 
I.  Background on PCP ............................................................................................................. 136 
II.  The Fz PCP pathway in the Drosophila wing ................................................................... 137 
III.  The Fz PCP pathway in the Drosophila eye ..................................................................... 138 
IV.  Project 1: Chmp1 may regulate Fz PCP signaling ........................................................... 140 
vii 
 
V.  Project 2: Expression of pk and sple in pupal wings ....................................................... 146 
VI. Project 3: Pk and Sple protein isoforms in patterning of the Drosophila eye .............. 149 
VII.  Project 4: Localization of the Sple isoform in pupal wing cells .................................... 151 
Appendix ................................................................................................................................................ 156  
IRB approval letter ............................................................................................................... 156  
References .............................................................................................................................................. 157 
 
 
 
viii 
 
LIST OF FIGURES 
Figure 1.1 Timeline of major developments in Drosophila research ................................................. 2 
Figure 1.2 Development of the Drosophila wing .................................................................................. 5 
Figure 1.3 Development of the Drosophila eye .................................................................................... 7 
Figure 1.4 The UAS-Gal4 System ........................................................................................................ 10 
Figure 1.5 The Inducible FLP/FRT System: generate homozygous clones in heterozygous     
tissue........................................................................................................................................................... 13 
Figure 1.6 Variation of the FLP/FRT system with UAS-Gal4.......................................................... 15 
Figure 1.7 Examples of crosses in Drosophila .................................................................................... 18 
Figure 1.8 A simplified diagram of the DER pathway ....................................................................... 20 
Figure 1.9 ESCRT-III function on the endosome ............................................................................... 23 
Figure 1.10 Chmp1 protein structure in Drosophila ........................................................................... 25 
Figure 2.1 Experimental Design ............................................................................................................ 40 
Figure 3.1 Orientation of fly heads in resin block for eye sectioning .............................................. 50 
Figure 4.1 Chmp1 is conserved ............................................................................................................. 52 
Figure 4.2 Cross design to test ubiquitous Chmp1 knockdown ........................................................ 54 
Figure 4.3 Expression patterns of wing drivers ................................................................................... 56  
Figure 4.4 Chmp1 knockdown cross design ........................................................................................ 57  
Figure 4.5 Chmp1 knockdown at 30oC ................................................................................................. 59  
Figure 4.6 Cross design for Chmp1 knockdown in Chmp1 heterozygous background ................. 60 
Figure 4.7 Chmp1 knockdown results in thickened wing veins ........................................................ 62  
Figure 4.8 Chmp1 knockdown in wings heterozygous for the Chmp1 gene: wing vein 
measurements ............................................................................................................................................ 63  
ix 
 
Figure 4.9 Cross design for rescue of Chmp1 knockdown with Chmp1 over-expression ............. 66 
Figure 4.10 Chmp1 over-expression rescues the Chmp1 knockdown phenotype .......................... 69  
Figure 4.11 Chmp1 over-expression rescues Chmp1 knockdown: wing vein measurements ...... 71  
Figure 4.12 Cross design testing for interaction between Chmp1 and DER   regulators  ............. 73 
Figure 4.13 Chmp1 interacts with regulators of DER signaling in Drosophila .............................. 76  
Figure 4.14 Chmp1 knockdown and DER signaling regulators wing vein measurements ........... 78  
Figure 4.15 Cross design for Chmp1 knockdown marked with GFP in the posterior wing        
disc ............................................................................................................................................................. 79 
Figure 4.16 Cross design for generating Chmp1 knockdown clones marked with GFP in wing 
discs ............................................................................................................................................................ 80  
Figure 4.17 Chmp1 knockdown reduced Bs staining in imaginal discs .......................................... 82  
Figure 4.18 Cross design for Chmp1 and forked knockdown clones in the adult wing ................. 83  
Figure 4.19 Clones of Chmp1 and forked knockdown in the adult wing......................................... 85  
Figure 4.20 Cross design for achieving Chmp1 over-expression in the Drosophila wing ............ 86  
Figure 4.21 Chmp1 over-expression with MS1096-Gal4 in the Drosophila wing causes vein 
deltas .......................................................................................................................................................... 88  
Figure 4.22 Chmp1 over-expression in the Drosophila wing causes deltas .................................... 90 
Figure 4.23 Rare phenotypes caused by Chmp1 over-expression in the Drosophila wing ........... 91  
Figure 4.24 Cross design to test for an interaction between Chmp1 and Notch using the MS1096-
Gal4 driver ................................................................................................................................................ 93 
Figure 4.25 Cross design to test for an interaction between Chmp1 and Notch using the dpp-
Gal4 driver ................................................................................................................................................ 96  
Figure 4.26 Variable notching phenotypes associated with various genotypes .............................. 98 
x 
 
Figure 4.27 Control cross design to show interaction between Car and Deltex ........................... 101  
Figure 4.28 Cross design to test for an interaction between Chmp1 and Deltex .......................... 102  
Figure 4.29 Interaction between Chmp1 and Deltex ........................................................................ 104 
Figure 4.30 Cross design using Chmp1 over-expression transgenes to test for an interaction 
between Chmp1 and DER regulators .................................................................................................. 105  
Figure 4.31 Chmp1 over-expression and DER regulators ............................................................... 107 
Figure 4.32 Cross design for Chmp1 knockdown in Drosophila eye ............................................. 108  
Figure 4.33 Chmp1 knockdown and over-expression in the Drosophila eye ................................ 110  
Figure 4.34 Cross design for HM-Chmp1 expression in both the anterior of embryonic 
parasegments and the posterior wing disc in larvae .......................................................................... 112  
Figure 4.35 Localization of HM-Chmp1 in wing imaginal discs ................................................... 114  
Figure 4.36 Cross design for HM-Chmp1 and YFP-Rab9 expression in the anterior of embryonic 
parasegments  .......................................................................................................................................... 116  
Figure 4.37 Relative subcellular localizations of HM-Chmp1 with endosome markers and     
Vps4 ......................................................................................................................................................... 117 
Figure 5.1 Model for Chmp1 regulation of the DER through the MVB pathway ........................ 132  
Figure 6.1 The Fz PCP pathway polarizes cells of the Drosophila wing and eye ........................ 140  
Figure 6.2 Chmp1 may regulate Fz PCP signaling ........................................................................... 145  
Figure 6.3 Genetic structure of the prickle gene ............................................................................... 146  
Figure 6.4 Amplification of pk, sple, and actin cDNA fragments .................................................. 149 
Figure 6.5 Pk and Sple in Fz PCP signaling in the Drosophila eye ................................................ 151 
Figure 6.6 Sple localization in the Drosophila pupal wing .............................................................. 155 
xi 
 
LIST OF TABLES 
Table 1.1 The effect of temperature on life cycle length in Drosophila .........................................3 
Table 1.2 Summary of balancer chromosomes and dominant markers used in this research .........9 
Table 1.3 Protein interactions with Drosophila Chmp1 ................................................................34 
Table 3.1 Fly stocks used ..............................................................................................................44 
Table 3.2 Fly lines generated in this study ....................................................................................45 
Table 3.3 Antibodies used for immunostaining ............................................................................49 
Table 4.1 Chmp1 over-expression can rescue the Chmp1 knockdown phenotype .......................70 
Table 4.2 Notching frequencies of individual genotypes ..............................................................99 
Table 6.1 Primers used to amplify pk, sple, and actin cDNA .....................................................147 
  
xii 
 
LIST OF ABBREVIATIONS 
 
A498   Renal Cell Carcinoma cell line 
Act5c   Actin5c 
acv   Anterior Cross Vein 
AMSH    Associated Molecule with the SH3-domain of STAM  
Aos  Argos 
AP   Anteroposterior 
ATM   Ataxia Telangiectasia Mutated 
ATRA   All-trans Retinoic Acid 
B1   Bar 
Bc   Black Cell 
BMI1   B Lymphoma Moloney Murine Leukemia Virus Insertion 
Region 1 Homolog 
Bs   Blistered 
BSA   Bovine Serum Albumin 
Car   Carnation 
CCT   Phosphocholine Cytidylyltransferase 
ce  Columnar Epithelium 
Chmp1   Chromatin Modifying Protein, Charged Multivesicular Protein 
CRBP-1   Retinol Binding Protein-1 
Cy   Curly 
CyO   Curly of Oster 
D1   Dichaete 
DER   Drosophila Epidermal Growth Factor Receptor 
Dgo   Diego 
DNA 
Dox  
 Deoxyribonucleic acid 
Doxycycline 
DPiM   Drosophila Protein Interaction Map 
Dpp   Decapentaplegic 
Drk   Downstream of Receptor Kinase 
Ds   Dachsous 
Dsh   Dishevelled 
DSOR1   Downstream of Ras1 
DSRF   Drosophila Serum Response Factor 
dsRNA   double stranded RNA 
Dx   Deltex 
EcR-293   Human Embryonic Kidney cell line, expresses Ecdysone 
Receptor 
EGFR   Epidermal Growth Factor Receptor 
en   Engrailed 
xiii 
 
ESCRT   Endosomal Sorting Complex Required for Transport 
F1   First Filial Generation 
F2   Second Filial Generation 
F3   Third Filial Generation 
FLPase   FLP recombinase 
FM   First Multiple 
Fmi   Flamingo 
FRT   FLPase Recombination Target 
Ft   Fat 
Fz   Frizzled 
GFP   Green Fluorescent Protein 
Gla   Glazed 
GMM   Gary’s Magic Mountant 
GOI    Gene of Interest 
hAPF   hours After Pupal Formation 
HEK-293T   Human Embryonic Kidney cell line, non-tumorigenic 
Hh   Hedgehog 
HM   His-Myc 
hpRNA   hairpin RNA 
Hrs   Hepatocyte Growth Factor Receptor Substrate 
hs   heat shock 
hs-flp   heat shock FLP recombinase 
If   Irregular Facets 
ILV   Intralumenal Vesicle 
INK4   Inhibitor of CDK4 
kD   kiloDaltons 
Kek-1   Kekkon-1 
LIP5    Lyst-Interacting Protein 5 
m  Myoblast 
MAPK   Mitogen-Activated Protein Kinase 
MF   Morphogenetic Furrow 
MIM   MIT-Interacting Motif 
MIT   Microtubule Interaction and Transport 
mPcl1   mammalian Polycomblike 
mRNA   messenger RNA 
MVB   multivesicular body 
NICD  Notch Intracellular Domain 
NLS   Nuclear Localization Sequence 
P   Parental Generation 
PanC1   Human Pancreatic Ductal Tumor cell line 
xiv 
 
PBS   Phosphate Buffer Saline 
PBST   Phosphate Buffer Saline with Triton-X 
PcG   Polycomb Group 
Pcl   Polycomblike 
PCP   Planar Cell Polarity 
PCR   Polymerase Chain Reaction 
pcv   Posterior Cross Vein 
Pk   Prickle 
pm  Peripodial Membrane 
PM  Plasma Membrane 
ptc   Patched 
qPCR  Quantitative real-time PCR 
Rho   Rhomboid 
RISC   RNA Induced Silencing Complex 
RNA 
RNAi  
 Ribonucleic Acid 
RNA interference 
RT  Reverse Transcription 
RTK   Receptor Tyrosine Kinase 
Sal1   Supernumerary Aleurone Layers 1 
Sb   Stubble 
Ser   Serrate 
shRNA   short hairpin RNA 
siRNA   short interfering RNA 
SKD1   Suppressor of K+ Transport Growth Defect 
SM   Second Multiple 
SOS   Son of Sevenless 
Sple   Spiny Legs 
Stan   Starry night 
Stbm   Strabismus 
Sty   Sprouty 
Tb   Tubby 
TM   Third Multiple 
TRiP   Transgenic RNAi Project 
Tsg101   Tumor Susceptibility Gene 101 
UAS   Upstream Activating Sequence 
UBPY    Ubiquitin-specific processing Protease Y 
Vang   Van-gogh 
VDRC   Vienna Drosophila Resource Center 
Vn   Vein 
Vps4   Vacuolar Protein Sorting 4 
xv 
 
Vta1p   Vps Twenty Associated 1 Protein 
Wg   Wingless 
WgSp1   Sternopleural 
YFP   Yellow Fluorescent Protein 
 
 
  
xvi 
 
ABSTRACT 
A critical step in cellular signaling through transmembrane receptors is the down-regulation of 
activated receptors through the multivesicular body (MVB) pathway to the lysosome. MVB 
generation is mediated by the highly conserved ESCRT (0, I, II, and III) protein complexes. 
Though the ESCRT-III complex provides the core function of the ESCRT machinery, it is the 
least characterized of the ESCRT complexes. The Chmp1 protein is an ESCRT-III component 
and a putative tumor suppressor that has been linked to pancreatic and renal cancers in humans. 
However, published data on Chmp1 activity are conflicting and its role during tissue 
development is not well defined.  
Drosophila melanogaster (the common fruit fly) provides a powerful model system for 
investigating the function of genes involved in human development and disease. In this study, 
knockdown and over-expression techniques were used to investigate the function of Chmp1 in 
Drosophila. RNAi was used to reduce Chmp1 expression, and transgenic fly lines that allow for 
expression of either wild-type or epitope tagged Chmp1 were used to investigate over-
expression, as well as the subcellular localization of Chmp1. 
Knockdown of Chmp1 expression using RNAi was lethal in the fly, suggesting that Chmp1 is an 
essential gene for Drosophila development. In the wing, loss of Chmp1 activity caused a cell fate 
change from intervein to vein, which was likely a result of de-regulation of the Drosophila 
Epidermal Growth Factor Receptor (DER) pathway. Genetic interactions between Chmp1 and 
regulators of DER signaling suggest that Chmp1 negatively regulates DER signaling. 
Furthermore, Chmp1 knockdown also decreased Blistered expression, which is repressed by 
DER signaling.  
xvii 
 
Over-expression of Chmp1 had mild phenotypic effects, suggesting that dosage of Chmp1 is not 
critical for cellular function. Some of the epitope tagged Chmp1 protein was detected at the late 
endosome in Drosophila embryonic epithelial cells. This is consistent with Chmp1 functioning as 
an ESCRT-III component during MVB formation. Therefore, Drosophila Chmp1 may negatively 
regulate DER signaling through its role in MVB formation as an ESCRT-III component. 
 
1 
 
CHAPTER 1  
BACKGROUND AND INTRODUCTION 
For over 100 years Drosophila melanogaster, or the common fruit fly, has been used as 
model for biological and medical research (Figure 1.1). From Thomas Hunt Morgan’s fly room 
at Colombia University in the early 1900’s to the sequencing of the genome in 2000, the fruit fly 
has become one of the most studied organisms around the world. The sequencing of the fly 
genome provided an important resource to biologists and identified about 14,000 genes [4]. After 
many years of work on Drosophila, today’s researchers are supplied with an extensive base of 
knowledge of this species, along with many sophisticated genetic and molecular tools that have 
been developed for studying gene and protein function, many of which are unique to this 
organism [2]. Although Drosophila is particularly useful in the fields of genetics and 
developmental biology, it is increasingly becoming a useful model for human disease, especially 
neurodegenerative disorders [5, 6]. Importantly, there is a great deal of homology between 
human genes and Drosophila genes; it is thought that about 75% of human disease genes have 
homologues in Drosophila [7, 8].  
In the research presented in this dissertation, Drosophila was used as a model organism to 
study proteins involved in human development and disease. Therefore, it is appropriate to 
describe relevant aspects of Drosophila research, including the fly life cycle, the development 
and anatomy of the eye and wing, and the genetic tools and techniques used in these studies. 
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Figure 1.1 Timeline of major developments in Drosophila research [9, 10] 
 
I. Fly development  
The short life cycle of the fruit fly is one of the attributes that make it such a fine model 
organism. Drosophila development is well studied and includes multiple stages: embryogenesis, 
three instar larval stages, the pupal stage, and adult. Under ideal conditions, the entire life cycle 
is completed in 9-10 days, allowing for the analysis of multiple generations over a short period 
of time.  
A. Life cycle  
The length of the Drosophila life cycle is temperature dependent, completing in only 10 
days at room temperature (Table 1.1) [11]. The life cycle begins with embryogenesis (described 
in [12]). There are 17 well documented stages of embryogenesis that take place in 21-22 hours at 
25oC [13]. Early embryonic cellular divisions are synchronous and rapid, occurring nearly every 
10 minutes. Division of the cytoplasm does not occur at this early stage, and consequently a 
single multinucleate cell, or syncytium, is formed. After 13 divisions forming about 6000 nuclei, 
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cellularization begins, which is followed by gastrulation and segmental patterning along the 
anteroposterior axis of the embryo. Embryogenesis is followed by three instar larval stages, each 
with a molt in between. The larval stages are followed a very short prepupal period before 
progressing on to the pupal stage. Morphogenesis from larva to fly takes place in the pupal stage.  
During embryogenesis, tissues called imaginal discs form. These tissues will become 
most of the external adult structures, e.g., the eyes, antennas, wing, legs, etc. Imaginal discs grow 
and become patterned throughout the larval and pupal stages.  
 
Table 1.1 The effect of temperature on life cycle length in Drosophila 
B. Wing development 
In most of the studies presented in this dissertation, the developing or adult Drosophila 
wing was used to investigate the function of the Drosophila Chmp1 protein. The adult 
Drosophila wing is a cuticular structure that is quite a lot like a flattened balloon (wing 
development reviewed in [14, 15]). It has opposing dorsal and ventral surfaces, both decorated 
with a regular array of distally-pointing hairs (Figure 1.2A and B). The major cell types that 
compose the adult Drosophila wing are vein cells and intervein cells. The vein cells form 
conduits called wing veins that span the surface of the wing. The wing veins provide rigidity and 
support for the wing, and also carry trachea and neurons. There are four longitudinal wing veins 
(L2-L5), two marginal wing veins (L1 and L6), and two shorter transverse veins (anterior cross 
vein [acv] and posterior cross vein [pcv]) (Figure 1.2A). The longitudinal veins L3, L5, and 
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distal portion of L4 are positioned on the dorsal surface of the wing, while L2 and the remainder 
of L4 are on the ventral surface of the wing. 
Wing development begins in the embryo, when imaginal disc precursor cells are 
specified. As the larva grows, the wing disc becomes larger through cell proliferation, and cell 
fates become established through activation of and interaction between many signaling 
pathways, including Decapentaplegic (Dpp, Bone Morphogenetic Protein [BMP] in humans) 
signaling, Wingless (Wg, Wnt in humans) signaling, Hedgehog (Hh) signaling, the Drosophila 
Epidermal Growth Factor Receptor (DER) pathway, Notch signaling, and the Frizzled (Fz) 
Planar Cell Polarity (PCP) pathway. The mature wing disc is a pear shaped tissue that can be 
divided into three parts, each giving rise to different structures of the adult fly: the wing pouch, 
which will form the wing blade; the hinge region, which will form the wing hinge; and the body 
wall region, which is composed of cells that will become part of the thorax (Figure 1.2C). The 
wing disc is composed of three major types of cells: disc proper cells, which are columnar 
epithelial cells that give rise to the epidermis in the adult fly and make up the majority of the 
disc, including the wing pouch; peripodial cells, which are squamous cells that form a thin 
membrane overlaying the wing disc; and adepithelial cells, which are myoblasts that will form 
the trachea and flight muscles (Figure 1.2D). 
DER, Notch, Wg, Hh, and Dpp signaling pathways interact to form an adult wing with 
the wild-type wing vein pattern (reviewed in [14, 15]). First, provein and intervein territories are 
established in the imaginal wing disc. The proveins are broad stripes, 5-6 cells in width that are 
vein competent, i.e., they have the potential to differentiate into wing vein [16]. The DER and 
Notch signaling pathways interact extensively during wing vein specification. DER signaling is 
activated in the center of the provein and promotes vein cell fate, while Notch signaling is 
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activated in the cells bordering the provein and represses vein cell fate [17-20]. The fate of vein 
and intervein cells is refined to produce a narrow stripe of vein cells as development progresses 
through the pupal stage. In fact, some genes involved in vein specification are active quite late in 
pupal development, suggesting that the final choice between differentiation into vein and 
intervein cells is not settled until late developmental stages [15, 21]. 
 
 
At the pupal stage of development the wing disc undergoes major structural changes in 
which the layer of epithelial cells of the wing pouch everts (pushes out) to form a folded layer of 
epithelial cells. The basal surfaces of these cell layers adhere to one another and form the dorsal 
and ventral surfaces of the wing.  Each wing cell produces a hair and secretes a layer of cuticle 
on its apical surface. When metamorphosis has completed and the fly emerges, the intervein 
Figure 1.2 Development of the Drosophila wing. A. Light microscope image of an adult 
female fly wing. Wing veins are labeled: L2-L5 (longitudinal), L1 and L6 (marginal), acv and 
pcv (transverse). Dorsal and ventral surfaces are in the plane of the page. B. Individual wing 
cells are hexagonally packed and each cell produces a distally pointing hair. C. The wing 
imaginal disc gives rise to cells of the body wall (orange), the wing hinge (blue) and the wing 
blade (pink). D. A schematic side view of the wing disc shown in C. There are three cell 
layers. Cells that give rise to the body wall, wing hinge, and wing blade are ce cells. The pm is 
composed of squamous cells. The apical surfaces of the pm and ce cells are adjacent. m form a 
third layer. P is posterior, D is distal, Ant is anterior, Post is posterior, acv is anterior cross 
vein, pcv is posterior cross vein, pm is peripodial membrane, m is myoblast, ce is columnar 
epithelium. Images generated by M. Valentine. Panels C and D modified from [1]. 
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wing cells delaminate, die, and are cleared out of the wing, leaving behind the cuticle of the adult 
wing.  
C. Eye development 
The Drosophila eye was also used in these studies to investigate the function of the 
Drosophila Chmp1 protein. Like the wing, the development and structure of the eye are well 
understood, making it a suitable tissue for investigating protein function. The adult Drosophila 
eye is a typical insect eye, composed of around 800 hexagonal ommatidia, or facets (Figure 
1.3A). Each ommatidium is composed of eight photoreceptors (R1-R8) in an asymmetric pattern, 
four cone cells, pigment cells, and a sensory bristle, totaling 22 cells. The ommatidia are 
arranged in a symmetrical fashion with respect to the equator, or the dorsal/ventral boundary of 
the eye, so that cells of the dorsal and ventral halves are mirror images (Figure 1.3B). 
The Drosophila eye, like the wing, begins as a set of precursor cells specified in the 
embryo and grows into the eye-antennal disc during larval development (eye development 
reviewed in [3]). This disc gives rise to the adult eye and antenna, as well as the head capsule 
and mouthparts (Figure 1.3C). Throughout the first and second instar larval stages, the cells of 
the eye disc proliferate in an undifferentiated state. During the third instar larval stage, the cells 
of the eye begin to differentiate from posterior to anterior of the disc. This process appears as a 
wave of differentiation traveling from posterior to anterior, called the morphogenetic furrow, and 
is visible as an indentation in the disc (Figure 1.3C). As the morphogenetic furrow passes, 
ommatidial cells are recruited and specified sequentially. The first cell to differentiate is the R8 
photoreceptor, followed in pairs by R2 and R5, R3 and R4, R1 and R6, and lastly R7. As 
differentiation occurs, the photoreceptor clusters rotate 90o away from the equator (clockwise in 
the dorsal half of the eye, counter-clockwise in the ventral half), producing the symmetrical 
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arrangement of the eye (Figure 1.3B and C). Morphogenesis occurs during the pupal stage of 
development, and the eye-antennal discs evert and fuse to form the head. 
As in the wing disc, the development of the eye disc requires the work of many signaling 
pathways. For example, DER signaling is required for differentiation of all of the photoreceptor 
cells, except R8, and is important for proper rotation as well [22, 23]. Additionally, Fz PCP and 
Notch signaling are required for the R3 and R4 photoreceptor cell fate decision, which 
determines the chirality, or handedness, of the photoreceptor clusters, and likely direction of 
rotation as well [24, 25].  
 
 
II. Fly genetics 
As discussed above, the quick life cycle and well-studied development of Drosophila 
make it a useful model organism. A second attribute of the fruit fly that contributes to its facility 
as a model organism is its genetics. Drosophila genetics are rather simple compared to mammals. 
Figure 1.3 Development of the Drosophila eye. A. SEM image of the adult fly eye. 
Ommatidia and eye bristles are easily identified. B. A light microscope image of a one micron 
thick tangential section of a Drosophila eye stained with toluidine blue. Individual ommatidia 
are composed of 8 photoreceptor cells and arranged in a symmetrical fashion around the 
equator (drawn in black). C. The eye imaginal disc is compound and gives rise to cells of the 
eye (yellow) and antenna (blue). The MF progresses from posterior to anterior. Cells posterior 
to the MF become progressively more differentiated and begin to rotate 90o away from the 
equator.  MF is morphogenetic furrow, ant is anterior, post is posterior. Images generated by 
M. Valentine. Panel C modified from [3]. 
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The fruit fly is a diploid organism and its genome includes about 14,000 genes on four 
chromosomes: X/Y (1), 2, 3, and 4 (very small). In most cases the fly genome carries only one 
copy of a gene, which eliminates problems of genetic redundancy that are often encountered in 
studies with mammals. Additionally, there are many useful tools and techniques that were used 
for the research presented here that make studying the fly particularly convenient, including 
balancer chromosomes, UAS-Gal4, and FLP/FRT (discussed below). 
A. Balancer chromosomes 
One of the advantageous tools available for Drosophila genetics is the balancer 
chromosome, which was used in nearly every fly cross performed in this research (Table 1.2). 
Balancer chromosomes are artificially generated chromosomes that were introduced into fly 
research in 1918 by H.J. Muller, who had been a student of T.H. Morgan at Colombia University 
[26]. Balancer chromosomes carry multiple inversions, as well as dominant marker mutations or 
transgenes. The multiple inversions carried by balancer chromosomes suppress recombination 
with wild-type homologous chromosomes during meiosis. If recombination does occur between 
a wild-type and a balancer chromosome, the recombinant chromosomes carry deletions, 
duplications and/or lose the centromere, all of which are usually lethal in the progeny. Balancer 
chromosomes are also homozygous lethal, so progeny receiving two copies of a balancer should 
not been seen in the offspring. Therefore, the advantage of balancers is that they allow for the 
stable maintenance of homozygous lethal mutations in a heterozygous condition as neither 
chromosome is homozygous viable, and the lethal mutation cannot switch to the balancer 
chromosome through recombination. Additionally, they carry dominant markers that allow for 
easy identification by phenotype and tracking of the balancer chromosome through single or 
multi-generation crosses (Table 1.2).  There are balancer chromosomes for the first/X (first 
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multiple [FM]), second (second multiple [SM]), and third (third multiple [TM]) chromosomes 
(Table 1.2). There are also several fly lines, or balancer stocks, that carry multiple balancers and 
can be used to “balance” homozygous lethal mutations or transgenes. 
 
 
B. UAS-Gal4 
The UAS-Gal4 system is a gene expression system that was used throughout the research 
presented in this dissertation [27]. This system is a standard procedure used in fly labs to control 
the expression of a transgene in the fly. It is a fairly simple system requiring only two 
components, a UAS (upstream activating sequence) enhancer and the Gal4 transcription factor 
(Figure 1.4). The disadvantage to the system is that it requires two transgenic fly lines. The 
advantage is the many combinatorial possibilities. Due to its popularity in the fly research 
Table 1.2 Summary of balancer chromosomes and dominant markers used in this 
research. FM: first multiple, CyO: Curly of Oster, TM: third multiple 
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community, many transgenic lines have already been created and are available for immediate 
use.  
 
 
The UAS-Gal4 system requires that the gene of interest is under the control of a UAS 
enhancer (Figure 1.4). There are many plasmids available that allow for insertion of cDNA of a 
gene of interest downstream of the UAS enhancer, followed by insertion into the fly’s genome.  
The UAS enhancer allows for controlled expression of the transgene, as it is only responsive to 
the Gal4 transcription factor (Figure 1.4).  So control of expression of the transgene is dependent 
on control of expression of Gal4. Consequently, there are thousands of Gal4 lines, often called 
drivers, available from Bloomington Drosophila Stock Center at Indiana University. These lines 
vary in Gal4 expression, ranging from ubiquitous expression, to expression in specific tissues, to 
expression at specific time points during development, giving the researcher fine spatial and 
temporal control over transgene expression. The UAS-Gal4 system is also increasingly effective 
Figure 1.4 The UAS-Gal4 System. The UAS-Gal4 system requires two components: a Gal4 
transgene under the control of a specific promoter or a genomic enhancer, and the gene of 
interest downstream of a UAS (upstream activating sequence) enhancer. When both of these 
components are in a fly, Gal4 is expressed in specific cells and binds the UAS enhancer to 
activate expression of the gene of interest. 
11 
 
with increasing temperature, from 18oC to 30oC. This gives control over the strength of each 
individual driver as well, as raising progeny at varying temperatures can provide a range of 
driver strengths and thus phenotype strength. 
C. RNAi in flies 
The UAS-Gal4 system is a useful way of controlling expression of a transgene in 
Drosophila. However, for years its main use was to study the effects of over-expression of a 
wild-type or mutated Drosophila gene, or expression of a gene from another organism. In 2007, 
Dietzl et al. published their work of generating a genome wide transgenic library of RNAi fly 
lines (Vienna Drosophila RNAi Center [VDRC]), which allowed for the controlled knockdown 
of genes in specific cells and tisues of the organism using the UAS-Gal4 system, providing an 
invaluable resource to the fly research community [28]. Several RNAi fly lines were used in the 
research presented in this dissertation, so it is appropriate to review their mechanism of action.  
The RNAi fly lines were generated using short inverted DNA repeats complementary to 
specific mRNAs. These were inserted into a plasmid downstream of a UAS enhancer and then 
inserted into the genome of the fly. When transcribed, a short hairpin RNA (shRNA) is formed 
and cleaved by the enzyme DICER into pieces of short double stranded RNA (dsRNA), each 
about 21 nucleotides in length. Then, the RNAi induced silencing complex (RISC) unwinds the 
dsRNA into a single stranded short interfering RNA (siRNA) and uses it as a template to find the 
native complementary mRNA in the cell. Binding of the siRNA to its complementary mRNA 
induces its degradation, thus expression of the target is lowered. Since the creation of the first 
genome wide RNAi library, other libraries have been created, including Harvard’s Transgenic 
RNAi Project (TRiP) [29]. Since these lines were created for use with the UAS-Gal4 system, fly 
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researchers now have the ability to control the intensity, tissue, and/or developmental timing of 
knockdown of any gene in the Drosophila genome. 
D. FLP/FRT 
Another technique available to the Drosophila research community is FLP/FRT, a 
method of targeted DNA recombination that is similar to Cre/Lox in mammals [30]. The 
FLP/FRT system provides a way of generating clones, or groups of cells descendant from the 
same parent cell, of a desired genotype within the living fly (Figure 1.5). Unlike vertebrates, cell 
migration and integration during development are limited in Drosophila. So often, daughter cells 
descendant from a single parent cell remain clustered together within the tissue. The FLP/FRT 
system can be used to cause a genomic change in the parent cell to generate, for example, clones 
of cells homozygous for a mutation in a heterozygous tissue, or clones of cells expressing a 
transgene that is not expressed in the rest of the tissue. A marker is generally used to identify the 
clones, making borders of clones obvious and providing a useful method for studying the effects 
of protein mutation and expression on cells within a developing tissue. 
Like UAS-Gal4, FLP/FRT is a two-component system derived from yeast. It requires 
FLP recombinase (FLPase), an enzyme that mediates recombination between FLPase 
recombination targets (FRTs). FRTs are 34 base pair DNA sequences 
(GAAGTTCCTATTCTCTAGAAAGTATAGGAACTTC) and have been inserted into many 
places within the Drosophila genome. So when FLPase is expressed, it can mediate 
recombination between two FRT sites. Several transgenic FLPase stocks have been generated, 
including the commonly used hs-FLPase (hs-flp), which expresses FLPase under the control of 
the heat shock promoter, hsp70. When using hs-flp to generate clones in flies, an increase in 
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ambient temperature activates expression of FLPase. This gives the researcher temporal control 
over the developmental time point at which the recombination takes place.  
 
 
FLP/FRT recombination rates are generally quite low, so that only a few cells within a 
tissue experience a successful recombination event. However, the number of clones obtained can 
vary, depending on the induction conditions used and the position of the FRT sites. Additionally, 
Figure 1.5 The Inducible FLP/FRT System: generate homozygous clones in 
heterozygous tissue. The FLP/FRT system for generating homozygous mutant clones 
requires two components: FRT sites on identical loci of homologous chromosomes (in 
yellow), and FLPase, which mediates recombination between those sites.  The gene mutation 
of interest (in blue) must be distal to the FRT site on the chromosome, and having a visible 
marker such as GFP (in green) on the wild-type chromosome makes finding clones easier. A. 
During mitosis, homologous chromosomes are duplicated and the daughter cells receive one 
copy of each chromosome. B. If flies carry chromosomes with FRT sites on identical loci 
and hs-flp, heat shocking the flies during development will activate expression of FLPase, 
which can then mediate recombination between the two FRT sites. One of the daughter cells 
will receive two copies of the gene mutation of interest and no copy of the marker, while the 
other daughter cell receives two copies of the marker and no copy of the gene mutation of 
interest. 
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the recombination rate is similar for the same induction conditions, so that the size of clones 
generated is dependent upon the developmental time point at which FLPase was induced, i.e., 
clones generated at early time points will be fewer but larger, while those generated at late 
developmental time points will be smaller but numerous.  
E. Variations of FLP/FRT 
Since the development of the FLP/FRT system, variations on the system using the 
FLP/FRT components have been generated. When clones were generated in the research 
presented here, a variation which brings together the FLP/FRT and UAS-Gal4 systems was used 
(Figure 1.6). This merged system allowed for the generation of clones of knockdown or over-
expression of the gene of interest, and allows for temporal control over the generation of those 
clones during development. This system required three components, two of which have already 
been discussed: the hs-flp transgene, which provided the temporal control over FLPase 
expression and thus clone generation, and the gene or RNAi of interest under the control of a 
UAS enhancer, allowing for either over-expression or knockdown. The third component was a 
transgene containing the Gal4 coding sequence downstream of an Actin promoter, but separated 
by a fragment containing a transcription stop (CD2-polyA) sequence flanked by FRT sites. This 
means transcription from the Actin promoter will terminate before the Gal4 coding sequence is 
reached. When these three transgenes are in the same fly, a heat shock activates expression of 
FLPase, which mediates recombination between the FRT sites, removing the CD2-polyA 
sequence. The Actin promoter can then activate expression of Gal4, which binds to the UAS 
enhancer and activates expression of the gene of interest in the clone. Again, this may be used to 
over-express a Drosophila gene, express a transgene, or knockdown expression of a gene using 
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an RNAi fly line. Like the traditional FLP/FRT system, the recombination is induced in only a 
few cells, so usually a small number of clones are generated in each fly. 
 
 
 
 
F. Fly crosses 
The advantages of using Drosophila as a model organism culminate in the fly cross. The 
short life cycle and many genetic tools available make it possible to accomplish sophisticated 
genetics in a relatively short period of time. However, multiple generation fly crosses may be 
required to drive expression of a transgene or RNAi using the UAS-Gal4 system, to test for 
Figure 1.6 Variation of the FLP/FRT system with UAS-Gal4. This system allows for 
generation of clones of over-expression or knockdown of a gene of interest. It requires three 
transgenes, labeled 1-3. Heat shock induces production of FLPase, which mediates 
recombination between FRT sites and removes the CD2-polyA sequence. This removes the 
transcription stop signal and allows expression of Gal4 regulated by the Actin promoter. 
Gal4 then binds to the UAS enhancer, activating expression of the gene of interest. The gene 
of interest may be a copy of a cDNA for over-expression analysis, but may also be sequence 
to express hpRNA, to allow for knockdown analysis. 
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genetic interactions between proteins and pathways, or to generate mutant clone cells within the 
developing tissues of the fly.  
Setting up a fly cross in Drosophila is usually simple, and there are many features of the 
fly that make it convenient. In Drosophila, homologous recombination between chromosomes 
does not occur in males. This means chromosomes can be transmitted unaltered through the male 
line. Also, it is usually possible to generate large numbers of offspring from Drosophila crosses. 
A healthy female fly can lay up to 60 eggs per day. However, females can store males’ sperm 
after mating, so the females used in a cross must be virgin, otherwise, the genotype of the 
offspring cannot be predicted. Adult flies do not mate for several hours after eclosion, so female 
virgins can be identified by an immature phenotype. This can include a light body color and 
large body indicating immature cuticle, folded wings, or a dark spot, the meconium (the remains 
of the last meal before pupation), on their ventral abdomen. For most crosses, it is a good idea to 
mate at least 10 virgin females of one genotype to a similar number of males of the second 
genotype. By moving the adult flies to a new containment vial with fresh food every 2 to 3 days, 
a large number of offspring can be collected. 
 There is a standard nomenclature used for denoting fly genotypes [2]. As in other 
organisms, wild-type chromosomes or alleles are represented as plus sign. Homologous 
chromosomes are separated with forward slash. So for a wild-type fly, the third chromosome 
would be represented as +/+. However, if a fly was heterozygous for UAS-Chmp1, a Chmp1 
over-expression transgene, on the third chromosome, the genotype of the fly would be written as 
UAS-Chmp1/+. Another custom is to separate two genes that are on the same chromosome with a 
comma. Additionally, different chromosomes are separated with a semicolon. One fly line used 
often in these studies is en-Gal4, UAS-GFP. en-Gal4 is a driver that expresses Gal4 in the 
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pattern of the gene engrailed, and UAS-GFP is a transgene that allows for expression of GFP; 
both are located on second chromosome and so are separated with a comma. A fly with the 
genotype en-Gal4, UAS-GFP/+; UAS-Chmp1/+ would represent a fly that has en-Gal4 and 
UAS-GFP on one copy of the second chromosome, and UAS-Chmp1 on one copy of the third 
chromosome, while the remaining second and third chromosomes are wild-type.  
When performing crosses, Punnett Squares are useful for keeping track of chromosomes 
to identify progeny of the correct genotype.  In an example for homozygous parents, virgin 
females of the genotype ey-Gal4/ey-Gal4 (on the second chromosome, expresses Gal4 in eye) 
can be crossed to males of the genotype UAS-Chmp1/UAS-Chmp1 (on the third chromosome, 
allows expression of Chmp1) to generate progeny over-expressing Chmp1 in the eye (Figure 
1.7A). Using a Punnett Square to track each chromosome would show that all offspring obtained 
from this cross will be of the genotype: ey-Gal4/+; UAS-Chmp1/+. Therefore, 100% of the 
offspring will over-express Chmp1 in the eye.  
However, there are many cases in which the flies to be crossed are not homozygous 
viable for the mutation or transgene of interest, and so are balanced in the heterozygous state. In 
an example of heterozygous parents, virgin females of the genotype ey-Gal4/CyO can be crossed 
to males of the genotype UAS-Chmp1/TM3Ser, again to generate flies over-expressing Chmp1 in 
the eye (Figure 1.7B). However, this time the Punnett Squares would show that there are several 
possible genotypes in the offspring. On the second chromosome, the genotype of the progeny 
will be either ey-Gal4/+ or CyO/+. On the third chromosome the genotype will be either UAS-
Chmp1/+ or TM3Ser/+. So only flies that are not Cy (curly wings) and not TM3Ser (notched 
wings) will be of the correct genotype. This example shows how quickly crosses can become 
complex, and at the same time illustrates the utility of balancer chromosomes and dominant 
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markers. Without balancers in this scenario, it would be much more difficult to know which 
offspring were of the correct genotype.  
 
 
III.  The DER pathway 
The DER pathway (Figure 1.8) is involved in multiple stages of development and in 
multiple tissues in Drosophila, including but not limited to embryogenesis, oogenesis, and wing 
and eye development [31]. The DER is a traditional receptor tyrosine kinase (RTK) that signals 
through the Mitogen-Activated Protein Kinase (MAPK) pathway. The DER is expressed almost 
ubiquitously in the fly, so the patterned DER signaling that is required throughout development 
is specified through localized expression/activation of activators and repressors of the DER.  
Figure 1.7 Examples of crosses in Drosophila. A. When crossing two homozygous stocks to 
drive expression of a transgene using UAS-Gal4, all offspring are of the correct genotype. B. 
Crosses are more complicated when dealing with heterozygous stocks. Only a quarter of the 
offspring will have the correct genotype. The dominant markers on balancer chromosomes are 
very useful in this situation, as they help to keep track of the chromosomes in the progeny. P is 
parental generation, F1 is the first filial generation. GOI = gene of interest. Roman numerals 
represent the chromosome on which the transgenes are located: II = second chromosome, III = 
third chromosome.  
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The DER has four activating ligands: Vein (Vn), Spitz, Gurken, and Keren. Gurken is an 
activator of the DER limited to the oocyte where it is required for early development in 
Drosophila [32]. Spitz is similar to the mammalian ligand, TGFα, and is the primary DER 
activating ligand during the development of most Drosophila tissues [33-35]. Spitz, Gurken, and 
Keren are all expressed as transmembrane proteins that must be cleaved by Rhomboid (Rho), a 
transmembrane protease that resides in the Golgi, in order to become active [32, 34, 36-38]. 
Additionally, these transmembrane activating ligands require the activity of Star, which is 
involved in the trafficking of these proteins from the endoplasmic reticulum to the Golgi where 
they are cleaved by Rho [37].  Vn is different from the other activating DER ligands in that it is 
secreted and constitutively active [39]. Comparatively, Vn is a weak activator of the DER, but it 
acts as a major ligand during wing, leg, and muscle development [40-42].  
There are three inhibitors of DER signaling that were investigated in this study: Argos 
(Aos), Kekkon-1 (Kek-1) and Sprouty (Sty). Argos is a secreted protein that binds to the 
activating ligand Spitz, inhibiting its ability to activate the DER [43, 44]. Kek-1 is a 
transmembrane protein that binds and inhibits the DER, so its inhibiting ability is limited to the 
cell that expresses it [45, 46]. Sty is a general intracellular inhibitor of tyrosine kinase signaling, 
as it inhibits Ras1 [47]. The DER is the only RTK known to signal during the development of the 
Drosophila wing. 
Activation of the DER by ligand binding is followed by dimerization, phosphorylation 
and activation of a classical RTK signaling cascade through Ras and the MAPK pathway. In 
Drosophila, the activated receptor binds the adaptor protein Downstream of Receptor Kinase 
(Drk, mammalian GRB2 homologue), which then activates the guanine nucleotide exchange 
factor, Son of Sevenless (SOS). SOS then activates Ras1 by exchanging guanosine diphosphate 
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(GDP) for guanosine triphosphate (GTP). Ras1 then activates the MAPKKK, Raf1, which 
phosphorylates and activates the MAPKK, Downstream of Ras1 (DSOR1). DSOR1 then 
phosphorylates and activates the MAPK, Rolled (mammalian ERK homologue). In the nucleus, 
Rolled induces changes in gene expression, including the repression of Blistered (Bs) through 
phosphorylation of transcription factors, including Yan and Pointed [48, 49]. 
Proper cell signaling requires regulation of activation cellular signaling. Signaling 
pathways must be activated at the proper time. Additionally, it is crucial for signaling to be 
down-regulated when appropriate. Many receptors, including the DER, require a group of 
protein complexes called the Endosomal Sorting Complexes Required for Transport (ESCRT) 
for proper down-regulation. 
 
 
 
Figure 1.8 A simplified diagram of the DER pathway. Vein (Vn) is a secreted activating 
ligand of the Drosophila Epidermal Growth Factor Receptor (DER). Rhomboid (Rho) activates 
the DER from the Golgi by cleaving the transmembrane proteins Spitz, Gurken, and Keren (not 
shown) into DER activating ligands. When the DER is active, it activates the canonical MAPK 
pathway. Ras1 activates Raf1 (a MAPKKK), which phosphorylates Downstream of Ras1 
(DSOR1, a MAPKK), which phosphorylates Rolled (homologue of ERK1/2, a MAPK). One 
effect of DER signaling is repression of Blistered (Bs) expression. Argos (Aos), Kekkon-1 
(Kek-1) and Sprouty (Sty) negatively regulate DER signaling. Positive regulators are in green, 
negative regulators are in red. 
21 
 
IV. The ESCRT machinery 
The membrane of a cell is decorated with membrane receptor proteins that work to 
transmit an extracellular signal to the inside of the cell. Many of these are transmembrane 
receptors, such as the DER, that follow a classical signaling cascade: the signal (a ligand) binds 
the extracellular portion of the receptor, causing a conformational change in the receptor that 
relays the signal to the inside of the cell and usually results in changes in gene expression. As 
important as it is for a cell to be able to recognize and transmit the signal, down-regulation of the 
signal is also crucial for proper cellular signaling. The multivesicular body (MVB) pathway is 
one method of signal down-regulation of activated transmembrane receptors in the cell. MVB 
generation requires the ESCRT (Endosomal Sorting Complexes Required for Transport) protein 
complexes, which are highly conserved in eukaryotes. These complexes are involved in many 
cellular processes in addition to MVB generation, including HIV budding, membrane abscission 
during cytokinesis, autophagy, sorting lysosomal/vacuolar proteins from the Golgi, and others 
[50-55]. Essentially, the ESCRT complexes modify the shape of cellular membranes. All of the 
processes mentioned above are similar membrane modification events. They involve the 
deformation and budding of the membrane away from the cytoplasm to form a vesicle, followed 
by scission, or “pinching off” of the membrane. For example, during HIV budding, ESCRTs aid 
in the budding of the plasma membrane away from, i.e., out of the cell. There are four ESCRT 
complexes that are recruited sequentially to membranes through lipid and proteins interactions: 
ESCRT-0, -I, -II, and –III, as well as the Vacuolar Protein Sorting 4 (Vps4, Suppressor of K+ 
transport growth defect [SKD1] in humans) complex and several accessory proteins. However, 
some ESCRT-mediated processes do not require all of the ESCRT complexes. For example, 
ESCRT-II is not required for HIV budding or cytokinesis [56, 57].  
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MVB formation is the best described of all ESCRT-mediated cellular process and it 
requires the activity of all four ESCRT complexes. As mentioned above, the MVB pathway is 
important for regulation of cellular signaling pathways through down-regulation of 
transmembrane receptors. At the membrane, activated receptors are ubiquitinated and 
endoytosed into the endosome. The ESCRT machinery aids in the formation of the MVB from 
the endosome by mediating the invagination of the late endosomal membrane to form 
intralumenal vesicles (ILVs) (Figure 1.9A). This separates the receptors from the cytoplasm, 
thereby silencing the signals. The ILVs are then sorted to the lysosome where the receptors are 
degraded. Many membrane receptors have been reported to require ESCRT components for 
proper signaling in Drosophila and cultured mammalian cells, including the Epidermal Growth 
Factor Receptor (EGFR) and the Notch receptor [50, 58-61]. 
Ubiquitin acts as a sorting signal to target proteins, either activated membrane receptors 
or endosomal proteins from the trans-Golgi network to the endosome [62, 63]. MVB formation 
begins at the endosome with the ESCRT-0 complex, which organizes ubiquitinated cargo on the 
membrane into clusters and recruits deubiquitinating enzymes. ESCRT-I and –II assemble next 
on the membrane and begin the inward budding of the MVB membrane. Next, ESCRT-III is 
recruited and provides the scission activity of the ESCRT machinery. It still is not completely 
clear how this occurs and several models have been proposed [64, 65]. Studies have shown in 
vivo and in vitro that ESCRT-III components homo- and heteropolymerize with each other on 
membranes to form helical structures in circular arrays [66-69]. One model for membrane 
scission is that the ESCRT-III components oligomerize on the MVB membrane in a spiral and 
constrict the neck of the ILV (Figure 1.9B). Then the Vps4 complex binds and mediates the 
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disassembly of the ESCRT-III complex in an ATP-dependent process, completing MVB 
formation and recycling the ESCRT components back to the cytosol.  
 
 
The ESCRT-III complex is required for all ESCRT-mediated activities and provides the 
core function of the ESCRT machinery, which is the scission activity or “pinching off” of the 
membrane [70, 71]. ESCRT-III components are recruited late during ESCRT processes and are 
only transiently present on the membrane [72, 73]. Most of the proteins that make up the 
ESCRT-III complex are known as Chmps and they are highly conserved among eukaryotes. 
There are seven Chmps (1-7), all of which are structurally similar. Chmps have a charged five 
helical core, a basic helical N-terminus that targets localization to membranes, and an acidic C-
terminal region that often binds regulatory factors through a MIT (microtubule interaction and 
transport) -interacting motif (MIM) [74-76]. The MIM allows Chmps to bind proteins that 
contain MIT domains [77]. The C-terminal region of Chmps can bind and autoinhibit the N-
Figure 1.9 ESCRT-III function on the endosome. A. A multivesicular body (MVB) is 
formed by formation of intralumenal vesicles (ILVs) from the membrane of the late endosome. 
The ILVs contain activated receptor proteins (green and yellow) from the cell membrane. 
ESCRT-III components (red) assemble at the neck of the forming ILV (indicated by black 
arrow) and mediate the scission of the membrane. B. A view looking down onto the endosomal 
membrane (blue) on the constriction neck of the forming ILV. ESCRT-III components (red 
spiral) assemble into helical tubes and form a ring structure that closes the neck (dark blue) of 
the ILV. 
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terminal region to form a closed, or inactive conformation of the protein. This blocks membrane 
localization and interaction with other proteins [78, 79]. The open, or active, conformation is 
able to bind regulatory proteins and also allows for homo- and heterodimerization of Chmps [75, 
80]. It is not known what causes the change in conformation from inactive to active protein. 
V. Structure and function of Chmp1 
A. Chmp1 Structure 
Chmp1 (Chromatin Modifying Protein; Charged Multivesicular Protein) is a component 
of the ESCRT-III complex. Chmp1 is highly conserved from simple to complex eukaryotes and 
is known by different names in different organisms: Chmp1 (Drosophila melanogaster), 
VPS46p/Did2p (Saccharomyces cerevisiae), and Sal1 (Zea mays). To avoid confusion, I will 
refer to all homologues as Chmp1 from now on. Many organisms, including yeast, Drosophila, 
and some plants, express a single Chmp1 protein. Other organisms, including many insects, 
zebrafish, mammals and Arabidopsis thaliana express two Chmp1 proteins that are similar in 
sequence, called Chmp1A and Chmp1B. Chmp1 is a charged protein, about 200 amino acids in 
length. The N-terminus contains a nuclear localization sequence (NLS) and the extreme C-
terminal region contains a MIM, (D/E/Q)-XX-L-XX-(Q/R)L-XX-L(K/R), where the indicated 
amino acids are those known to be involved in binding to an MIT domain  (Figure 1.10) [81-84]. 
A protein BLAST identified two conserved domains in the Drosophila Chmp1 sequence, a Snf7 
domain and a Vps24 domain (Figure 1.10). The Snf7 domain is found in the SNF multidomain 
family proteins that are involved in protein sorting and transport from the endosome to the 
vacuole/lysosome in eukaryotes. The Vps24 domain is found in a superfamily of conserved 
proteins involved in secretion. Additionally, an analysis of the primary amino acid sequence of 
Drosophila Chmp1 using protein structure prediction software Jpred3 (University of Dundee) 
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identifies 5 alpha helices, consistent with previous analyses of Chmp structures (Figure 1.10) 
[76].  
 
 
Published studies on Chmp1 have mostly been performed in either yeast or mammalian 
cell culture. These studies have identified roles for Chmp1 in regulating growth, protein sorting, 
and mitosis, and have found evidence of two seemingly distinct roles for Chmp1 in the nucleus 
and in the cytoplasm.  
A. Chmp1 and survival 
Most investigations of Chmp1 function have been performed in cell culture. However, a 
few studies have been performed in developing organisms and addressed the essentiality of 
Chmp1 for survival. In Nicotiana benthamiana, a close relative of the tobacco plant, loss of 
Chmp1 activity had no apparent negative effect on development or viability and only caused 
slight changes in leaf morphology and color [85]. Additionally, in the filamentous fungus 
Aspergillus nidulans, Chmp1 was not essential for survival [86]. On the other hand, in 
Arabidopsis thaliana, Chmp1A/1B mutation caused lethal developmental defects in embryos 
[87]. The results of these studies are inconsistent, suggesting that the requirement of Chmp1 for 
survival is different depending upon the organism. Given the conservation of the Chmp1 
Figure 1.10 Chmp1 protein structure in Drosophila. The Drosophila Chmp1 protein is 203 
amino acids in length. It contains putative Snf7 (green) and Vps24 (purple) domains, as well as 
5 alpha helices (red). It has a basic N-terminus and an acidic C-terminus. The N-terminal region 
contains a nuclear localization sequence (NLS, blue) and the C-terminal region contains a MIT-
interaction motif (MIM, yellow). 
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sequence and ESCRT function, it is possible, and likely, that Chmp1 is involved in the same 
cellular processes across species. However, it seems that the overall consequences of Chmp1 
loss, i.e., the developmental defects that may be caused by mis-regulation of signaling pathways, 
vary between organisms. 
B. Control of growth 
Studies in plant and mammalian cell culture, as well as in zebrafish and plants, suggest 
that Chmp1 plays a role in regulation of growth. However, the results of these studies on are 
inconsistent. While some studies suggest that Chmp1 negatively regulates growth, others suggest 
that Chmp1 positively regulates growth.  
Several in vitro studies have suggested Chmp1 has a role in controlling growth, 
specifically proposing that Chmp1 is a novel tumor suppressor. For example, in HEK293T 
(Human Embryonic Kidney, non-tumorigenic) and PanC1 (human pancreatic ductal tumor) 
cultured cells, knockdown of human Chmp1A promoted cell growth [88, 89]. On the other hand, 
over-expression of human Chmp1A halted the cell cycle in S-phase in EcR-293 cells (human 
embryonic kidney, stably expresses the ecdysone receptor), and also reduced cell growth in 
PanC1 and A498 (renal cell carcinoma) cell lines, compared to controls [81, 88, 89]. Together, 
these studies suggest Chmp1 negatively regulates cell growth. 
A few in vivo studies also support a role for Chmp1 as a negative regulator of growth and 
even as a tumor suppressor. Similar studies from two different labs showed that HEK293T cells 
with reduced human Chmp1A activity formed tumors when injected into nude mice, while 
control HEK293T cells did not [88, 89]. Interestingly, when tumorous cells, either PanC1 or 
A498, were injected into mice and tumors formed, over-expression of human Chmp1A, either by 
Dox activation or injection of a Chmp1 over-expression plasmid, reduced the growth of the 
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tumor [88, 89]. Additionally, reduction of Chmp1A activity has been linked to pancreatic and 
renal cancer in humans, as these tumors showed a considerable reduction of Chmp1 activity [88-
90]. Taken together, these data strongly support a role for Chmp1 as a negative regulator of 
growth, and possibly as a tumor suppressor.  
Contrary to the evidence for Chmp1 as a tumor suppressor, some studies showed that loss 
of Chmp1 had the opposite effect that would be expected from a tumor suppressor. For example, 
in the study with Aspergillus nidulans, loss of Chmp1 caused conidiation (production of asexual 
spores) and impaired growth [86]. Additionally, in the Arabidopsis thaliana study, a Chmp1A/1B 
mutant caused stunted growth in seedlings [87]. Of course, this might be attributed to the 
requirement for Chmp1A/1B for survival in this species, rather than a specific effect on growth. 
However, in 2013 a study in humans linked homozygous Chmp1A mutations to pontocerebellar 
hypoplasia (small, underdeveloped cerebellum) and microcephaly (small head) [91]. The same 
study showed that cells grown in culture from the Chmp1A-mutant individuals had a very slow 
growth rate [91]. Additionally, Chmp1A knockdown in zebrafish reduced the size of the 
cerebellum and forebrain [91]. Together, these studies suggest a possible role for Chmp1 in 
positive regulation of growth. 
There is also evidence of a role for Chmp1 in regulating cell fate decisions. In Zea mays 
(maize), loss of the Chmp1 homologue supernumerary aleurone layers 1 (sal1) caused extra 
layers of aleurone cells to form in cultured endosperm [92, 93]. Though this could be an over-
growth phenotype caused by over-proliferation, the authors of this study claimed that it was due 
to increased fate specification of aleurone cells caused by faulty endosomal trafficking [92, 93].  
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C. Chmp1 in the nucleus 
Chmp1was first discovered in a yeast two-hybrid screen for conserved proteins that 
interacted with the mammalian Polycomb-group (PcG) protein, polycomblike (mPcl1), and the 
Drosophila homolog, Pcl [81]. The PcG proteins, which were discovered in Drosophila, are a set 
of proteins that induce chromatin condensation, mediating gene silencing epigenetically during 
development. Chmp1 interacted with Pcl, suggesting that it may play a role in gene silencing. 
Additionally, a bipartite NLS was found within the Chmp1 N-terminus [81]. The NLS is a 
conserved feature of the Chmp1 sequence. In Nicotiana benthamiana the Chmp1 N-terminus 
(but not the whole protein) localized to the nucleus [85]. Chmp1 was also detected in the nucleus 
in zebrafish and human cultured cells [81, 90, 91]. So it is possible that, although the Chmp1 
protein may normally localize to the cytosol, it is targeted to the nucleus upon an unknown cell 
signal. 
On western blots, the human Chmp1 protein is detected as a doublet with bands at 32kD 
and 35kD, and cell fractionization studies showed that these bands corresponded to cytoplasmic 
and nuclear Chmp1, respectively [81].  Twelve years after the initial discovery of the two Chmp1 
bands, it was reported that they are likely due to different phosphorylation states of human 
Chmp1, as phosphatase treatment of cellular lysates resulted in a single band [94].  This study 
reported the identification of three phosphorylation sites within the human Chmp1 C-terminus 
[94].  
Interestingly, the nuclear form of human Chmp1 was only detectable by immunostaining 
during M phase of the cell cycle. It was closely associated with chromatin and recruited the PcG 
protein and transcriptional repressor, BMI1, to condensed chromatin [81]. Supporting this study, 
more recent investigation showed a genetic interaction between Chmp1 and BMI1 in zebrafish, 
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which suggested that they function together in regulating gene expression during neural 
development [91]. This same study showed that cultured cells from humans carrying Chmp1A 
mutations expressed high levels of the cell cycle regulator and tumor suppressor protein INK4, 
whose expression is normally suppressed by BMI1. The function of BMI1 was likely reduced 
due to the Chmp1A mutation, supporting a functional interaction between BMI1 and Chmp1. 
Although Chmp1 and BMI1 did not co-localize in zebrafish, this finding supports previous 
results suggesting a function for Chmp1 in negatively regulating gene expression [91]. 
Additional studies demonstrate interaction of Chmp1 with other nuclear proteins. In 
2009, a study connected Chmp1 with All-trans Retinoic Acid (ATRA) signaling [95]. The study 
found that over-expression of human Chmp1A in PanC1 cells reduced cell growth and increased 
cellular levels of retinol binding protein 1 (CRBP-1) [95]. Treatment of PanC1 cells with ATRA 
caused an increase in total Chmp1A protein, as well as an increase in nuclear Chmp1A [95]. This 
increase in Chmp1A nuclear localization suggested a function for Chmp1A in the nucleus. 
Additionally, the same group showed that Chmp1A may regulate Ataxia Telangiectasia Mutated 
(ATM) through activating phosphorylation [90]. They showed that over-expression of human 
Chmp1A activated ATM and that Chmp1A colocalized with ATM in the nucleus and also 
increased the amount of phospho-p53 in the nucleus [89, 90]. Although ATM could be activated 
when the Chmp1A MIM was deleted, the increase in phospho-p53 in the nucleus required the 
NLS in the N-terminal region of Chmp1A, suggesting a nuclear requirement for Chmp1A [90]. 
p53 is a substrate for ATM, so the results of this study suggested that the ability of over-
expressed Chmp1A to reduce cell growth might have been mediated through ATM signaling.  
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D. Chmp1 in the cytoplasm 
Chmp1 also plays a role in the cytoplasm as a component of the ESCRT-III complex in 
MVB generation. Many localization studies, from yeast to plants to mammalian cell culture 
support this role for Chmp1, showing that it localizes in the cytoplasm to early and late 
endosomes [85, 86, 90, 91, 93, 96, 97]. Information from studies in yeast, fungus, and cell 
culture help to delineate the steps of MVB formation that require Chmp1. Late in the ESCRT 
pathway, Chmp1 is recruited to the endosomal membrane. Then, through the MIM, Chmp1 binds 
the MIT domain protein, AAA-ATPase Vps4 [82]. This binding mediates the ATP-dependent 
dissociation and recycling of ESCRT-III complex, completing MVB formation [96, 98]. This 
model for Chmp1 function is consistent with cell fractionization studies with human Chmp1, 
showing that most of Chmp1 in the cell is soluble, but some is peripherally associated with 
membranes [97]. It appears that binding of Chmp1 to Vps4 to mediate ESCRT-III disassembly is 
not crucial for MVB biogenesis, as MVBs are still formed when Chmp1 function is lost in yeast 
and Aspergillus nidulans [86, 96]. However, Chmp1 mutations do cause protein trafficking 
defects: in Arabidopsis, Chmp1A/1B mutation reduced the number of ILVs detected in the MVB; 
in human cell culture, expression of a functionally mutant Chmp1 protein caused enlarged 
endosomes; and in yeast, Chmp1 mutations caused accumulation of ESCRT-III components on 
endosomes [78, 87, 96, 97]. Additionally, studies show that Chmp1 mutations in yeast, 
Aspergillus nidulans, and Arabidopsis thaliana cause broad protein sorting defects, i.e., protein 
transport from Golgi to MVB is altered [82, 86, 87, 96]. Of course, it is possible that Chmp1 has 
different or additional roles in different organisms. Therefore, studies in yeast and plants may not 
be equivalent to flies or humans.  
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Many of the studies discussed above suggest that Chmp1 plays a role in the nucleus, as 
well as the cytoplasm. In the cytoplasm, Chmp1 is required for proper ESCRT-III function 
during MVB generation, protein sorting, and cytokinesis. Chmp1 is also involved in 
chromosome stability and gene silencing, but it remains unknown how Chmp1 interacts with 
chromatin. There are reports of ESCRT components in the nucleus, including the tumor 
suppressor and ESCRT-I component, Tumor Susceptibility Gene 101 (Tsg101) [99]. 
E. Chmp1 and mitosis 
Mutations in Chmp1 can result in severe mitotic/cytokinetic defects. In HeLa cells 
knockdown of both Chmp1A and Chmp1B was associated with multiple defects during mitosis, 
including multinucleated cells, fragmented nuclei, unaligned metaphase chromosomes, visible 
midbodies (Flemming bodies, narrow intracellular bridges dense with microtubules that connect 
two daughter cells near the end of cell division), and multipolar spindles [69, 100]. Although 
human Chmp1A and Chmp1B are similar in sequence to Chmp1 in other species, they may have 
separate functions. Unlike human Chmp1A, human Chmp1B is involved in membrane abscission 
during cytokinesis in cell culture, where it recruits and binds Spastin, a microtubule-severing 
enzyme, at the midbody [69, 77, 101]. Indeed, in HeLa cells knockdown of both human Chmp1A 
and Chmp1B induced cytokinesis arrest [69]. This implies that the ESCRT-III complex may 
recruit a different version of the Chmp1 protein depending on the cellular process involved. 
Chmp1A and Chmp1B may have different binding partners (see below), giving the ESCRT 
machinery a way of recruiting different proteins for different jobs in the cell.  
F. Conserved binding partners of Chmp1 
Chmp1 has multiple known binding partners, many of which are part of the ESCRT 
machinery and most of which are conserved between species. For example, through its MIM 
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motif, Chmp1 in Aspergillus nidulans and yeast binds the MIT of the ATPase, Vps4/SKD1 [82, 
84, 86, 96]. Chmp1-Vps4 binding was also observed in Arabidopsis thaliana and human cultures 
cells, and was required for completion of MVB biogenesis and the disassociation of ESCRT-III 
complexes from the MVB membrane [75, 83, 84, 87, 96, 97]. Multiple studies in human cells 
and yeast showed that Chmp1 also binds Increased Sodium Tolerance-1 (Ist1), a component of 
the Vps4 complex that inhibits Vps4 activity [69, 94, 102-104]. Studies in yeast, Arabidopsis, 
and human cultured cells showed an interaction with Chmp1 with the MIT domain protein LIP5 
/Vta1p (Lyst-interacting protein 5/ Vps twenty associated 1 protein), an important component of 
the Vps4 complex which binds and activates Vps4 [84, 87, 98, 105-107]. Human Chmp1A and 
1B also bound the endosome associated ubiquitin hydrolases, AMSH (Associated Molecule with 
the SH3-domain of STAM) and UBPY (Ubiquitin-specific processing Protease Y) [75, 108]. 
Additionally, the first study that identified Chmp1 in human cells showed that it physically 
interacted with both the human and Drosophila PcG protein, Pcl [81]. Human Chmp1 proteins 
also interact with each other, through both homodimerization and heterodimerization with other 
Chmps [75]. All of these proteins reported to bind Chmp1 are either ESCRT components (i.e. the 
Chmps) or recruited to the site of ESCRT activity (e.g. Vps4, AMSH). 
Many organisms, including humans, express two Chmp1 proteins: Chmp1A and 
Chmp1B. Their sequences are similar, and they share many binding partners, they do not share 
the same binding affinities. For example, human Chmp1A and 1B both interacted and 
colocalized with Calpain-7, a calcium-dependent cysteine protease, but Chmp1B bound much 
more strongly than Chmp1A [109]. Additionally, Chmp1B associated with the ATPase Spastin 
during cytokinesis, but Chmp1A did not [77, 101]. 
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G. Binding partners of Drosophila Chmp1 
There have been no functional studies on Chmp1 in Drosophila. However, Chmp1 has 
been included in some large scale protein interaction studies, including the Drosophila Protein 
Interaction Map (DPiM), the goal of which is to generate a protein interaction map of the entire 
Drosophila proteome [2, 110, 111]. These have identified many binding partners for Chmp1 in 
Drosophila (Table 1.3). Interestingly, although several of these proteins are involved in protein 
transport and phagocytosis, both of which are known to require ESCRTs, other cellular processes 
are represented. Of the 27 binding partners of Chmp1, 5 play a role in translation, 6 in mRNA 
processing, and 2 in regulation of gene expression. This suggests that Chmp1 may play a role in 
regulation of gene expression, possibly at the level of translation. However, it is important to 
note that these interactions were identified through co-immunoprecipitation and mass 
spectroscopy, and so are purely physical and have not yet been confirmed through genetic 
studies in Drosophila. Interactions between Chmp1 and several of the binding partners listed, for 
example, CG10103, Vps4, and Chmp4B, have been observed in other organisms as well [69, 75, 
82, 86, 97]. This suggests that these interactions are conserved and are therefore much more 
likely to be true binding partners in Drosophila. 
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Table 1.3 Protein interactions with Drosophila Chmp1. *Predicted function based on 
sequence similarity. Information retrieved from [2]. 
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CHAPTER 2 
RATIONALE, SPECIFIC AIMS AND HYPOTHESIS  
I. Rationale 
Many cellular signaling pathways share a common cascade structure, in which an 
extracellular signal is transmitted into the cell through a transmembrane receptor, ultimately 
causing a change in gene expression. Down-regulation of the signal is crucial for proper cellular 
function. One method for down-regulation of activated transmembrane receptors is the MVB 
pathway, which utilizes the ESCRT protein complexes, 0, I, II, and III. The ESCRT-III complex 
provides the core function of the ESCRT machinery, which is the scission of the neck of the ILV 
at the MVB. This step is crucial for MVB biogenesis, as failure to complete ILV formation 
impedes down-regulation of the receptor and leads to prolonged signaling to the cytoplasm.  
Chmp1 is a component of the ESCRT-III complex. As an ESCRT-III component, Chmp1 
binds the AAA ATPase Vps4, which completes formation of the ILV and mediates 
disassociation of the ESCRT-III components from the MVB membrane. There are numerous 
studies in yeast on Chmp1 and other ESCRT components, which focus heavily on the physical 
binding domains and partners of Chmp1. Other work in mammalian cell culture focuses mainly 
Chmp1 as a regulator of growth. Many of the results of these studies are contradictory. For 
example, results of over-expression and knockdown studies have linked Chmp1 to pancreatic and 
renal cancers in humans, and identified Chmp1 as a putative tumor suppressor [81, 88-90, 92, 
95]. On the other hand, some studies show that loss of Chmp1 has minimal negative effects on 
cellular function, and others that loss of Chmp1 impairs growth, which seems to contradict its 
role as a tumor suppressor [85-87, 91].  
36 
 
As most information on the activity of Chmp1 has been inferred from its biochemical 
interactions or from studies of single cells, little is known about its role in tissue development 
and differentiation. Indeed, few studies have investigated the mechanisms, i.e., genetic or 
biochemical pathways, underlying the Chmp1 phenotypes that have been reported. Two studies 
from the Park lab suggest the effect of Chmp1 on growth is due to its role in the nucleus, as it 
appears to be involved in ATRA and ATM/p53 signaling [89, 90, 95]. Another study showed 
that Chmp1 may regulate expression of the BMI-INK4 locus in humans, and suggested that 
Chmp1 functions in the nucleus through a physical interaction with BMI [91]. Apart from these 
few studies, however, there is little information about the pathways by which Chmp1 has an 
effect on cell development and differentiation. In addition, the only studies on the role of Chmp1 
in a multicellular organism have been completed in plants or fungus, rather than in an animal 
model [85-87, 92].  
No investigation of Chmp1 function in invertebrates has been published. Drosophila 
provides an easily manipulated model system for the analysis of Chmp1 function and its 
importance for development. In this research, the effects of loss (knockdown) and gain (over-
expression) of Chmp1 activity on tissue development were investigated with the aim of 
identifying the genetic or biochemical pathways Chmp1 may regulate. Because Chmp1 has not 
been studied in Drosophila, resources are limiting, i.e., no Chmp1 mutant or antibody exists. 
However, with the development of the genome-wide Drosophila RNAi libraries, the effects of 
loss of Chmp1 activity could be investigated with Chmp1 mRNA knockdown. Additionally, 
transgenic fly lines that can express either wild-type or epitope-tagged Chmp1 protein were 
generated to investigate effects of Chmp1 over-expression, as well as Chmp1 subcellular 
localization. The results of these studies should help to characterize the cellular function of 
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Chmp1. Additionally, the results should provide some mechanisms (e.g., regulation of cellular 
signaling pathways) underlying Chmp1 phenotypes. 
II. Specific Aims and Experimental Design 
A. Specific Aim 1: Establish that Drosophila is an appropriate model to investigate Chmp1 
function. Conservation of amino acid sequence, functional domains, and protein interaction 
domains would suggest that Chmp1 function is conserved between flies and other species. 
Therefore, conclusions obtained from studies on Chmp1 function in Drosophila would be 
suggestive of its function in other organisms. 
1. Align Drosophila and human Chmp1 protein sequences to identify the degree of sequence 
similarity. 
2. Identify conserved domains and binding partners through sequence analysis and data 
mining. 
B. Specific Aim 2: Investigate the effects of loss of Chmp1 in the developing fly. No Chmp1 
mutant exists, so loss of Chmp1 was investigated using fly lines that express RNAi specific for 
Chmp1 mRNA. Analysis of Chmp1 knockdown phenotypes in the fly should provide 
information to address the following questions: 
1. Is Chmp1 essential? No investigation of the essentiality of Chmp1 has been published in 
invertebrates. 
I. Verify that RNAi is effective and specific. RNAi is likely effective and specific if 
similar phenotypes are observed from the expression of Chmp1 RNAi with 
independently created RNAi lines.  
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II. Verify whether flies survive ubiquitous Chmp1 knockdown. Lethality associated 
with ubiquitous Chmp1 knockdown during fly development would suggest that 
Chmp1 is essential to development.   
2. What is the phenotypic effect of Chmp1 knockdown in specific tissues in the fly (i.e., the 
wing and eye)? Phenotypes obtained should give clues about which developmental 
pathways Chmp1 regulates. 
I. Knock down Chmp1 expression in the wing and eye using specific Gal4 drivers. 
Analyze the phenotypes that result and hypothesize which signaling pathways are 
altered by Chmp1 loss. 
3. What signaling pathways does Chmp1 regulate? 
I. Investigate whether the Chmp1 knockdown phenotype is enhanced/suppressed by 
altered activity of the specific developmental pathways identified in B.2.I. 
II. Investigate whether downstream targets of pathways regulated by Chmp1 are 
affected when Chmp1 is knocked down. 
C. Specific Aim 3: Investigate the effects of gain of Chmp1 in the developing fly. No fly line that 
allows for Chmp1 over-expression exists, so transgenic fly lines were generated that allow for 
expression of wild-type or his-myc (HM)-tagged Chmp1 protein. Analysis of Chmp1 over-
expression phenotypes in the fly should provide information to address the following questions: 
1. What is the phenotypic effect of Chmp1 over-expression in specific tissues in the fly (i.e., 
the wing and eye)? Phenotypes observed should give clues about which developmental 
pathways Chmp1 regulates. 
39 
 
I. Verify that Chmp1 over-expression lines express functional Chmp1 protein. 
Rescue of Chmp1 knockdown by Chmp1 over-expression would suggest that the 
transgenic fly lines generated express functional Chmp1 protein. 
II. Over-express Chmp1 in the eye and wing of the fly using specific Gal4 drivers. 
Analyze the phenotypes that result and hypothesize which signaling pathways are 
altered by Chmp1 over-expression. 
2. What signaling pathways does Chmp1 regulate? Investigate whether the Chmp1 over-
expression phenotype is enhanced/suppressed by altered activity of specific 
developmental pathways identified in C.1.II. 
D. Specific Aim 4. What is the subcellular localization of Chmp1 in fly tissues? No antibody has 
been developed specifically against Drosophila Chmp1. To investigate subcellular localization of 
Chmp1 protein, express HM-Chmp1 in tissues of the developing fly (i.e., embryos and larval 
tissues). 
1. How does HM-Chmp1 localize in cells of fly tissues? It is reported that Chmp1 functions 
in the cytoplasm and the nucleus. The subcellular localization of HM-Chmp1 should 
indicate where Chmp1 functions in Drosophila cells.  
I. Express HM-Chmp1 in the embryo and larval tissues using specific Gal4 
drivers. Detect HM-Chmp1 localization with an anti-c-Myc antibody. 
2. Does HM-Chmp1 localize to the endosome? 
I. Express HM-Chmp1 in the embryo using specific Gal4 drivers and 
investigate co-localization with endosomal markers, including Rab5 and 
Rab9, markers for the early and late endosome, respectively. 
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III. Hypotheses 
A. Sequence alignments suggest that the structure of Chmp1 is conserved across species. 
Hypothesis: Alignment of amino acid sequence between Chmp1 from flies and other 
species will likely indicate a high degree of sequence similarity. Therefore, Chmp1 
function as a component of the ESCRT-III pathway and in the nucleus is likely 
conserved in Drosophila. Additionally, conclusions inferred from studies in 
Drosophila should give insight into Chmp1 function in other species.  
B. & C. Chmp1 is a ubiquitously expressed protein and a component of the ESCRT-III 
complex, which is required for receptor down-regulation. Hypothesis: Chmp1 is 
essential for Drosophila development. Loss or gain of Chmp1 function will disrupt 
ESCRT-III function, including MVB biogenesis, and alter the activity of cell 
Figure 2.1. Experimental design 
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signaling pathways. The resulting phenotypes will provide clues as to which specific 
pathways are regulated by Chmp1. 
D.  Chmp1 is a component of the ESCRT-III complex, which is required for MVB 
biogenesis from the endosome. Numerous studies report Chmp1 localization to the 
early and/or late endosome. Chmp1 localization has also been observed in the 
nucleus. Hypothesis: Drosophila Chmp1 localizes to the endosome and nucleus. 
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CHAPTER 3 
MATERIALS AND METHODS 
I. Alignment of Chmp1 sequences 
Chmp1 protein sequences were obtained from the National Center for Biotechnology 
Information (NCBI) webpage (http://www.ncbi.nlm.nih.gov/). Accession numbers for protein 
sequences used are as follows: NP_649051.3 for Drosophila melanogaster Chmp1, 
NP_065145.2 for Homo sapiens Chmp1B, and NP_002759.2 for Homo sapiens Chmp1A. 
Conserved domains were identified through the NCBI webpage and confirmed in the literature 
when possible. Alignment of the Chmp1 protein sequences was performed through the European 
Bioinformatics Institute (EBI) webpage (www.ebi.ac.uk/ena/) using the program ClustalX. 
Identical residues were labeled with an asterisk, and similar residues were labeled with one or 
two dots, depending on the degree of similarity.  
II. Generation of transgenic fly lines 
Transgenic fly lines that express Chmp1 under the control of a Gal4 responsive UAS 
enhancer were generated. The clone GH26351, which contains Chmp1 cDNA in the pOT2 
vector, was obtained from the Drosophila Genomics Resource Center (DGRC). Two plasmids 
were used, pUAST and pUASHM, which allow for insertion into the Drosophila genome. The 
Chmp1 coding sequence was amplified by PCR with the following primer pairs (Invitrogen): 
UAS-HM-Chmp1 forward (GGGCCCGGATCCACGTCGCATATGTCTACGAGTTCCATGG) 
and UAS-HM-Chmp1 reverse (TACCACCTCGAGTTATTCAGCCTGGCGGAGACG) for 
insertion into pUASHM, and UAS-Chmp1 forward 
(ACGTCGGAATCCATGTCTACGGAGTTCCATGG) and UAS-Chmp1 reverse 
(TACCACCTCGAGTTATTCAGCCTGGCGGAGACG) for insertion into pUAST. These 
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primers added Nde1, Xho1, and EcoR1 restriction enzyme recognition sites (underlined) that 
allowed for insertion of the Chmp1 cDNA into the pUAST and pUASHM plasmids. Chmp1 
cDNA was inserted downstream of a UAS enhancer into the EcoR1/Xho1 sites of pUAST and 
the Nde1/Xho1 sites of pUASHM. The pUASHM vector allows the expression of Chmp1 protein 
tagged with an N-terminal His-Myc (HM) tag. The amplified and cloned Chmp1 sequence was 
verified by nucleotide sequencing. The UAS-HM-Chmp1 and UAS-Chmp1 plasmids were sent to 
BestGene Inc., where the transgenic flies were generated. Balanced stocks carrying the UAS-
HM-Chmp1 and UAS-Chmp1 transgenes were produced in the Collier fly lab. 
III. Fly stocks and genetics 
All flies were cultured on standard cornmeal/yeast media at 25oC, unless otherwise 
stated. The fly stocks used in this study are listed in Table 3.1. P[GD11219]v21788 (UAS-
Chmp1-RNAi VDRC) and P[GD1443]v33200 (UAS-forked-RNAi ) were obtained from the 
Vienna Drosophila Resource Center (VDRC).  TRiP.HM05117 (UAS-Chmp1-RNAi TRiP) was 
obtained from the Transgenic RNAi Project (TRiP) stocks at Harvard. N55e11/FM7Bar, UAS-
Dx17, and car1; dpp-Gal4/TM6b were a gift from Martin Baron. All other fly lines were from 
Bloomington Stock Center at Indiana University. Additionally, six transgenic fly lines were 
generated that were used in this study (Table 3.2): the UAS-HM-Chmp1-1 through UAS-HM-
Chmp1-4 lines can express HM-tagged Chmp1 protein; the UAS-Chmp1-1 and UAS-Chmp1-2 
lines can express wild-type Chmp1 protein. 
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IV. Mounting fly wings 
 Flies were anesthetized with CO2 and wings were dissected from flies using fine tipped 
forceps under a light microscope. Wings were mounted in Gary’s Magic Mountant (GMM), 
which is an approximately 1:1 mixture of Canada balsam and methyl salicylate. 
V. Measurements and statistics  
To quantify changes in vein thickness, the area of the L3 wing vein was measured from 
its junction with the anterior cross vein and for 200µm in the distal direction using ImageJ 
software [112]. At least 10 individual wings were measured for each genotype. For each wing, 
the L3 wing vein area was measured three times and the mean of the measurements was used for 
the quantification. Measurements for each genotype were represented in a box and whisker plot 
generated with Microsoft Excel 2007.  
To determine rescue of Chmp1 knockdown by Chmp1 over-expression, L3 wing vein 
areas of less than 3400µm2 were considered fully rescued. The value of 3400µm2 was chosen as 
Table 3.1 Fly stocks used. The white- fly stock carries a mutation in the white gene, the 
function of which is required for the red eye color present in wild-type flies. Transgenic fly 
stocks or mutants are often generated in flies with white eyes (white-), which is why the first 
chromosome is listed as an affected chromosome in nearly all of the stocks used in this 
study.  
Table 3.2 Fly lines generated in this study. 
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the threshold of complete rescue because of the wild-type wing veins measured, wing vein areas 
approached but were never more than 3400µm2. An L3 wing vein area of greater than 5200µm2 
was considered not rescued. The value 5200µm2 was chosen as the threshold of no rescue 
because of the Chmp1 knockdown wing veins measured, wing vein areas approached but were 
never less than 5200µm2. Therefore, L3 wing vein areas between 3400µm2 and 5200µm2 were 
considered partially rescued.  
All statistical analyses were performed using IBM SPSS Statistics software. First, a two-
tailed student’s t-test (p<0.05) was used to determine whether the mean L3 wing vein area of 
wild-type and Chmp1 knockdown wings were different. Then, a one-way ANOVA with a post-
hoc Dunnett’s t-test (p<0.05) was used to determine whether the mean L3 wing vein area of 
Chmp1 knockdown wings was different from wings expressing Chmp1-RNAi in varying genetic 
backgrounds (e.g., wings carrying heterozygous mutations for regulators of DER signaling, 
wings carrying heterozygous deletions of the Chmp1 gene, etc.). Statistically significant 
differences were denoted with an asterisk on the box and whisker plot. 
VI. Immunohistochemistry of embryos   
Embryos were collected for 20-24 hours onto a yeasted apple juice agar plate in an 
embryo collection bottle at 25oC, unless otherwise stated. The embryos were washed with 
distilled water into a mesh basket. The Drosophila embryo is protected by a shell composed of an 
outer chorion, as well as an inner impermeable vitelline membrane. These layers must be 
removed to use Drosophila embryos for immunostaining. The embryos were first dechorionated 
in 50% bleach solution and then washed well with distilled water. 0.5mL of 4% formaldehyde 
fix and 0.5mL of heptane were added to a microcentrifuge tube. The heptane and formaldehyde 
formed distinct upper (heptane) and lower (formaldehyde) layers. The embryos were collected 
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gently from the mesh basket with a fine brush and added to the microcentrifuge tube, where they 
settled to the bottom of the heptane layer. To fix the embryos, the microcentrifuge tube was 
shaken vigorously for 10 minutes. The fixative was then removed and the embryos were 
devitellinized by the addition of ice cold methanol, followed by shaking. The methanol was 
removed and followed by a second addition of ice cold methanol. The methanol was removed 
and the embryos were blocked for 1 hour in 0.1% bovine serum albumin in 0.1% PBS-Triton-X 
(BSA-PBST) with rotating. A fresh solution containing the primary antibody diluted in BSA-
PBST was added to the embryos in the microcentrifuge tube, and they were incubated for 1 hour 
to overnight (at 4oC if overnight) with rotating. After incubation with the primary antibody, the 
embryos were washed two times in BSA-PBST for 10 minutes each with rotating. A 
fluorescently-tagged secondary antibody diluted in BSA-PBST was added to the microcentrifuge 
tube containing the embryos, and they were incubated for 1 to 3 hours with rotating. The tube 
was wrapped in foil during this step and for the remainder of the protocol to shield the 
fluorescently tagged secondary antibody from light. After incubation with the secondary 
antibody, the embryos were washed two times in BSA-PBST for 10 minutes each with rotating. 
They were then mounted onto a glass slide in Vectashield mounting media with DAPI, sealed 
with nail polish, and stored at 4oC protected from light until the time of imaging. Embryos were 
imaged on a Leica confocal microscope. All steps were carried out at room temperature, unless 
otherwise stated.  
VII. Immunohistochemistry of imaginal discs  
Imaginal discs were dissected from crawling 3rd instar larvae in 1X PBS. Using forceps, 
the larva, with its dorsal side up, was held about a third or half way from its posterior end. Using 
a second pair of forceps, the anterior end of the larva was pinched and pulled anteriorly. If pulled 
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slowly, the wing discs are usually easily identified. To prevent damage to the discs by handling, 
they were left attached to either a portion of the head or the trachea of the larva, if possible. The 
discs were collected into a small mesh basket filled with 1X PBS contained in a well of a 24 well 
plate. The basket was moved to a new well for each solution used in the following protocol. The 
discs were fixed in 4% formaldehyde fix for 20 minutes to 1 hour with rocking. They were 
washed twice for 30 minutes each in 1mL of 0.1% bovine serum albumin in 0.1% PBS-Triton-X 
(BSA-PBST) with rocking. The discs were blocked in 1mL BSA-PBST for 1 hour with rocking. 
They were then incubated in 1mL primary antibody diluted in BSA-PBST and incubated for 1 
hour to overnight (at 4oC if overnight) with rocking. Then, the discs were incubated with the 
fluorescently-tagged secondary antibody and incubated for 1 to 3 hours with rocking. During this 
incubation and the remaining steps of the protocol, the discs were protected from light. The discs 
were then washed twice in 1mL of BSA-PBST for 30 minutes each with rocking. Under a 
dissecting microscope, the wing discs were dissected away from the head/trachea in 80% 
glycerol on a glass microscope slide. The discs were mounted in Vectashield mounting media 
with DAPI onto a microscope slide and imaged using a Leica confocal microscope. All steps 
were carried out at room temperature, unless otherwise stated.   
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VIII. Antibodies used for immunostaining  
 
 
IX. Eye preparation and sectioning  
 Flies were anesthetized on a CO2 pad, the heads were cut off using a scalpel, and very 
carefully a part of one eye was cut off to allow for penetration of the fixative. The heads were 
transferred to 200μL of 2% gluteraldehyde in 0.1M sodium phosphate buffer pH 7.2 in a 
microcentrifuge tube on ice. The heads were fixed for 10 minutes and spun in a microcentrifuge 
for 1 minute at 10,000 rpm. Then 200μL of 2% OsO4 in 0.1M sodium phosphate buffer pH 7.2 
(osmium solution) was added and the eyes were fixed for 1 hour on ice. The 
gluteraldehyde/osmium solution was replaced with 200μL of osmium solution and the eyes were 
incubated on ice for 1-6 hours. The fixative was removed and the eyes were dehydrated in 10 
minute steps with an ethanol (EtOH) series on ice: 30%, 50%, 70%, 90%, and then twice with 
100% EtOH at room temperature. The eyes were then washed in propylene oxide (Fisher, 
reagent grade) twice for 10 minutes each at room temperature. The propylene oxide was replaced 
with a 1:1 propylene oxide:Durcupan resin mixture and rotated slowly overnight at room 
temperature. The following mixture of components created a suitable soft resin of Durcupan for 
mounting and sectioning the eyes: 13.5g resin A, 11.125g hardener B, 0.625g accelerator C, and 
Table 3.3 Antibodies used in these studies for immunostaining of embryos and imaginal wing 
discs. 
50 
 
2.5g plasticizer D. The 1:1 mixture of propylene oxide:Durcupan was replaced with a 100% 
Durcupan mixture and incubated for 3 hours at room temperature. The heads were then 
transferred to 100% Durcupan resin and arranged within a mold (Figure 3.1A). They were baked 
overnight at 70oC. The sectioning surface of the resin containing the fly heads was then trimmed 
with a razor blade into an asymmetric trapezoid (Figure 3.1B). This minimized the area of the 
block for better sectioning, and provided a way to identify the orientation of the eye tissue within 
the sections. The embedded eyes were sectioned with a newly cut glass knife on a Sorvall 
MT5000 into 0.5 to 1.0μm thick sections, which were transferred with a small wooden spatula to 
drops of water on a glass slide. The water was dried on an 80oC hot plate and cooled to adhere 
the sections to the slide. Drops of 0.1% Toluidine blue (w/v) were applied to the sections, and the 
microscope slide was set on an 80oC hot plate for 20 seconds (just until the Toluidine dye began 
to bubble). The slides were rinsed thoroughly with distilled water and air dried. A drop of DPX 
mounting medium was added on top of the sections. A cover slip was laid onto the DPX and 
weighted with two pennies. The DPX was allowed to dry overnight. The sections were imaged 
on a compound light microscope with a 60X oil immersion lens. 
 
Figure 3.1 Orientation of fly heads in resin block for eye sectioning. A. The uncut eye of the 
fly head was positioned anterior side up near the edge of the mold. B. The sectioning surface of 
the resin block was trimmed into an uneven trapezoid shape so that the dorsal and ventral eye 
could be identified in the sections. 
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CHAPTER 4 
RESULTS  
I. Chmp1 is conserved and essential  
The Drosophila Chmp1 protein (Flybase ID: FBgn0036805) is encoded by the Chmp1 
gene (CG4108), which is located in the region 75D6 on the left arm of the third chromosome 
(Figure 4.1A). The Drosophila genome carries a single Chmp1 gene. The genomes of many 
model organisms, including mammals, contain two Chmp1 genes, Chmp1A and Chmp1B, both of 
which are highly homologous to Drosophila Chmp1. This makes Drosophila an ideal model to 
study Chmp1 function as there is not the complication of genetic redundancy caused by the 
activity of closely related genes. Alignment of the Drosophila Chmp1 protein sequence with 
human Chmp1A and Chmp1B reveals that they share a conserved NLS, as well as an MIM 
(Figure 4.1B). Drosophila and human Chmp1 proteins also share Snf-7 and Vps24 domains. In 
amino acid sequence, Drosophila Chmp1 is most like human Chmp1B; they are 74% identical 
and 90% similar (Figure 4.1B). Through co-immunoprecipitation assays and mass spectroscopy, 
Drosophila Chmp1 has been shown to bind many proteins, including Vps4 and the Drosophila 
homologue of Ist1, CG10103 (Table 1.3) [111]. Reports show that Chmp1 binds these proteins in 
yeast and human cultured cells, suggesting that the function of Chmp1 is well conserved between 
yeast, humans, and Drosophila [82, 104]. Interestingly, other Chmp1 binding partners include 
quite a few proteins involved in translation and mRNA processing, as well as phagocytosis 
(Table 1.3). To summarize, as Drosophila expresses only one Chmp1 protein that shares binding 
partners and sequence features of mammalian Chmp1 proteins, it provides a good model to study 
the function of Chmp1.  
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Figure 4.1 Chmp1 is conserved. A. Genomic region surrounding the Chmp1 gene (boxed in 
red). The genomic regions removed by the chromosomal deletions Df(3L)BSC832 and 
Df(3L)BSC416 are indicated. The positions of genes located near Chmp1 are indicated by blue 
arrows. B. ClustalX alignment of the human and Drosophila Chmp1 protein sequences. The 
Chmp1 protein contains a nuclear localization sequence (NLS, purple), an MIT-interacting 
motif (MIM, yellow), and Snf-7 (blue) and Vps24 (green) domains as predicted by sequence 
analysis. Phosphorylation sites identified for human Chmp1A are highlighted in pink.  Residues 
that are similar in all three sequences are indicated by one or two dots (depending upon the 
degree of similarity) below the alignment, and identical residues are indicated by an asterisk.  
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Most information on the activity of Chmp1 has been inferred from biochemical or cell 
culture studies, so little is known about its role in tissue development and differentiation. 
Expression analysis has revealed that Drosophila Chmp1 is expressed throughout development in 
all larval and adult tissues assayed, which suggests that Chmp1 activity can be studied in a range 
of tissues [2, 113]. Observing the phenotypic effects of loss of Chmp1 activity should give novel 
insights into Chmp1 function, i.e., what proteins it interacts with or which signaling pathways it 
regulates. The effect of loss of Chmp1 was assessed using two independent Drosophila RNAi 
lines, one from the VDRC (UAS-Chmp1RNAi-VDRC) and one from the TRiP stocks (UAS-
Chmp1RNAi-TRiP) that allowed for targeted Chmp1 knockdown (UAS-Chmp1RNAi) [28]. These 
fly lines express hpRNAs under the control of a Gal4-responsive UAS enhancer that target 
different regions of the Chmp1 mRNA. To test whether Chmp1 was essential for viability, 
Chmp1 was knocked down ubiquitously throughout development. tub-Gal4/TM3Sb and act5c-
Gal4/TM6Tb males were crossed to UAS-Chmp1RNAi-TRiP and UAS-Chmp1RNAi-VDRC/Cy 
virgin females in four separate crosses (Figure 4.2). Because the UAS-Gal4 system is 
temperature dependent, the F1 generation from each cross was raised at 25oC, 28oC, and 30oC to 
compare phenotypes at different temperatures.  
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When Chmp1 was knocked down ubiquitously during fly development at 30oC and 28oC, 
the only progeny that eclosed were Sb, Tb, or Cy, indicating that they either did not carry the 
Gal4 driver or did not carry the UAS transgene (i.e. they were not Chmp1 knockdown flies). At 
25oC, no flies survived ubiquitous knockdown using the TRiP RNAi line. Additionally, no flies 
survived when Chmp1 was knocked down ubiquitously using the VDRC RNAi line with tub-
Gal4. In these crosses, expression of Chmp1 RNAi was lethal at or before the pupal stage of 
development. However, occasional escapers, all of which were female, survived ubiquitous 
Chmp1 knockdown using the VDRC RNAi line with act5c-Gal4. The surviving flies had 
thickened wing veins, mildly rough eyes, and a general failure to thrive. This is possibly 
indicative of degree of Chmp1 knockdown, i.e., the RNAi line from the TRiP stocks may have 
provided a more effective knockdown than the VDRC line. It is also possible that the tub-
Gal4/TM3Sb fly line drives Gal4 expression stronger than the act5C-Gal4/TM6Tb fly line.  
Figure 4.2 Cross design to test ubiquitous Chmp1 knockdown. A. Cross design for 
ubiquitous Chmp1 knockdown using the VDRC RNAi insert, located on the second 
chromosome. B. Cross design for ubiquitous Chmp1 knockdown using the TRiP RNAi insert, 
located on the third chromosome. P is parental generation, F1 is filial generation. Only F1 
progeny of the desired genotype are shown. 
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It is possible that the lethality observed with Chmp1 RNAi expression was caused by off 
target RNAi effects. In fact, according to the VDRC website, the UAS-Chmp1RNAi-VDRC line 
has a potential off-target of the gene natalisin (CG34388), which is involved in male mating 
behavior [114]. Additionally, knockdown of natalisin using a VDRC RNAi fly line is lethal 
before the pupal stage, similarly to Chmp1 knockdown [115]. The fact that only female survivors 
were observed could also support the possibility of the off-target effects causing lethality. 
However, Chmp1 knockdown was lethal using two independent RNAi lines that target different 
portions of the Chmp1 mRNA. Therefore, Chmp1 may be essential for proper development in 
Drosophila. 
II. Chmp1 knockdown produces a cell fate change in the wing 
Because ubiquitous Chmp1 knockdown was lethal, the UAS Gal4 system was used to 
limit knockdown to the wing, a well-characterized tissue that is not essential for Drosophila 
development. MS1096-Gal4, salm-Gal4, ptc-Gal4, or en-Gal4 drivers were used to drive Chmp1 
knockdown. Each driver expresses Gal4 in the pattern of a developmental gene in the wing 
(Figure 4.3).  
The MS1096-Gal4 driver expresses Gal4 protein relatively strongly in the dorsal 
compartment of the wing. This is a useful driver for several reasons. First, as sometimes over-
expression or knockdown of a gene has weak phenotypic effects, the MS1096-Gal4 driver allows 
for stronger over-expression or knockdown of the gene-of-interest to generate stronger 
phenotypes. Second, the MS1096-Gal4 driver only expresses Gal4 on the dorsal wing, so it only 
affects the dorsal wing veins: L3, L5 and distal L4 (Figure 4.3). When studying genes involved 
in wing vein patterning, the ventral wing veins remain unaffected and can provide an in-tissue 
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negative control. Third, the MS1096-Gal4 transgene is inserted on the X chromosome, which can 
increase the ease with which genetic crosses can be performed.  
The salm-Gal4, ptc-Gal4, and en-Gal4 driver transgenes are each located on the second 
chromosome and drive Gal4 expression on both dorsal and ventral wing surfaces. salm-Gal4 and 
ptc-Gal4 are moderate drivers. salm-Gal4 drives Gal4 expression from the posterior of the L2 
wing vein to midway between the L4 and L5 wing veins (Figure 4.3). ptc-Gal4 has a similar but 
narrower region of expression between the L3 and L4 wing veins (Figure 4.3). en-Gal4 is a 
stronger driver and has a very precise boundary of expression. en-Gal4 expresses Gal4 in the 
pattern of the engrailed gene, in the anterior cells of each parasegment of the developing fly. In 
the wing, this corresponds to the posterior compartment. The anterioposterior (AP) compartment 
boundary in the wing is located a few cells anterior of the L4 wing vein. The expression of 
engrailed begins a few cells anterior to the AP compartment boundary (Figure 4.3).  
 
 
Figure 4.3 Expression patterns of wing drivers. Diagrams of the Drosophila wing showing 
expression of Gal4 in color by different drivers. Distal is right, anterior is uppermost.  
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To achieve Chmp1 knockdown in the wing, UAS-Chmp1RNAi-TRiP homozygous and 
UAS-Chmp1RNAi-VDRC/Cy virgin females were crossed to MS1096-Gal4, salm-Gal4, ptc-Gal4, 
or en-Gal4 homozygous males and the progeny was grown at 25oC, 28oC, and 30oC (Figure 4.4). 
Straight winged (not Cy) flies were of the correct genotype. Wings from females were dissected 
and mounted onto a microscope slide in GMM.  
 
 
Knockdown of Chmp1 primarily on the dorsal side of the wing (MS1096-Gal4/X; UAS-
Chmp1RNAi-VDRC/+) resulted in thickening of the dorsal wing veins, L3, L5, and distal L4 
(Figure 4.7B). Thickening of the wing veins was observed with Chmp1 knockdown using several 
Gal4 drivers, and the phenotype was only observed in the pattern of the driver (i.e., en-Gal4 
expresses Gal4 in the posterior wing, and only posterior wing veins were thickened), suggesting 
that the vein phenotype was specifically due to expression of Chmp1 RNAi, rather than due to 
other genetic interactions (Figures 4.7E and G). 
Figure 4.4 Chmp1 knockdown cross design. A. Cross design for Chmp1 knockdown in the 
wing using the TRiP RNAi insert, located on the third chromosome. B. Cross design for Chmp1 
knockdown in the wing using the VDRC RNAi insert, located on the second chromosome. P is 
parental generation, F1 is filial generation. Only F1 progeny of the desired genotype are shown. 
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Similar thick vein phenotypes were observed using the independently created TRiP RNAi 
fly line that targeted a different portion of the Chmp1 mRNA, showing that the vein thickening 
was likely due to Chmp1 knockdown rather than off target effects, in which the hpRNA causes 
degradation of other mRNAs (Figure 4.7D, F, and H). Chmp1 knockdown with the TRiP line 
resulted in a stronger wing vein phenotype (i.e., thicker wing veins) than was observed with the 
VDRC line, suggesting that the TRiP line produced more effective knockdown than the VDRC 
line, which is consistent with the findings with ubiquitous Chmp1 knockdown.  
In order to produce the thick veins phenotype, it seemed that Chmp1 expression had to be 
reduced rather strongly. That is, strong drivers (MS1096-Gal4 and en-Gal4) and higher 
temperatures (28oC and 30oC) were required to observe a phenotype that differed much from 
wild-type. At 25oC, the wing vein thickening was discernible, at 28oC it was moderate, and at 
30oC it was severe. In fact, at 30oC the wing veins became so thick that they could not easily be 
distinguished from the intervein tissue (Figure 4.5). Therefore, 28oC was used to analyze the 
effects of Chmp1 knockdown on wing vein development, as this would allow identification of 
both enhancement and suppression of the vein phenotype. Although the Chmp1 protein levels 
were not measured to quantify the level of Chmp1 knockdown, the mildness of the vein 
thickening phenotype may suggest that, at least during wing development, a relatively small 
amount of functional Chmp1 was sufficient for cellular function and tissue development. 
However, it could also indicate that the RNAi fly lines are not particularly effective, or that 
Chmp1 is highly expressed and therefore difficult to reduce significantly, or that the Chmp1 
protein perdures though mRNA levels are reduced. 
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The change in wing vein thickness between wild-type and Chmp1 knockdown wings was 
statistically significant. To quantify the change in wing vein thickness between genotypes, the 
area of the L3 wing vein was measured for 200 microns past the anterior cross vein (acv) in at 
least 10 individual flies. The measured values were plotted in a box and whisker plot (Figure 
4.8). A student’s t-test (p<0.05) was used to compare the area of the L3 wing vein between 
Chmp1 knockdown and wild-type flies. 
 To provide further evidence that the observed phenotype was due to Chmp1 knockdown, 
Chmp1 was knocked down in flies heterozygous for loss of the Chmp1 gene. No Chmp1 mutant 
currently exists, so two chromosomal deletions, Df(3L)BSC416 and Df(3L)BSC832 that remove 
the Chmp1 gene were used (Figures 4.1 and 4.6). MS1096-Gal4; GlaBc/Cy virgin females were 
crossed to UAS-Chmp1RNAi-VDRC/Cy males. From the F1 generation, males that were 
MS1096-Gal4/Y; Gla/UAS-Chmp1RNAi-VDRC were collected and crossed to virgin females that 
were either Df(3L)BSC832/TM6Sb or Df(3L)BSC419/TM6Sb. From this cross, flies that were 
female, not Gla, and not Sb were of the correct genotype (MS1096-Gal4/X; UAS-Chmp1RNAi-
VDRC/+; Df(3L)BSC832/+ and MS1096-Gal4/X; UAS-Chmp1RNAi-VDRC/+; 
Df(3L)BSC419/+).  
Figure 4.5 Chmp1 knockdown at 30oC. Light micrographs of wings from female Drosophila 
raised at 30oC. Distal is right, anterior is uppermost. A. en-Gal4/UAS-Chmp1RNAi-VDRC. B. 
MS1096-Gal4/X; UAS-Chmp1RNAi-VDRC/+. 
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When Chmp1 was knocked down in the wings of flies carrying heterozygous 
chromosomal deletions that removed the Chmp1 gene, the Chmp1 knockdown phenotype was 
enhanced (Figures 4.7I and J). To quantify the changes in wing vein thickness, the area of the L3 
wing vein was measured for 200 microns past the anterior cross vein (acv) in at least 10 
individual flies and the values were represented in a box and whisker plot (Figure 4.8). A one-
way ANOVA with a post-hoc Dunnett’s t-test (p<0.05) compared the area of the L3 wing vein of 
flies with Chmp1 knockdown in a Chmp1 heterozygous background to flies with Chmp1 
knockdown alone and showed that they were not significantly different (Figure 4.8). However, 
the general enhancement of the Chmp1 knockdown phenotype observed in a Chmp1 
heterozygous background supports the finding that the thick vein phenotype is due to loss of 
Chmp1. 
 As reduced Chmp1 activity results in thickened wing veins, it appears that one role of 
Chmp1 is to negatively regulate wing vein size. Thickened wing veins are classically associated 
with a cell fate change from intervein to vein cell in the wing [14]. So it is important to note that, 
Figure 4.6 Cross design for Chmp1 knockdown in Chmp1 heterozygous background. P is 
parental generation, F1 is first filial generation, F2 is second filial generation. Only F1 and F2 
progeny of the desired genotypes are shown. 
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although it appears that Chmp1 knockdown causes wing veins to overgrow, the wing vein 
thickening was not due to extra growth, but a change in cell fate. In wild-type wings, veins are 
only a few cells in width. However, when Chmp1 was knocked down, cells that would normally 
border the wing vein as intervein cells adopted a vein fate instead, causing a thickened wing vein 
in the adult. This caused the number of cells between veins to appear reduced, and was especially 
obvious when Chmp1 was knocked down with ptc-Gal4 (Figure 4.7H). So, as Chmp1 
knockdown results in thickened wing veins, Chmp1 appears to be a negative regulator of wing 
vein differentiation, favoring an intervein cell fate over a vein fate. 
Driving Chmp1 knockdown on the dorsal wing with MS1096-Gal4 produced an upward 
curving of the wing at the margin, resulting in a concave wing. This phenotype was likely caused 
by a reduction in the area of the dorsal wing surface, perhaps due to smaller cell size. During 
wing development, each wing cell produces one hair. This means that hair density on the wing 
surface gives an indication of the apical surface size of wing cells [116, 117]. When Chmp1 
knockdown was driven by MS1096-Gal4 or en-Gal4, intervein regions had increased wing hair 
density, suggesting a smaller cell size than wild-type cells (compare Figure 4.7K with 4.7L). 
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Figure 4.7 Chmp1 knockdown results in thickened wing veins. Light micrographs of adult 
female wings raised at 28oC. The L3 or L4 wing vein is indicated, distal is right, anterior is 
uppermost. A. Oregon R.  B, D, F, and H. Chmp1 knockdown in the wing with the TRiP line 
caused thickened wing veins. B. MS1096-Gal4/X; UAS-Chmp1RNAi-TRiP/+. D. salm-Gal4/+; 
UAS-Chmp1RNAi-TRiP/+. F. en-Gal4/+; UAS-Chmp1RNAi-TRiP/+. H. ptc-Gal4/+; UAS-
Chmp1RNAi-TRiP/+. C, E, and G. Chmp1 knockdown using the VDRC line causes thick 
veins. C. MS1096-Gal4/X; UAS-Chmp1RNAi-TRiP/+. E. en-Gal4/UAS-Chmp1RNAi-VDRC. G. 
en-Gal4/UAS-Chmp1RNAi-VDRC.   I and J. Heterozygosity for two chromosomal deletions 
(Figure 4.1) containing the gene encoding Chmp1 enhances the Chmp1 knockdown phenotype. 
I. MS1096-Gal4/X; UAS-Chmp1RNAi-VDRC/+; Df(3L)BSC832/+. J. MS1096-Gal4/X; UAS-
Chmp1RNAi-VDRC/+; Df(3L)BSC416/+. K. Wing hairs are spaced evenly in MS1096-Gal4 
wings. L. Chmp1 knockdown results in a higher density of wing hairs. Region shown is 
posterior to the L5 wing vein. MS1096-Gal4/X; UAS-Chmp1RNAi-VDRC. Images A-J taken at 
the same magnification. Images K and L taken at the same magnification.  
Figure 4.8 Chmp1 knockdown in wings heterozygous for the Chmp1 gene: wing vein 
measurements. A box and whisker plot depicting the area of the measured L3 wing vein in 
square microns. The upper and lower brackets represent the maximum and minimum 
measurements, respectively. Heterozygosity for the Chmp1 gene enhances the Chmp1 
knockdown phenotype, though not statistically significantly. All genotypes shown had wing 
veins that were significantly thicker than wild-type. Statistical differences were determined by a 
one-way ANOVA with post-hoc Dunnett’s, p<0.05. 
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To further evaluate Chmp1 function in Drosophila, two transgenic fly lines were 
generated that allowed for over-expression of either the wild-type Chmp1 protein or an N-
terminal His-Myc (HM) tagged Chmp1 [118]. Two vectors, pUAST and pUASHM were used to 
generate these fly lines (see Chapter 3 Section I for method). The vectors contained a white+ 
marker and a multiple cloning site downstream of a UAS enhancer, all flanked by p-element 
ends that mediated insertion into the genome of the fly. The Chmp1 cDNA was inserted into the 
multiple cloning site of each vector. The pUASHM vector added an HM tag to Chmp1. The 
pUAST and pUASHM vectors containing the Chmp1 cDNA were sent to BestGene Inc., where 
the transgenic flies (UAS-Chmp1 and UAS-HM-Chmp1, respectively) were generated. 
Transgenic flies were crossed to a fly stock containing multiple balancer chromosomes to 
determine the chromosomal location of each insertion, and to generate a balanced stock. Twenty 
independent lines were generated that carried a random insertions of one of the constructs within 
their genome, usually on the second and/or third chromosomes. Transgenes in different 
chromosomal locations may show different levels of expression, so having a selection of 
different insertions is useful. Also, having insertions on different chromosomes provides more 
flexibility when generating specific genetic combinations.  
As the insertions were marked with white+, dark red eyes in transgenic fly lines usually 
indicate that the insertion can be expressed at higher levels than flies with lighter orange or 
yellow eyes. Varying eye colors were likely due to the site of insertion, i.e., if the insertion was 
located within a highly expressed portion of the fly genome, then a darker eye resulted. On the 
other hand, if the insertion was located within a portion of the genome that is not highly 
expressed, a lighter eye resulted. Dark red eyes can also indicate the presence of multiple 
insertions. So of the twenty fly lines received, those with the darkest eyes were chosen first for 
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balancing in an attempt to select for highly expressing lines. When balancing the fly lines, the 
chromosome carrying the insertion was determined through crossing to a fly stock carrying 
multiple balancers and dominant markers. All insertions were on either the second or the third 
chromosome, and only fly lines with a single insertion chromosome were used in the study.  
If the Chmp1 transgenes can produce functional Chmp1 protein, then they should rescue 
the Chmp1 knockdown phenotype. To test this, UAS-Chmp1 or UAS-HM-Chmp1, UAS-
Chmp1RNAi, and a driver had to be present in the same fly. Different crosses were required for 
lines carrying UAS-Chmp1 or UAS-HM-Chmp1 on the second chromosome (UAS-Chmp1-1 and -
2, UAS-HM-Chmp1-3) or the third chromosome (UAS-HM-Chmp1-1, -2, and -4) (Figure 4.9A 
and B). For lines carrying UAS-Chmp1 or UAS-HM-Chmp1 on the second chromosome (Figure 
4.9A), UAS-Chmp1 or UAS-HM-Chmp1/Cy; D1/TM3Ser virgin females were crossed to If/Cy; 
UAS-Chmp1RNAi-TRiP/TM3Sb males. From the progeny of that cross, Cy, D1 males (UAS-
Chmp1 or UAS-HM-Chmp1/Cy; UAS-Chmp1RNAi-TRiP/ D1) were collected and crossed to 
MS1096-Gal4 virgin females. From this cross, females that were not Cy and not D1 were of the 
correct genotype (MS1096-Gal4/X; UAS-Chmp1 or UAS-HM-Chmp1/+; UAS-Chmp1RNAi-
TRiP/+). For lines carrying UAS-Chmp1 or UAS-HM-Chmp1 on the third chromosome (Figure 
4.9B), If/Cy; UAS-HM-Chmp1/TM6Sb or TM3Ser virgin females were crossed to UAS-
Chmp1RNAi-VDRC/Cy; D1/TM3Ser males. From the progeny, Cy, D1 males (UAS-Chmp1RNAi-
VDRC/Cy; UAS-HM-Chmp1/ D1) were collected and crossed to MS1096-Gal4 virgin females. 
From this cross, females that were not Cy and not D1 were of the correct genotype (MS1096-
Gal4/X; UAS-Chmp1RNAi-VDRC/+; UAS-HM-Chmp1/+). Wings were dissected and mounted 
in GMM on a microscope slide. 
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As a control, a fly line that allows for expression of GFP under Gal4 control, UAS-GFP 
was used in place of the Chmp1 over-expression transgene. In this case, the UAS-GFP and UAS-
Chmp1RNAi transgenes had to be present in the same fly, along with a driver (Figure 4.9C). 
UAS-GFP males were crossed to MS1096-Gal4; GlaBc/Cy virgin females. From the progeny, 
males that were Gla and not Cy (MS1096-Gal4/Y; UAS-GFP/Gla) were collected and crossed to 
UAS-Chmp1RNAi-VDRC/Cy virgin females. From this cross, females that were not Cy and not 
Gla were of the correct genotype (MS1096-Gal4/X; UAS-GFP/UAS-Chmp1RNAi-VDRC). 
 
 
Figure 4.9 Cross design for rescue of Chmp1 knockdown with Chmp1 over-expression. A. 
Cross design for lines in which UAS-Chmp1 or UAS-HM-Chmp1 was located on the second 
chromosome. B. Cross design for lines in which UAS-Chmp1 or UAS-HM-Chmp1 was located 
on the third chromosome. C. Cross design for control cross, using UAS-GFP. P is parental 
generation, F1 is first filial generation, F2 is second filial generation. Only F1 and F2 progeny 
of the desired genotypes are shown. 
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To quantify the changes in wing vein thickness, the area of the L3 wing vein was 
measured for 200 microns past the anterior cross vein (acv) in at least 10 individual flies and the 
values were represented in a box and whisker plot (Figure 4.11). A one-way ANOVA with a 
post-hoc Dunnett’s t-test (p<0.05) compared the area of the L3 wing vein of flies expressing 
Chmp1RNAi, concomitant with UAS-Chmp1, UAS-HM-Chmp1, or UAS-GFP to flies expressing 
Chmp1RNAi alone (Figure 4.11). Expression of UAS-Chmp1 or UAS-HM-Chmp1 concomitant 
with Chmp1RNAi under MS1096-Gal4 control significantly decreased the thick vein phenotype 
in all lines tested. In fact, expression of UAS-Chmp1 completely rescued the thick vein 
phenotype in over 60% of wings (Figure 4.10E and F, 4.11, and Table 4.1), while partial rescue 
was observed in 34% of wings (Figure 4.10E’ and F’, 4.11, and Table 4.1). Only 3% of wings 
showed no rescue of the Chmp1 knockdown phenotype by Chmp1 over-expression (Figure 
4.10E’’, 4.11, and Table 4.1). Expression of the HM-Chmp1 partially rescued the Chmp1 
knockdown phenotype in over 80% of wings analyzed (Figure 4.10A’- 4.10D’, 4.11, and Table 
4.1), while full rescue was observed in about 13% of wings (Figure 4.10A - 4.10D, 4.11, and 
Table 4.1), and no rescue in 5% of wings (Figure 4.10A’’- 4.10B’’, 4.11, and Table 4.1). The 
rescue observed in these experiments was not simply the result of reduced Gal4 binding to the 
Chmp1RNAi promoter due to the presence of a second UAS promoter, as wings with over-
expression of a gratuitous protein (UAS-GFP) concomitant with Chmp1RNAi were not 
significantly different from wings with Chmp1 knockdown alone. Additionally, expression of 
UAS-GFP concomitant with Chmp1RNAi never fully rescued the wing vein phenotype and only 
provided partial rescue in approximately 30% of wings (Table 4.1, Figure 4.11).  
These results suggest that the Chmp1 over-expression transgenes can produce a 
functional Chmp1 protein. The low frequency of failure to rescue might be explained by the 
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activity of Chmp1 RNAi, which inevitably targets both Chmp1 mRNA from both the endogenous 
Chmp1 gene and the Chmp1 over-expression transgenes. The ability of wild-type Chmp1 to 
provide better rescue than HM-Chmp1 suggests that HM-Chmp1 may be less active or less stable 
than the wild-type Chmp1. This could be due to the epitope tag that either caused HM-Chmp1 to 
be degraded more quickly than the wild-type Chmp1, or inhibited some of the function of 
Chmp1. It could also be due to the insertion site of the transgenes; perhaps by chance the HM-
Chmp1 transgenes tested were in regions of chromatin that are less accessible to transcription 
compared to the wild-type Chmp1 transgenes. The finding that over-expressed Chmp1 can rescue 
the thick vein phenotype further supports the conclusion that this phenotype results specifically 
from Chmp1 knockdown, rather than off-target effects. It also supports the proposal that Chmp1 
negatively regulates wing vein differentiation and promotes intervein cell fate. Additionally, it 
confirms that the Chmp1 over-expression lines are functional and may be used for further 
studies. 
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Figure 4.10 Chmp1 over-expression rescues the Chmp1 knockdown phenotype. Light 
micrographs of adult female wings raised at 28oC. L3 vein is indicated, distal is right, anterior 
is uppermost. A-F. Complete rescue of Chmp1 knockdown with Chmp1 over-expression. Area 
of L3 wing vein less than 3400µm2. A’-F’. Partial rescue of the Chmp1 knockdown phenotype 
with Chmp1 over-expression. Area of L3 wing vein between 3400 and 5200µm2.  A’’-E’’. No 
rescue of the Chmp1 knockdown phenotype with Chmp1 over-expression. Area of L3 wing 
vein larger than 5200µm2.  A-A’’. MS1096-Gal4/X; UAS-Chmp1RNAi-VDRC/+; UAS-HM-
Chmp1-1/+. B-B’’. MS1096-Gal4/X; UAS-Chmp1RNAi-VDRC/+; UAS-HM-Chmp1-2/+. C-C’. 
MS1096-Gal4/X; UAS-Chmp1RNAi-VDRC/UAS-HM-Chmp1-3. All wings of this genotype 
displayed at least partial rescue. D-D’. MS1096-Gal4/X; UAS-Chmp1RNAi-VDRC/+; UAS-
HM-Chmp1-4/+. All wings of this genotype displayed at least partial rescue. E-E’’. MS1096-
Gal4/X; UAS-Chmp1RNAi-VDRC/UAS-Chmp-1. F-F’. MS1096-Gal4/X; UAS-Chmp1RNAi-
VDRC/UAS-HM-Chmp1-2. All wings of this genotype displayed at least partial rescue.   
Table 4.1 Chmp1 over-expression can rescue the Chmp1 knockdown phenotype. 
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III. Chmp1 interacts with regulators of DER signaling  
Studies suggest that ESCRT machinery negatively regulates EGFR signaling. For 
example, in mammalian cells over-expression of the ESCRT-0 component hepatocyte growth 
factor receptor substrate (Hrs) or loss of the ESCRT-I component Tsg101 [58, 119] caused 
impaired EGFR degradation. Additionally, losing activity of Hrs in Drosophila impaired 
degradation of the DER, causing enhanced EGFR signaling indicated by increased phospho-ERK 
[59, 120]. In Drosophila, the DER signaling pathway promotes the development of wing veins. 
Figure 4.11 Chmp1 over-expression rescues Chmp1 knockdown: wing vein measurements. 
A box and whisker plot depicting the area of the measured L3 wing vein in square microns. The 
upper and lower brackets represent the maximum and minimum measurements, respectively. 
All genotypes shown had wing veins that were significantly thicker than wild-type. Asterisks 
mark genotypes with wing veins that were significantly thinner than Chmp1 knockdown. 
Significant differences were determined by a one-way ANOVA with post-hoc Dunnett’s, 
p<0.05. 
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When the activity of two positive regulators of DER, Rhomboid (Rho) and Vein (Vn), is lost (a 
rhove-1, vn1 homozygous mutant wing), veins are lost as well (Figure 4.13C). On the other hand, 
enhanced DER signaling, e.g., by over-expression of rho, causes thickened and extra wing veins 
[36]. So the thick wing veins observed with Chmp1 knockdown might have been caused by over-
active DER signaling, due to a failure of ESCRT machinery to down-regulate the DER. If 
Chmp1 negative regulates the DER signal, then reducing DER signaling in a Chmp1 knockdown 
wing should suppress the thick vein phenotype. On the other hand, increasing DER signaling 
should enhance the Chmp1 knockdown phenotype. 
To test this, Chmp1 was knocked down in wings heterozygous for loss of function alleles 
of either positive or negative regulators of DER signaling. To achieve this, the Chmp1 RNAi 
transgene, a driver, and one loss of function allele for regulators of the DER had to be present in 
the same fly (Figure 4.12). Positive regulators of the DER tested were Rho and Vn, and negative 
regulators tested were Kekkon-1 (Kek1), Sprouty (Sty) or Argos (Aos). MS1096-Gal4; Cy/Sco 
virgin females were crossed to UAS-Chmp1RNAi-VDRC/Cy males. From this cross, Sco males 
(MS1096-Gal4/Y; UAS-Chmp1RNAi-VDRC/Sco) were crossed to virgin females carrying loss of 
function alleles for regulators of DER signaling that were either homozygous viable or balanced 
with TM3Sb. From the progeny, females that were not Sco and not Sb were of the desired 
genotype. Wings were dissected off and mounted in GMM on a microscope slide. 
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To quantify the changes in wing vein thickness, the area of the L3 wing vein was 
measured for 200 microns past the anterior cross vein (acv) in at least 10 individual flies and the 
values were represented in a box and whisker plot (Figure 4.14). A one-way ANOVA with a 
post-hoc Dunnett’s t-test (p<0.05) compared the area of the L3 wing vein of flies expressing 
Chmp1RNAi in backgrounds heterozygous for mutations in DER regulators to flies expressing 
Chmp1RNAi alone (Figure 4.11).  
In Chmp1 knockdown wings that were also heterozygous for loss of function alleles of 
two positive regulators of the DER pathway, rhove-1 and vn1 (MS1096-Gal4/X; UAS-
Chmp1RNAi-VDRC/+; rhove-1, vn1/+), the wing vein phenotype was partially suppressed (Figure 
4.13D). This genetic interaction was a first indication that Chmp1 may regulate DER signaling in 
the Drosophila wing. Wings that were just heterozygous for rhove-1 vn1 appeared wild-type, 
which means that the suppression of the vein thickening phenotype was not simply an additive 
effect. No suppression was observed when Chmp1 was knocked down in rhove-1 heterozygous 
Figure 4.12 Cross design testing for interaction between Chmp1 and DER regulators. All 
loss of function alleles for regulators of DER signaling used were on the third chromosome, as 
was the aos over-expression transgene (UAS-aos). The loss of function alleles used were rhove-
1, vn1, kek1, styΔ5, aosΔ7, aosrlt, and aosw11. styΔ5, aosΔ7, and aosw11 were balanced with TM3Sb, 
the others alleles and UAS-aos were homozygous. P is parental generation, F1 is first filial 
generation, F2 is second filial generation. Only F1 and F2 progeny of the desired genotypes are 
shown 
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wings, although partial suppression was observed in vn1 heterozygous wings (Figure 4.13E and 
F). This suggests that the suppression observed in rhove-1, vn1 heterozygous wings was due to loss 
of vn, rather than loss of rho. An interaction with Vn rather than Rho, is interesting, especially as 
these two proteins are reported to have a synergistic role in the wing [121, 122]. This result could 
be due to the relatively strong ability of Rho to activate the DER, while Vn is considered a 
relatively weak activator. Thus, a single copy of the rho gene might still enhance DER signaling 
significantly, but a single copy of the vn gene may provide little activity.  
Reduced activity of positive regulators of the DER pathway suppressed the Chmp1 
knockdown phenotype in the wing, suggesting that Chmp1 negatively regulates DER signaling. 
If Chmp1 negatively regulates the DER signal, then reduced activity of negative regulators of 
DER signaling should enhance the Chmp1 knockdown phenotype. When Chmp1 was knocked 
down in wings heterozygous for loss of function alleles for negative regulators of DER signaling, 
Kek-1 (MS1096-Gal4/X; UAS-Chmp1RNAi-VDRC/+; kek1DG23812/+), Sty (MS1096-Gal4/X; 
UAS-Chmp1RNAi-VDRC/+; styΔ5/+), Aos (MS1096-Gal4/X; UAS-Chmp1RNAi-VDRC/+; 
aosΔ7/+, MS1096-Gal4/X; UAS-Chmp1RNAi-VDRC/+; aosr/t/+, and MS1096-Gal4/X; UAS-
Chmp1RNAi-VDRC/+; aosw11/+), wing veins were thicker than those observed with Chmp1 
knockdown alone (Figure 4.13F-J). However, wings that were heterozygous for just kek1DG23812, 
styΔ5, aosr/t, aosw11, or aosΔ7 appeared wild-type, suggesting that the enhancement of the vein 
phenotype is not simply an additive effect. The opposite effects of the loss of positive and 
negative DER regulators on the Chmp1 knockdown phenotype are consistent with a role for 
Chmp1 in negative regulation of the DER signaling pathway.  
Argos negatively regulates DER signaling by binding to and suppressing the function of 
Spitz and Keren, which are DER activating ligands. Over-expression of aos with MS1096-Gal4 
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causes loss of portions of the dorsal wing veins. Interestingly, when MS1096-Gal4 drove both 
Chmp1 RNAi and aos over-expression, the portions of the wing vein normally lost with aos 
over-expression are absent, but the remaining veins are thickened (Figure 4.13L). The inability 
of Chmp1 knockdown to restore wing vein differentiation suggests that loss of Chmp1 cannot 
restore the DER signaling lost when aos is over-expressed. This is consistent with a role for 
Chmp1 downstream of Aos.  
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When the mean of L3 wing vein area of each genotype was plotted in a box and whisker 
plot, it became apparent that wild-type wings and Chmp1 knockdown wings had a narrower 
range of wing vein areas than Chmp1 knockdown wings that were heterozygous for loss of 
function alleles of DER signaling regulators (Figure 4.14). As Chmp1 knockdown driven with 
Gal4 is sensitive to temperature, this could reflect an increased sensitivity of the Chmp1 
knockdown phenotype to changes in ambient temperature in different genetic backgrounds. 
However, though Chmp1 did not genetically interact with Rho, the mean for the other Chmp1-
DER regulator interaction genotypes was consistent with the proposal that Chmp1 negatively 
regulates DER signaling. First, loss of function alleles for all the negative regulators of DER 
signaling tested increased the wing vein area in Chmp1 knockdown wings. Three different 
negative regulators of DER signaling were investigated, each with a different mechanism of 
Figure 4.13 Chmp1 interacts with regulators of DER signaling in Drosophila. Light 
micrographs of adult female wings raised at 28oC. Distal is right, anterior is uppermost. A. 
Oregon R. B. MS1096-Gal4/X; UAS-Chmp1RNAi-VDRC/+. Chmp1 knockdown caused thick 
wing veins. C. rhove-1, vn1. Wings homozygous for loss of function alleles of positive regulators 
of DER signaling, rhove-1, vn1 have lost most wing veins. D. MS1096-Gal4/X; UAS-
Chmp1RNAi-VDRC/+; rhove-1, vn1/+. A heterozygous rhove-1, vn1 background partially 
suppressed the Chmp1 knockdown phenotype. E. MS1096-Gal4/X; UAS-Chmp1RNAi-
VDRC/+; rhove-1/+. Heterozygous rhove-1did not suppress the Chmp1 knockdown. F. MS1096-
Gal4/X; UAS-Chmp1RNAi-VDRC/+; vn1/+. Heterozygous vn1 suppressed the Chmp1 
knockdown phenotype. G-K. Wings heterozygous for loss of function alleles for negative 
regulators of DER enhanced the Chmp1 knockdown phenotype. G. MS1096-Gal4/X; UAS-
Chmp1RNAi-VDRC/+; kek1DG23812/+. H. MS1096-Gal4/X; UAS-Chmp1RNAi-VDRC/+; styΔ5/+. 
I. MS1096-Gal4/X; UAS-Chmp1RNAi-VDRC/+; aosΔ7/+. J. MS1096-Gal4/X; UAS-
Chmp1RNAi-VDRC/+; aosrlt. K. MS1096-Gal4/X; UAS-Chmp1RNAi-VDRC/+; aosw11. L. 
MS1096-Gal4/UAS-aos; UAS-Chmp1RNAi-VDRC/UAS-aos. Wing veins that are not lost 
through over-expressing aos are thickened due to Chmp1 knockdown. The wings shown for 
each genotype are representative of the means of all the wings analyzed. For quantification see 
Figure 4.9. 
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action on DER signaling.  Second, positive and negative regulators of DER had opposite effects 
on the thickened wing veins caused by Chmp1 knockdown.  
 
 
IV. Chmp1 negatively regulates DER signaling 
The results presented in the previous section suggest that Chmp1 negatively regulates 
DER signaling, as reduced activity of positive and negative regulators of DER signaling had 
Figure 4.14 Wing vein measurements for Chmp1 knockdown flies with altered DER 
signaling. A box and whisker plot depicting the area of the measured L3 wing vein in square 
microns. The upper and lower brackets represent the maximum and minimum measurements, 
respectively. Heterozygosity for loss of Vn activity, a positive regulator of DER signaling, 
partially suppressed the Chmp1 knockdown phenotype. Heterozygosity for loss of activity of 
Sty, Kek, or Aos, negative regulators of DER signaling, show an enhanced Chmp1 knockdown 
phenotype. All genotypes shown had significantly thicker wing veins than wild-type. Asterisks 
represent a statistically significant difference from Chmp1 knockdown. Significant differences 
were determined by a one-way ANOVA with post-hoc Dunnett’s, p<0.05. 
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opposite effects on the thick wing vein phenotype caused by Chmp1 knockdown. If Chmp1 
regulates DER signaling, then the expression of genes regulated by the DER signaling pathway 
should be altered under Chmp1 knockdown conditions. Blistered (Bs, also called Drosophila 
Serum Response Factor [DSRF]) is a transcription factor whose expression is negatively 
regulated by DER signaling. So if Chmp1 knockdown causes an over-active DER signaling 
pathway, Bs expression should decrease in Chmp1 knockdown cells. To test this, Chmp1 was 
knocked down in third instar wing discs under the control of en-Gal4 (Figure 4.15). UAS-
Chmp1RNAi-TRiP homozygous males were crossed to en-Gal4, UAS-GFP homozygous virgin 
females and progeny were grown at 30oC. Crawling third instar larvae wing discs were dissected, 
immunostained for Bs, and imaged on a confocal microscope. en-Gal4 drove Chmp1 knockdown 
in the posterior of the wing disc (marked by GFP fluorescence from UAS-GFP), so that Bs 
staining intensity could be compared between the anterior and posterior of the disc. 
Unexpectedly, there was no striking difference in the intensity of fluorescence between the 
halves of the disc. 
 
 
As an alternative approach, clones of Chmp1 knockdown marked by GFP expression 
were generated in the wing disc. To achieve this, hs-flp; UAS-Chmp1RNAi-TRiP virgin females 
were crossed to FRT-Gal4; UAS-GFP males (Figure 4.16). The progeny were developed at 25oC, 
heat shocked at 37oC for 1 hour between 48-72 hours into development to induce Chmp1 
Figure 4.15 Cross design for Chmp1 knockdown marked with GFP in the posterior wing 
disc. P is parental generation, F1 is first filial generation, F2 is second filial generation. 
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knockdown clones (see Chapter 1, Section II.E.). To induce maximal Chmp1 knockdown in 
clones, larvae were grown for the remaining developmental time at 30oC, as the UAS-Gal4 
system is more active at higher temperatures. Female crawling third instar larvae (hs-flp/FRT-
Gal4; UAS-GFP/+; UAS-Chmp1RNAi-TRiP/+) were of the correct genotype and so were 
selected, and wing discs were dissected and immunostained for Bs.  
 
 
Some flies from this cross were allowed to develop to the adult stage to ensure that clones 
were being generated. The GFP marker was not visible in adult wings, but areas of thickened 
wing veins were present, suggesting that clones of Chmp1 knockdown were being generated 
(Figure 4.17D and E). Bs is normally expressed in the intervein regions of the wing disc and 
repressed in provein regions (Figure 4.17A and A’). Large clones (>120 cells) of Chmp1 
knockdown that spanned vein and intervein regions reduced Bs expression within the clone 
(Figures 4.17B, B’ and C, C’). However, smaller clones of Chmp1 knockdown did not have an 
observable effect on Bs expression even though similar sized clones could induce vein formation 
(shown below, Figure 4.19C). This was possibly because Bs levels were observed in imaginal 
disc clones, but the final fate decision between vein and intervein cell does not occur until well 
into the pupal stage, by which time Bs levels may be altered [15, 21]. Therefore, it is possible 
Figure 4.16 Cross design for generating Chmp1 knockdown clones marked with GFP in 
wing discs. Developing flies of the F1 generation were heat shocked for 1 hour between 48-72 
hours of development. All F1 females were of the correct genotype. P is parental generation, F1 
is first filial generation. Only the desired F1 progeny is shown. 
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that it takes more time to see an effect of Chmp1 knockdown on Bs expression than had elapsed 
since the induction of these small imaginal disc clones. Alternatively, Chmp1 protein may 
perdure through clone formation, so it may still be present in small clones even though the 
Chmp1 mRNA levels are reduced. 
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To investigate the effect of Chmp1 knockdown in the wing further, clones of both Chmp1 
and forked knockdown were generated in the adult wing. forked knockdown caused a wing hair 
phenotype in the clones, giving a way to distinguish the clone cells from the rest of the wing 
cells. To achieve this, FRT-Gal4/FM6B1; Cy/UAS-forkedRNAi virgin females were crossed to 
hs-flp/Y; UAS-Chmp1RNAi-VDRC/Cy males (Figure 4.18). The progeny were allowed to grow 
for 120-144 hours at 25oC, and then heat shocked for 1 hour at 37oC, and grown at 28oC for the 
remaining development. Adult females that were not Cy and not B1 were of the correct genotype 
(FRT-Gal4/hs-flp; UAS-forkedRNAi/UAS-Chmp1RNAi-VDRC). 
 
 
Figure 4.17 Chmp1 knockdown reduced Bs staining in imaginal discs. A-C’. Confocal 
images showing clones of Chmp1 knockdown marked with GFP (green) in the third instar wing 
disc from larvae raised at 30oC. All wings shown were of the genotype hs-flp/FRT-Gal4; UAS-
Chmp1RNAi-TRiP/+; UAS-GFP/+. Discs were immunostained for Blistered (Bs). Scale bar is 
20μm. A. Bs (red) is expressed in the intervein regions of the wing disc and is repressed in the 
provein territories. Longitudinal proveins, L3, L4, and L5, and wing margin are labeled. A’. 
The same disc as A, but thresholded. B and C. Large clones (>120 cells) of Chmp1 knockdown 
marked by GFP expression (green).  B’ and C’. Same clones as B and C respectively, but 
thresholded with the GFP fluorescence removed and clones outlined in green. D and E. Light 
micrographs of adult female wings showing clones of Chmp1 knockdown indicated by regions 
of wing vein thickening. Distal is right, anterior is uppermost. 
Figure 4.18 Cross design for Chmp1 and forked knockdown clones in the adult wing. The 
developing F1 generation was heat shocked for 1 hour at 37oC 120-144 hours into 
development. Adult F1 females that were not Cy and not B1 were of the correct genotype and 
are the only F1 progeny shown. P is parental generation, F1 is first filial generation. 
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Clones of Chmp1 knockdown in adult wings that overlapped veins caused a cell fate 
change from intervein to vein, resulting in widening of the wing vein (Figure 4.19B). In these 
clones, only cells adjacent to the wing vein were converted to vein cells (i.e., the number of cells 
making up the thickness of the wing vein increased), even when the clone extended well into 
intervein tissue. The cell fate change was also restricted to clone cells, implying that the effect of 
Chmp1 knockdown is cell autonomous. Most of the Chmp1 knockdown clones had smooth 
edges, in contrast to the usual irregular edges observed in clonal analyses. Smooth edges were 
also characteristic of bs- clones, which is compatible with the finding that Bs expression was 
reduced in Chmp1 knockdown clones [123]. Interestingly, some of the Chmp1 knockdown 
clones that were located entirely within intervein tissue did not induce vein cell differentiation 
(Figure 4.19A), while other intervein clones did (Figure 4.19C). Therefore, it seems that the 
effect of Chmp1 on wing vein differentiation is spatially dependent, suggesting that Chmp1 does 
not directly determine whether a cell differentiates into a vein or intervein cell. Rather, Chmp1 
knockdown altered the balance of signaling within these cells and pushed towards adopting a 
vein fate, rather than an intervein fate. In fact, clones of Chmp1 knockdown typically caused 
intervein to vein cell fate changes in regions adjacent to normal veins, where the DER pathway 
should be most active. These results are consistent with a role for Chmp1 in negatively 
regulating the DER signaling pathway.  
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V. Over-expression of Chmp1  
Transgenic lines were created to investigate the effects of Chmp1 over-expression in the 
fly. If Chmp1 knockdown caused thick wing veins due to over-active DER signaling, then over-
expression may cause narrowing or loss of wing veins due to inhibited DER signaling. Chmp1 
knockdown and over-expression had opposite effects on growth in the mammalian cell culture 
studies, so the same antagonistic effects might be expected in Drosophila.  
To investigate the effect of Chmp1 over-expression, Chmp1 was over-expressed in the 
dorsal wing using MS1096-Gal4. Males carrying UAS-Chmp1 and UAS-HM-Chmp1 balanced 
with Cy, TM3Ser, or TM6SbTb were crossed to MS1096-Gal4 virgin females and progeny were 
grown at 25oC, 28oC, or 30oC (Figure 4.20A and B). Adult female and male flies that were not 
Cy, Ser, or Sb were of the correct genotype (MS1096-Gal4/+; UAS-Chmp1 or UAS-HM-
Chmp1/+), and their wings were mounted on a microscope slide in GMM.  
Figure 4.19 Clones of Chmp1 and forked knockdown in the adult wing. Light microscope 
images of adult female wings. Distal is right, anterior is uppermost A. Chmp1 knockdown clone 
located entirely within intervein tissue, posterior to the L5 wing vein showing no vein 
differentiation. B. Chmp1 knockdown clone that overlapped the L3 wing vein caused wing vein 
thickening. C. Chmp1 knockdown clone located within intervein tissue induced wing vein 
formation. 
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Chmp1 over-expression in the dorsal wing most commonly resulted in deltas, or 
widening of the distal tips of the dorsal wing veins (Figure 4.21A-F). Additionally, some wings 
showed ectopic wing vein formation (Figure 4.21A, C and D, white arrows). The over-
expression phenotype only increased slightly in penetrance and severity with the increasing 
culture temperature, which is expected to increase the activity of the UAS-Gal4 system. These 
over-expression phenotypes were mainly observed in male wings, while most female wings 
appeared wild-type. The MS1096-Gal4 transgene is located on the X chromosome and normally 
shows higher activity in males than females. Additionally, the MS1096-Gal4 transgene is 
inserted near the beadex gene and can increase beadex expression [2]. Beadex negatively 
regulates expression of Apterous, which in turn negatively regulates Serrate and Fringe, both of 
which are activating ligands of the Notch receptor [124-126]. Therefore, MS1096-Gal4 
Figure 4.20 Cross design for achieving Chmp1 over-expression in the Drosophila wing. A. 
Cross for over-expressing wild-type or HM-tagged Chmp1 protein from a second chromosome 
insertion with MS1096-Gal4. B. Cross for over-expressing HM-tagged Chmp1 protein from a 
third chromosome insertion with MS1096-Gal4. C. Cross for over-expressing wild-type or HM-
tagged Chmp1 protein from a second chromosome insertion with salm-Gal4 or en-Gal4. D. 
Cross for over-expressing wild-type or HM-tagged Chmp1 protein from a third chromosome 
insertion with salm-Gal4 or en-Gal4. UAS-Chmp1-1 and -2, and UAS-HM-Chmp1-3 insertions 
are on the second chromosome and balanced with Cy. UAS-HM-Chmp1-2 and -4 insertions are 
on the third chromosome balanced with TM3Ser. The UAS-HM-Chmp1-1 insertion is on the 
third chromosome and balanced with TM6SbTb. P is parental generation, F1 is first filial 
generation. Only F1 progeny of the desired genotype are shown. 
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occasionally interacts with certain genetic backgrounds to cause a phenotype in the wing, 
including the formation of deltas. So, it was possible the delta formation observed was an 
artifact. In fact, this idea is supported by the observation that there is little increase in phenotype 
with temperature. 
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Figure 4.21 Chmp1 over-expression with MS1096-Gal4 in the Drosophila wing causes vein 
deltas. Light micrographs of wings from adult males at 25, 28, and 30oC. Distal is right, 
anterior is uppermost. A-D. Over-expression of HM-Chmp1 under the control of MS1096-Gal4 
causes wing vein deltas that do not become more prominent with increasing cultivation 
temperature (i.e., increasing levels of Chmp1 expression). Ectopic vein formation indicated by 
white arrows. E and F. Over-expression of wild-type Chmp1 under the control of MS1096-
Gal4 also causes wing vein deltas that do not become more prominent with increasing 
temperature.  
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To test whether the deltas observed were a genuine result of Chmp1 over-expression 
rather than an artifact of an interaction with MS1096-Gal4, Chmp1 was over-expressed in the 
wing with two other drivers, salm-Gal4 and en-Gal4 (see Figure 4.4 for expression pattern). 
UAS-Chmp1 or UAS-HM-Chmp1 males were crossed to salm-Gal4 and en-Gal4 females and the 
progeny were grown at 25oC, 28oC, and 30oC (Figure 4.20). Male and female flies that were not 
Cy, Ser, or Sb were of the correct genotype. 
When Chmp1 was over-expressed with these different drivers, there were no deltas 
formed at 25oC or 28oC. However, at 30oC occasional deltas were observed, though the effect 
was much weaker than with MS1096-Gal4, and they were only present in a small number of 
wings (Figure 4.22). This may suggest that the delta phenotype observed was caused by Chmp1 
over-expression and was not due to a genetic interaction with the MS1096-Gal4 driver, though it 
was enhanced by the presence of the MS1096-Gal4 insert. The levels of over-expression of 
Chmp1 were not tested as there is no antibody against Drosophila Chmp1. However, the 
detection of HM-Chmp1 in Drosophila tissues (shown in Chapter 4, Section IX) and the ability 
of Chmp1 over-expression to rescue the Chmp1 knockdown wing vein phenotype suggest that 
functional Chmp1 protein is expressed from these transgenes. So the minor wing defects 
observed under presumably strong Chmp1 over-expression suggest that the development of this 
tissue is not especially sensitive to increased levels of Chmp1 protein. 
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In addition to the phenotypes discussed above, a second phenotype was observed 
occasionally in Chmp1 over-expression wings. Although it was only present in flies over-
expressing wild-type Chmp1 protein, this phenotype was observed with both the MS1096-Gal4 
and en-Gal4 drivers. In addition to vein defects (Figure 4.23B), wings from these flies also had 
disorganized hairs (discussed in Chapter 6). Often, the veins on these wings had ill-defined 
borders compared to wild-type (Figure 4.23). In some cases the wing vein appeared thickened 
(compare the L3 veins in Figure 4.23B and A), and in other cases small portions of wing veins 
were missing (Figure 4.23A). Some wings also had opaque regions, indicating a failure of 
Figure 4.22 Chmp1 over-expression in the Drosophila wing causes deltas. Light 
micrographs of wings from adult females at 30oC. Distal is right, anterior is uppermost. A and 
A’. en-Gal4/+; UAS-HM-Chmp1-1/+. A’ is an enlarged from A. Over-expression of HM-
Chmp1 caused loss of anterior cross vein (indicated in upper right box) and wing vein deltas. B 
and B’. en-Gal4/UAS-Chmp1-2. B’ is enlarged from B. Chmp1 over-expression caused 
occasional wing vein deltas. 
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imaginal disc cells to clear out of the wing at maturation, as well as wing vein deltas (Figure 
4.23B). The same phenotype appeared in both male and female flies and at all temperatures, 
though it was strongest at 30oC.  
 
 
VI. Investigation into Chmp1 regulation of Notch-Delta signaling 
Reduced activity of Delta, a Notch receptor ligand, causes the formation of ‘deltas,’ or 
distal widening of wing veins, in the Drosophila wing. Like the DER signaling pathway, Notch-
Delta signaling is involved in wing vein development. In fact, the DER and Notch signaling 
pathways interact antagonistically during wing vein specification. While the DER pathway 
promotes wing vein formation/fate, Notch signaling restricts wing vein formation/fate. So a gain 
of DER signaling can cause thickened wing veins, and a loss of Notch signaling can produce the 
same phenotype. Signaling through Notch is also important for formation of the wing margin and 
bristles; loss of Notch signaling can cause notching, or loss of the wing margin and loss of 
bristles (e.g. Figure 4.26A). 
Figure 4.23 Rare phenotypes caused by Chmp1 over-expression in the Drosophila wing. 
Light micrographs of wings from adult male cultivated at 30oC. Distal is right, anterior is 
uppermost. A and B. Over-expression of wild-type Chmp1 causes slightly thicker wing veins, 
deltas, disorganized hairs, and failure of clearing of imaginal cells out of the wing. A. en-
Gal4/UAS-Chmp1-2. B. MS1096-Gal4/Y; UAS-Chmp1-2/+. 
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In Drosophila, loss of the ESCRT-II component Vps25 caused an increase in Notch 
signaling, suggesting a requirement for ESCRT machinery for negative regulation of Notch-
Delta signaling [61]. Loss of other Drosophila ESCRT components, including Hrs, Tsg101, and 
Vps20, have been shown to cause mis-regulation of Notch signaling in Drosophila as well [59, 
61]. Thus, it is possible Chmp1 regulates Notch signaling. Although no classic Notch 
phenotypes, such as ectopic wing margin or notching of the wing margin, were observed under 
Chmp1 knockdown or over-expression conditions, the widened wing veins and deltas observed 
through Chmp1 over-expression may indicate that Chmp1 regulates Notch signaling. A 
hypomorphic Notch allele, N55e11, was used to investigate the possibility of Chmp1 regulating 
Notch signaling in the wing. Heterozygous N55e1/+ flies lose some Notch receptor function. 
Wings from these flies have slightly thicker wing veins, deltas, and show mild notching of the 
wing margin in approximately 20% of wings (Figure 4.26A). To test whether Chmp1 regulates 
Notch signaling, Chmp1 was knocked down under the control of the MS1096-Gal4 driver in a 
heterozygous N55e11 background (Figure 4.24). If Chmp1 negatively regulated Notch signaling, 
the concomitant loss of Notch and Chmp1 activity should cause the frequency and/or size of 
notches to decrease. On the other hand, if Chmp1 positively regulated Notch signaling, loss of 
both Notch and Chmp1 activity should cause the frequency and/or size of notches to increase. 
In order to test whether Chmp1 regulates Notch signaling, the Chmp1RNAi transgene, a 
driver, and the N55e11 allele had to be combined into the same fly. w; GlaBc/Cy virgin females 
were crossed to MS1096-Gal4 males (Figure 4.24A). From the progeny of that cross, Gla 
straight winged virgin females were collected (MS1096-Gal4/X; GlaBc/+) and crossed to UAS-
Chmp1RNAi-VDRC/Cy males. From the progeny of this cross, Gla (not Cy) males with the 
Chmp1 knockdown phenotype (MS1096-Gal4/Y; UAS-Chmp1RNAi-VDRC/GlaBc) were 
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collected. These males were crossed to N55e11/FM7Bar virgin females. Progeny from this cross 
were grown at 28oC to maintain consistency with previous Chmp1 knockdown crosses. Females 
among these progeny that were not Bar and not Gla were of the correct genotype (MS1096-
Gal4/N55e11; UAS-Chmp1RNAi-VDRC/+). Wings were dissected and mounted onto a glass slide 
in GMM. For a negative control cross, N55e11/FM7Bar virgin females were crossed to MS1096-
Gal4/Y males (Figure 4.24B). These flies carry the same Notch mutation and Gal4 transgene as 
the experimental flies, but do not carry the Chmp1-RNAi transgene, and so do not experience 
Chmp1 knockdown. The progeny were grown at 28oC to maintain consistency with the 
experimental cross. Females from the progeny of this cross that were not Bar were of the correct 
genotype (MS1096-Gal4/N55e11) and wings were mounted on a glass slide in GMM. 
 
 
When Chmp1 knockdown was driven with MS1096-Gal4 in the N55e11 heterozygous 
wing, the notches associated with N55e11 were completely suppressed (Figure 4.26D). Out of 31 
wings, none experienced notching. This result suggested that Chmp1 negatively regulated Notch 
signaling, and was consistent with expectations based on the established role of the ESCRT 
Figure 4.24 Cross design to test for an interaction between Chmp1 and Notch using the 
MS1096-Gal4 driver. A. Achieving Chmp1 knockdown under MS1096-Gal4 control in a 
heterozygous N55e11 background. The F3 generation was grown at 28oC. B. Control cross. F1 
generation was grown at 28oC. P is parental generation, F1 is first filial generation, F2 is second 
filial generation, F3 is third filial generation. Only progeny of interest are shown in each 
generation. 
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complexes in negatively regulating signaling pathways. However, notching was completely 
suppressed in the control wings (MS1096-Gal4/N55e11) as well, with zero out of 48 wings 
showing notching (Figure 4.26B). This suggested that the presence of the MS1096-Gal4 
transgene, rather than Chmp1 knockdown, suppressed the wing notches associated with the 
N55e11 allele. To test whether the MS1096-Gal4 insertion suppressed wing notching in general, 
the ability of MS1096-Gal4 to suppress the wing notching associated with the dominant Serrate 
(Ser) mutation was tested. MS1096-Gal4 virgin females were crossed to If/Cy; D1/TM3Ser males 
and progeny were grown at 28oC to maintain consistency with previous crosses. Flies from the 
offspring that were not D1 and therefore should carry the Ser mutation were analyzed (MS1096-
Gal4/X or Y; TM3Ser/+). These flies showed a complete suppression of notching, suggesting 
that the MS1096-Gal4 insertion indeed suppressed wing notching. Because Serrate is a Notch 
ligand, this result suggests that the MS1096-Gal4 insertion increases Notch signaling. This could 
occur through increased expression of Beadex, since the MS1096-Gal4 transgene is inserted near 
the beadex gene. As Beadex negatively regulates Notch ligands, increased Beadex activity might 
cause a decrease in Notch signaling. 
Because MS1096-Gal4 was unsuitable for driving Chmp1 knockdown in the N55e11/X 
background, the experiment was repeated with a different driver, dpp-Gal4, which is located on 
the third chromosome (Figure 4.25A). UAS-Chmp1RNAi-VDRC/Cy; D1/TM3Ser virgin females 
were crossed to wgSp1/Cy; dpp-Gal4/TM6Tb males. Larvae that were not Tb were collected, and 
Cy and D1 males that emerged from these larvae were of the genotype needed (UAS-
Chmp1RNAi-VDRC/Cy; dpp-Gal4/D1). These males were crossed to N55e11/FM7Bar virgin 
females and progeny were grown at 28oC to maintain consistency with previous Chmp1 
knockdown crosses. From these progeny, wings from females that were not Cy, not D1, and not 
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Bar (N55e11/X; UAS-Chmp1RNAi-VDRC/+; dpp-Gal4/+) were dissected and mounted in GMM 
on a microscope slide. Several control crosses were completed to verify that any changes 
notching frequency observed were in fact due to Chmp1 knockdown (Figure 4.25B-D). The first 
control cross generated flies that were N55e11/X to ensure that the FM7Bar balancer did not affect 
notching frequency. Oregon R males were crossed to N55e11/FM7Bar virgin females. From the 
progeny, wings from females that were not Bar were of the correct genotype (N55e11/X) and were 
mounted. In previous experiments, the presence of the MS1096-Gal4 transgene altered the 
notching frequency typically observed in N55e11 flies. To ensure this was not the case for the dpp-
Gal4 driver, a second control cross was performed that generated flies carrying the N55e11 allele 
and the dpp-Gal4. wgSp1/Cy; dpp-Gal4/TM6Tb males were crossed to N55e11/FM7Bar virgin 
females. From the progeny, wings from females that were not Tb and not Bar were of the correct 
genotype (N55e11/X; dpp-Gal4/+) and were mounted. To test the sensitivity of the N55e11 allele to 
genetic background, flies were generated that carried the N55e11 allele, as well as the Chmp1RNAi 
transgene. For the third control cross, UAS-Chmp1RNAi-VDRC/Cy males were crossed to 
N55e11/FM7Bar virgin females. From the progeny, wings from females that were not Cy and not 
Bar were of the correct genotype (N55e11/X; UAS-Chmp1RNAi-VDRC/+) and were mounted. 
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When Chmp1 was knocked down under the control of the dpp-Gal4 driver in a N55e11 
heterozygous background, both the thickened vein phenotype and the frequency of notches 
associated with N55e11 were slightly increased, which would seem to suggest that Chmp1 
positively regulates Notch signaling (Table 4.2). Although this was unexpected because other 
studies show that ESCRTs negatively regulate Notch signaling [61], it was a possible interaction 
and it would fit with the Chmp1 knockdown wing phenotype. It is known that Notch negatively 
regulates wing vein thickness. Thus, if Chmp1 positively regulated Notch signaling, then loss of 
Chmp1 activity would reduce Notch signaling and cause the thick wing veins associated with 
Chmp1 knockdown. However, notching frequency was highly variable depending upon the 
genetic background (Table 4.2). For example, in flies that carried the N55e11 allele alone, notching 
occurred in about 20% of wings. Flies carrying the N55e11 allele and just the dpp-Gal4 or the 
UAS-Chmp1RNAi-VDRC transgene had an increased notching frequency to about 40%. When 
the N55e11 allele was balanced with the FM7Bar balancer, the notching frequency increased to 
Figure 4.25 Cross design to test for an interaction between Chmp1 and Notch using the 
dpp-Gal4 driver.  A. Experimental cross to achieve Chmp1 knockdown with dpp-Gal4 in a 
heterozygous N55e11 background. The F2 generation was raised at 28oC. B-D. Control crosses. 
F1 generations were raised at 28oC. P is parental generation, F1 is first filial generation, F2 is 
second filial generation. Only genotypes of interest are shown. 
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over 60%. Notching was more frequent at higher temperatures, consistent with the temperature 
sensitivity of the N55e11 allele. The variability of the notching phenotype in different genetic 
backgrounds makes the data gained from these crosses difficult to interpret. 
Knockdown of Chmp1 caused a thickened wing vein when driven with either MS1096-
Gal4 or dpp-Gal4 (Figure 4.26C and F). A weaker but consistent wing vein phenotype, a slight 
thickening in the distal L3 wing vein, was observed when dpp-Gal4 was used to drive Chmp1 
knockdown as it drives Gal4 expression relatively weaker than MS1096-Gal4. Similarly, wings 
heterozygous for the N55e11 allele had a thicker wing vein (Figure 4.26A and A’). When Chmp1 
knockdown was driven with either MS1096-Gal4 or dpp-Gal4 in an N55e11 heterozygous wing, 
the wing vein was thicker than observed with Chmp1 knockdown or in an N55e11 heterozygote 
(Figure 4.26D and G). This is probably an additive effect, presumably due to a combination of 
over-active DER signaling caused by loss of Chmp1 activity and the partial loss of Notch 
activity associated with the N55e11 allele.  
The results showing the sensitivity of the N55e11 associated wing phenotype to genetic 
background are concerning, especially because testing suppression/enhancement of this 
phenotype is an established method used for analyzing interactions with the Notch signaling 
pathway. For example, the N55e11 allele was used in a similar experiment to provide evidence that 
the Drosophila phosphocholine cytidylyltransferase (CCT, the rate-limiting enzyme in 
phosphatidylcholine synthesis) positively regulates Notch signaling [127]. This single test was 
not the only evidence provided to support the finding. However, the validity of results obtained 
with this specific approach is questionable in light of the data presented here. 
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Notch signaling can be activated in a ligand-independent as well as a ligand-dependent 
manner. Ligand-independent activation of Notch requires Deltex (Dx), an E3 ubiquitin ligase and 
a positive regulator of Notch signaling. Dx promotes Notch monoubiquitination and induces 
Notch endocytosis and incorporation onto the late endosomal membrane. At the late endosome, 
γ–secretase mediates the cleavage of the intracellular domain (NICD), which propagates the 
Notch signal [128, 129]. Dx also suppresses the incorporation of Notch into MVBs. This causes 
retention of Notch in the endosomal membrane, increasing the number of Notch molecules 
cleaved by γ–secretase and thereby increasing the Notch signal. The cleaved NICD can then 
enter the nucleus and activate transcription factors that enhance or suppress expression of target 
Figure 4.26 Variable notching phenotypes associated with various genotypes. Light 
micrographs of adult wings raised at 28oC. Distal is right, anterior is uppermost A. N55e11 
heterozygous wing with a moderate wing phenotype (notching, deltas, and thick veins). A’. 
N55e11 heterozygous wing with a milder wing phenotype (notching, delta, and thick veins). B. 
Presence of MS1096-Gal4 in a N55e11 heterozygous wing completely suppressed notching. C 
and F. Driving Chmp1 knockdown under the control of MS1096-Gal4 or dpp-Gal4 caused 
thick wing veins. D. Driving Chmp1 knockdown under the control of MS1096-Gal4 in a 
heterozygous N55e11 background suppressed notching and enhanced the wide veins and delta 
phenotypes. E. The presence of dpp-Gal4 in a N55e11 heterozygous wing enhanced notching 
frequency. G. Driving Chmp1 knockdown under the control of dpp-Gal4 in a N55e11 
heterozygous wing slightly enhanced notching frequency, and enhanced the wide veins 
phenotype. Percentage of wings of each genotype showing notching is indicated at the bottom 
right of each panel.  
Table 4.2 Notching frequencies of individual genotypes. Wings were counted from flies that 
were raised at 28oC. 
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genes. In Dx-induced ligand-independent activation of Notch, the location of the Notch receptor 
is key; Notch must reach the late endosome to be activated, but must be kept out of the ILVs of 
the late endosome/MVB, as this would remove the NICD from the cytoplasm and prevent it 
being cleaved thus inhibiting the Notch signal [130]. Since Chmp1 is a component of the ESCRT 
machinery, which is involved in MVB formation, it is possible that Chmp1 is involved in the 
regulation of ligand-independent Notch signaling. If this is the case, faulty MVB formation 
caused by Chmp1 knockdown could prevent the normal degradation/silencing of the Notch 
receptor. This would allow more opportunity for Notch receptor cleavage, and could lead to 
increased Notch signaling, which would be evident as ectopic wing margin and bristles (i.e., 
margin and bristles extend into the wing blade).  
To test for involvement of Chmp1in the ligand-independent activation of Notch, the 
hypomorphic carnation mutation car1, and the UAS-dx transgene were used. When dx is over-
expressed, the Notch receptor is driven into the endocytic pathway and becomes over-activated. 
In the wing, dx over-expression causes ectopic wing margin and bristles due to increased Notch 
activation (Figure 4.29B). Carnation (Vps33p homologue) is a component of the homotypic 
fusion and vacuole protein sorting (HOPS) protein complex that is involved in trafficking from 
the early to the late endosome, and from the late endosome to the lysosome [129, 131, 132]. 
Mutation of Carnation, such as in the car1 mutant, can block progression of proteins, including 
Notch, from the early endosome to the lysosome where Notch would become activated. This 
causes loss of the Notch signal and therefore notching of the wing margin. Thus, the car1 allele 
was used in combination with dx over-expression as a control to show the phenotypic 
consequences of driving Notch into the endocytic pathway, and then blocking its activation (i.e., 
the opposite result of what was expected with Chmp1 knockdown and Dx over-expression). To 
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generate the control, car1; dpp-Gal4/TM6Tb males were crossed to UAS-dx17 virgin females and 
the progeny that were not Tb (car1/+; dpp-Gal4/UAS-dx17) were collected and wings mounted 
(Figure 4.27). 
 
 
When dx is over-expressed in a background heterozygous for car1, the ectopic wing 
margin phenotype caused by dx over-expression is transformed into a notch phenotype (Figure 
4.29C). Presumably, this is due to removal of Notch from the membrane by dx over-expression 
in combination with interference of the early endosome/lysosome pathway due to the car1 
mutation. This leads to a loss of Notch signaling indicated by wing notching. If loss of Chmp1 
disrupts endocytic trafficking and blocks Notch progressing to the lysosome as the car1 mutation 
does, then notching should occur when dx is over-expressed concomitantly with Chmp1 
knockdown. Another possibility is that loss of Chmp1 stalls MVB formation and increases the 
time Notch spends in the limiting membrane of the late endosome, so in this case, an increase in 
Notch signaling could be expected, resulting in ectopic margin. 
To test for a genetic interaction between Chmp1 and Dx, i.e., ligand-independent Notch 
signaling, Chmp1 knockdown and dx over-expression were driven in the same wing under the 
control of the dpp-Gal4 driver (Figure 4.28). UAS-Chmp1RNAi-VDRC/Cy virgin females were 
crossed to Cy/If; D1/TM6Sb males and from the progeny, virgin females that were Cy and Sb, but 
not If, were collected (UAS-Chmp1RNAi-VDRC/Cy; TM6Sb/+). In a separate cross, dpp-
Figure 4.27 Control cross design to show interaction between Car and Deltex.  Females 
that were not Tb were of the correct genotype. P is parental generation, F1 is first filial 
generation. Only the desired genotype in the filial generation is shown. 
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Gal4/TM6Tb males were crossed to Cy/If; D1/TM3Ser virgin females, and from the progeny 
males that were If and Ser, but not Cy (If/+; dpp-Gal4/TM3Ser) were collected. The UAS-
Chmp1RNAi-VDRC/Cy; TM6Sb/+ virgin females were then mated to the If/+; dpp-Gal4/TM3Ser 
males, and males that were If and Sb, but not Cy or Ser (UAS-Chmp1RNAi-VDRC/If; dpp-
Gal4/TM6Sb) were collected from the progeny. These males were crossed to UAS-Dx17 virgin 
females. Progeny from this cross that were not If and not Sb were of the correct genotype (UAS-
Chmp1RNAi-VDRC/+; dpp-Gal4/UAS-Dx17). 
 
As shown before, knockdown of Chmp1 with dpp-Gal4 causes thickening of the L3 wing 
vein (Figure 4.29A). Interestingly, when Chmp1 was knocked down in a wing over-expressing 
dx, the result was ectopic bristles within the wing blade, as well as a loss of marginal bristles, 
which could be considered a weak notching phenotype (Figure 4.29D). Additionally, the distal 
portion of the L3 wing vein was lost.  
These phenotypes are puzzling, because loss of wing vein and ectopic bristles are 
normally associated with gain of Notch function, while notching indicates a loss of Notch 
function. The loss of the distal wing vein was never observed when dx was over-expressed under 
Figure 4.28 Cross design to test for an interaction between Chmp1 and Deltex.  Females 
that were not If and not Sb were of the correct genotype. P is parental generation, F1 is first 
filial generation, F2 is second filial generation, F3 is third filial generation. Only the desired 
genotype from each filial generation is shown. 
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the control of dpp-Gal4, even though increased Dx activity is known to increase Notch signaling. 
In fact, the opposite was observed; dx over-expression generated slightly thicker wing veins. 
Likewise, wing vein loss was never observed under Chmp1 knockdown conditions alone. This 
suggests that the vein loss is a specific result of loss of Chmp1 activity in combination with gain 
of Dx activity. Over-expression of dx drives Notch into the endocytic pathway and prevents its 
incorporation into the MVB. If Chmp1 knockdown inhibits normal MVB formation then the 
combined effect of dx over-expression and Chmp1 knockdown might cause increased Notch 
signaling, which could explain the loss of distal wing vein and the ectopic bristles. However, this 
does not account for the minor notches observed, which may suggest that in some wing cells 
Notch was blocked from progressing to the late endosome where it would be activated. This 
seems unlikely as the literature reports that the role of Chmp1 and other ESCRT components is 
not the trafficking of Notch to the late endosome, but rather moving Notch from the limiting 
membrane of the late endosome into the ILVs of the MVB. Additionally, it does not seem likely 
that the same combination of factors might increase Notch activation in some cells and decrease 
it in other cells within the same tissue. The contradictory nature of these observed phenotypes 
make the results of this experiment difficult to interpret. However, the phenotypes indicative of 
activated Notch signaling, i.e., loss of the L3 wing vein and extra bristles within the wing blade, 
were more obvious and consistent than the notching phenotype, which would indicate loss of the 
Notch signal. 
It is also interesting that over-expression of dx causes a slightly thickened wing vein, 
especially considering that dx mutants also have thickened wing veins as well. This may suggest 
that driving Notch into the endocytic pathway has different effects in different parts of the wing, 
i.e., activating Notch at the wing margin, but inactivating it in the wing veins. An alternative is 
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that the effect of a certain dose of Dx is different in different parts of the wing. Possibly, the 
same amount of dx over-expression activates Notch at the wing margin, but has a dominant-
negative effect in vein tissue that reduces Notch signaling.  
 
 
VII. Testing for interactions between Chmp1 and regulators of the DER using Chmp1 over-
expression lines 
Heterozygosity for loss of function alleles of positive or negative regulators of the DER 
suppressed and enhanced the Chmp1 knockdown phenotype, respectively. This result suggested 
that Chmp1 negatively regulates DER signaling in the Drosophila wing. If Chmp1 over-
expression leads to an increase in Chmp1 activity and thus decreased DER signaling, then, for 
Figure 4.29 Interaction between Chmp1 and Deltex. Light micrographs of adult female 
wings grown at 25oC. Distal is right, anterior is uppermost. A. Chmp1 knockdown driven with 
dpp-Gal4 causes a slightly larger wing vein. B. Driving over-expression of dx with dpp-Gal4 
causes slightly wider wing vein, as well as ectopic wing margin. C. Driving dx over-expression 
with dpp-Gal4 in a background heterozygous for car1 causes wing notching. D. dx over-
expression and Chmp1 knockdown with dpp-Gal4 causes a wider wing vein, ectopic margin, 
and a mild notching phenotype (loss of distal marginal bristles). 
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example, heterozygosity for loss of function alleles of positive regulators of the DER 
concomitant with Chmp1 over-expression might cause thinning or loss of wing veins.  
To test for an interaction between Chmp1 and regulators of DER signaling, the en-Gal4 
driver, the UAS-Chmp1 or UAS-HM-Chmp1 transgene, and a loss of function allele for either 
positive or negative regulators of the DER had to be combined into the same fly (Figure 4.30). 
en-Gal4; D1/TM3Sb virgin females were crossed to female virgins carrying loss of function 
alleles for the DER regulators Sty (If/Cy;sty5/TM3Sb), Aos (If/Cy;argosw11/TM3Sb), or Rho and 
Vn (If/Cy;ve,vn). From this cross, males that were If and D1 (not Sb) were collected (en-Gal4/If; 
sty5, argosw11, or ve,vn/D1). These males were crossed to UAS-HM-Chmp1-3 or UAS-Chmp1-
2/Cy virgin females. Wings from females from this cross that were not If, Cy, or D1 were of the 
correct genotype (en-Gal4/UAS-HM-Chmp1-3 or UAS-Chmp1-2; rhove-1, vn1/+, en-Gal4/UAS-
HM-Chmp1-3 or UAS-Chmp1-2; styΔ5/+, en-Gal4/UAS-HM-Chmp1-3 or UAS-Chmp1-2; 
aosw11/+) and mounted onto a microscope slide in GMM. 
 
Figure 4.30 Cross design using Chmp1 over-expression transgenes to test for an 
interaction between Chmp1 and DER regulators. P is parental generation, F1 is first filial 
generation, F2 is second filial generation, F3 is third filial generation. Only the desired 
genotype from each filial generation is shown. 
106 
 
Expression of UAS-Chmp1-2 under en-Gal4 control in a background heterozygous for 
either aos or rho and vn resulted in similar phenotypes. In both cases, minor deltas were 
observed and the posterior wing was smaller, indicated by a slight curving to the posterior of the 
wing (Figure 4.31A and B). Additionally, sporadic and small portions of the L4 wing vein were 
lost, suggesting that cells adopted an intervein instead of a vein fate (Figure 4.31A and B). 
Expression of UAS-HM-Chmp1-3 in a background heterozygous for loss of function alleles for 
either aos or rho and vn caused minor but specific phenotypes, including loss of the acv and delta 
formation (Figure 4.31C and D). These phenotypes could indicate a loss of DER activity or a 
gain of Notch signaling. However, as similar phenotypes were observed when Chmp1 was over-
expressed in wings heterozygous for loss of function alleles for both positive and negative 
regulators of DER signaling, this effect does not seem specific. This suggests that over-
expression of Chmp1 has no significant effect on DER signaling and thus a precise dosage of 
Chmp1 is not crucial for normal DER signaling in wing vein development.  
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VIII. Chmp1 knockdown in the eye disrupts ommatidia 
 Chmp1 knockdown experiments suggested that Chmp1 negatively regulates DER 
signaling in the Drosophila wing. To investigate whether this was true for other Drosophila 
tissues, and to gain more insight into the function of Chmp1 in the developing organism, Chmp1 
was knocked down in the fly eye (Figure 4.32). During eye development, DER signaling is 
involved in specifying photoreceptors of the ommatidia. Loss of DER signaling usually results in 
loss of photoreceptors, while gain in DER signaling generally causes recruitment of additional 
Figure 4.31 Chmp1 over-expression and DER regulators. Light micrographs of adult female 
wings grown at 30oC. Distal is right, anterior is uppermost. A. en-Gal4/UAS-Chmp1-2; 
aosw11/+. B. en-Gal4/UAS-Chmp1-2; rhove-1,vn1/+. C. en-Gal4/UAS-HM-Chmp1-3; aosw11/+. 
D. en-Gal4/UAS-HM-Chmp1-3; rhove-1,vn1/+. Yellow arrows indicate loss of the anterior cross 
vein (acv). 
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photoreceptors. So if Chmp1 negatively regulates DER signaling, then Chmp1 knockdown might 
cause an increase in the number of photoreceptors within ommatidia. 
 To test this, two different drivers were used to drive Chmp1 knockdown in the eye: 
sevenless-Gal4 (sev-Gal4), which drives Gal4 expression in R cell and cone cell precursors, and 
eyeless-Gal4 (ey-Gal4), which drives Gal4 expression anterior to the morphogenetic furrow in 
the eye disc during larval development (see Chapter 1 Section I.C for description of eye 
development) [2]. sev-Gal4 or ey-Gal4 males were crossed to UAS-Chmp1RNAi-TRiP virgin 
females and the progeny were grown at 25oC, 28oC, or 30oC. The heads from the progeny were 
fixed, dehydrated, embedded in plastic, sectioned, stained and imaged on a light microscope (see 
Chapter 3 Section VII for methods).  
 
 
Driving Chmp1 knockdown with sev-Gal4 resulted in eyes that were largely wild-type, 
with the exception that rare defects were observed at 30oC, such as symmetrical ommatidia and 
loss of photoreceptor cells (Figure 4.33B). Symmetrical, or non-chiral ommatidia have either two 
R3 or two R4 photoreceptors, instead of one R3 and one R4. Chirality is determined by the 
position of the R3 and R4 photoreceptors within an ommatidium and is specified by the Notch 
and Fz PCP signaling pathways [133, 134]. Therefore the presence of symmetrical ommatidia 
could indicate faulty Notch or Fz PCP signaling. 
Figure 4.32 Cross design for Chmp1 knockdown in the Drosophila eye. The F1 generation 
was grown at 25oC, 28oC, or 30oC. P is parental generation, F1 is first filial generation. All 
progeny were of the desired genotype. 
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At 25oC a largely wild-type phenotype was observed when Chmp1 was knocked down 
under the control of ey-Gal4. But at 28oC and 30oC, Chmp1 knockdown caused major defects in 
ommatidial development (Figures 4.33C-E). These defects were usually severe enough to make 
it difficult to determine the site of the equator of the eye, or to determine the chirality of 
individual ommatidia. One common defect observed when Chmp1 knockdown was driven with 
ey-Gal4 was misaligned ommatidia. In wild-type eyes, ommatidia are perfectly aligned with each 
other within each half of the eye (Figure 4.33A). In eyes with Chmp1 knockdown, misaligned 
ommatidia were observed, which suggests that ommatidial rotation during eye development was 
impaired (Figures 4.33D and E). Misrotation of ommatidia is a classic problem associated with 
both under- and over-active DER signaling [133]. In rare cases, symmetrical ommatidia were 
observed, which again could indicate faulty Notch or Fz PCP signaling. However, as 
symmetrical ommatidia were quite rare, and since chirality, when observable, was normal, it 
appears Chmp1 knockdown has only a minor effect on these pathways.  
By far the most common abnormality observed in eyes with Chmp1 knockdown was loss 
of photoreceptor cells. Over-active DER signaling is known to cause recruitment of extra 
photoreceptors, suggesting that loss of photoreceptors might indicate a loss of DER signal. This 
would seem to contradict the results from the wing, which suggest that Chmp1 knockdown 
increases DER signaling. However, DER ellipse alleles (e.g., EGFRElpB1 – an amino acid 
substitution in kinase domain that activates tyrosine kinase activity and causes ligand-
independent signaling) are gain of function alleles that cause loss of photoreceptors, similar to 
the phenotype observed with reduced Chmp1 activity [127, 135, 136]. Since constitutively active 
DER and Chmp1 knockdown result in similar phenotypes, it appears that Chmp1 knockdown is 
equivalent to over-active DER. If Chmp1 knockdown disrupts the incorporation of the DER into 
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MVBs, this could result in persistent DER signaling since the DER would still be able to signal 
to the cytoplasm.    
Chmp1 was also over-expressed in the eye using the sev-Gal4 and ey-Gal4 drivers at 
25oC, 28oC, and 30oC. However, a wild-type phenotype was observed. This absence of a Chmp1 
over-expression phenotype in the eye and the weak phenotype observed in the wing may suggest 
that a precise dosage of Chmp1 in the cell is not critical for its normal activity. 
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IX. Drosophila Chmp1 localizes apically and to the cell membrane 
Most studies on the subcellular localization of Chmp1 have been performed in cell 
culture rather than in developing tissues, and different studies show different localizations for 
Chmp1. Reports in cultured mammalian cells and Aspergillus nidulans show Chmp1 localization 
to both the early and late endosome, localizations that are consistent with a role for Chmp1 as a 
component of ESCRT-III [86, 97]. Other reports in cultured mammalian cells, zebrafish, and 
Nicotiana benthamiana show localization to the nucleus [81, 85, 91, 95]. In mammalian cell 
culture, the localization of Chmp1 seemed to vary by cell treatment and type, a finding that was 
also observed in the zebrafish brain [91, 95]. Since the Chmp1 and HM-Chmp1 over-expression 
lines appeared to have some normal Chmp1 activity (shown in Chapter 4 Section II), and over-
expression of Chmp1 caused only weak localized phenotypes, the UAS-HM-Chmp1 fly line 
provided a suitable way to study the subcellular localization of the Chmp1 protein in cells of a 
developing tissue. Epithelial cells in embryos and wing imaginal discs were used to investigate 
the localization of Chmp1. Embryos were tried first because it is normally easy to collect large 
numbers (i.e., from a single embryo collection hundreds can be collected) and fairly 
straightforward to prepare for immunostaining. en-Gal4, which expresses Gal4 in the anterior of 
each parasegment, was used to drive expression of HM-Chmp1 and GFP. Therefore cells 
Figure 4.33 Chmp1 knockdown and over-expression in the Drosophila eye. Light 
microscope images of one micron thick tangential sections of adult Drosophila eyes. Images 
were taken at the equator of the eye, when possible. A. Oregon R. B. Chmp1 knockdown at 
30oC, (sev-Gal4/+; UAS-Chmp1RNAi-TRiP/+). C. Chmp1 knockdown at 28oC, (ey-Gal4/+; 
UAS-Chmp1RNAi-TRiP/+). D. and E. Chmp1 knockdown at 30oC, (ey-Gal4/+; UAS-
Chmp1RNAi-TRiP/+). F. Chmp1 over-expression at 30oC, (ey-Gal4/UAS-Chmp1-2). 
Schematics below each panel show the arrangement of each ommatium, including chirality and 
rotation. Ommatidia with dorsal chirality marked in purple, ommatidia with ventral chirality 
marked in blue, and symmetrical ommatidia are marked in yellow. Open black circles indicate 
ommatidia with fewer R cells than wild-type and thus chirality was undeterminable.   
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expressing HM-Chmp1 were marked by GFP expression. To achieve this, en-Gal4,UAS-GFP 
homozygous virgin females were crossed to UAS-HM-Chmp1-1/ TM6TbSb males (Figure 4.34). 
Embryos were fixed, an anti-c-Myc antibody was used to detect HM-Chmp1, and the embryos 
were mounted in Vectashield mounting media with DAPI. Only embryos that showed both GFP 
and c-Myc staining were imaged using a confocal microscope. 
 
 
In embryos expressing HM-Chmp1 and GFP under en-Gal4 control, c-Myc staining was 
observed specifically in GFP-expressing cells and no c-Myc staining was visible in the non-GFP-
expressing cells. This suggested that the c-Myc antibody was specific for HM-tagged Chmp1. 
HM-Chmp1 localized mostly to the apical plasma membrane of the embryonic epithelial cells 
(Figure 4.35). Nuclear HM-Chmp1 was not detected, despite the the presence of an NLS 
sequence in Drosophila Chmp1, and the fact that previous reports describe Chmp1 localizing to 
the nucleus. 
The subcellular localization of Chmp1 was also investigated in epithelial cells of the 
imaginal wing disc. The en-Gal4 driver was used again to drive expression of HM-Chmp1 and 
GFP in the posterior wing disc. To achieve this, en-Gal4,UAS-GFP homozygous virgin females 
were crossed to males carrying a UAS-HM-Chmp1 insertion on either the second or third 
Figure 4.34 Cross design for HM-Chmp1 expression in both the anterior of embryonic 
parasegments and the posterior wing disc in larvae. P is parental generation, F1 is first filial 
generation. Only desired genotypes are shown in the F1 generation. 
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chromosome (Figure 4.34). Larvae were grown at 18oC. At a lower temperature, the UAS-Gal4 
system is less active, so HM-Chmp1 is expected to be lower than at higher temperatures. This 
reduces the possibility of excessive over-expression resulting in aberrant localization of the 
protein. Third instar wing discs were dissected and an anti-c-Myc antibody was used to detect 
HM-Chmp1 in the discs. The discs were mounted onto a microscope slide in Vectashield with 
DAPI, and discs that showed both GFP and c-Myc staining were of the correct genotype and so 
were imaged with a confocal microscope.  
HM-Chmp1 consistently localized to the apical plasma membrane in the third instar 
larval wing disc when expressed from multiple independent HM-Chmp1 transgene insertions 
(Figure 4.35). These results suggest that the apical membrane localization observed is the 
genuine localization of HM-Chmp1, as multiple independent HM-Chmp1 transgene insertions in 
two separate tissues showed similar HM-Chmp1 localizations.  
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X. Chmp1 localizes to the late endosome 
If Drosophila Chmp1 regulates DER signaling through its function in the ESCRT 
complexes during MVB biogenesis, then Chmp1 should localize to the endosome. Localization 
of HM-Chmp1 at the early endosome was investigated by looking for co-localization of HM-
Chmp1 and the early endosome marker, Rab5. HM-Chmp1 and GFP were expressed in the 
anterior of parasegments in embryos under the control of the en-Gal4 driver (Figure 4.34). 
Embryos were collected and immunostained for HM-Chmp1 using anti-c-Myc and for Rab5 
using anti-Rab5. No apparent co-localization was observed between HM-Chmp1 and Rab5, 
suggesting that HM-Chmp1 does not localize to the early endosome (Figure 4.37A). Co-
localization between Chmp1 and its known binding partner, Vps4, was investigated as well. 
Using an antibody to detect Vps4, no obvious co-localization between Vps4 and HM-Chmp1 
was observed (Figure 4.37C). Although Chmp1 has been shown to bind Vps4 in yeast, humans, 
and Drosophila this binding is likely transient [72, 73], which could explain the lack of co-
localization [82, 97, 110]. 
Localization of HM-Chmp1 at the late endosome was investigated by looking for co-
localization of HM-Chmp1 and the late endosome marker, Rab9. HM-Chmp1 was expressed in 
Figure 4.35 Localization of HM-Chmp1 in wing imaginal discs. All images from en-
Gal4,UAS-GFP/+; UAS-HM-Chmp1/+ or en-Gal4,UAS-GFP/UAS-HM-Chmp1 flies. Confocal 
Z-series showing HM-Chmp1 localization (red) in wing discs. The Z-series began just above 
apical region of the columnar epithelial cells of the disc proper. HM-Chmp1 expression was 
driven under the control of the en-Gal4 driver using four independent HM-Chmp1 transgene 
insertions. Cells expressing HM-Chmp1 were marked with GFP (green). Scale bar is 10µm. A-
D. Wing discs were immunostained with anti-c-Myc for HM-Chmp1 (red). One section from a 
Z-series is shown. A’-D’. Images A-D merged with GFP (green) and nuclear (blue) images. 
Orthogonal X and Y sections, indicated by yellow lines, are below and to the left of the image 
respectively. White arrows indicate the apical localization of HM-Chmp1. The position of the 
orthogonal sections is indicated by yellow lines. Z-series depth for A’ was 11.78µm, B’ was 
6.38µm, C’ was 9.64µm, and D’ was 14.25µm. 
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embryos, along with YFP-tagged Rab9 under the control of the en-Gal4 driver (Figure 4.36). 
If/Cy; D1/TM3Ser virgin females were mated to UAS-YFPRab9 males. From the progeny of that 
cross, males that were Cy and Ser, but not If or Sb (UAS-YFP/Cy; TM3Ser/+), were collected and 
crossed to If/Cy; UAS-HM-Chmp1-1/TM6TbSb virgin females. From the offspring of this cross, 
males that were UAS-YFPRab9/Cy; UAS-HM-Chmp1/TM3Ser were collected and crossed to en-
Gal4, UAS-GFP virgin females. Embryos were collected at 18oC, immunostained with an anti-c-
Myc antibody to detect HM-Chmp1, and imaged with a confocal microscope. YFP expression, 
driven by the en-Gal4 driver, was only detected the anterior of each parasegment, along with 
GFP and HM-Chmp1. Additionally, only a proportion of embryos (~ 25% expected) had all three 
transgenes, so only a proportion of embryos expressed Chmp1, GFP, and YFP-Rab9. 
 
 
Although the fluorescent signals from YFP-Rab9 and HM-Chmp1 did not completely 
overlap, some co-localization was apparent (Figure 4.37B). This implies that Chmp1 localizes to 
the late endosome and suggests that Chmp1 is functioning there. In light of the literature, this 
localization is likely a function of the role of Chmp1 as a component of the ESCRT-III complex 
Figure 4.36 Cross design for HM-Chmp1 and YFP-Rab9 expression in the anterior of 
embryonic parasegments. P is parental generation, F1 is first filial generation, F2 is second 
filial generation, F3 is third filial generation. Only the desired genotypes in filial generations 
are shown. 
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in MVB generation. This suggests that the negative regulation of DER signaling by Drosophila 
Chmp1 may well be due to its function in MVB biogenesis. So, when Chmp1 is knocked down, 
MVB formation is incomplete, resulting in persistent DER signaling due to a failure to separate 
the DER from the cytoplasm. 
 
 
Figure 4.37 Relative subcellular localizations of HM-Chmp1 with endosome markers and 
Vps4. Confocal images of embryos driving UAS-HM-Chmp1-1 expression under the control of the en-
Gal4 driver. Embryos were immunostained with anti-c-Myc for HM-Chmp1 (red). One section 
from a confocal Z-series showing HM-Chmp1 localization is shown. Scale bar is 5µm. A. 
Localization of HM-Chmp1 (red) and Rab5 (yellow) and merged image, (en-Gal4,UAS-GFP/+; 
UAS-HM-Chmp-1-1/+). B. Localization of HM-Chmp1 and YFP-Rab9 (yellow) and merged image, 
(en-Gal4,UAS-GFP/UAS-YFPRab9; UAS-HM-Chmp1-1/+). C. Localization of HM-Chmp1 and 
Vps4 (yellow) and merged image, (en-Gal4,UAS-GFP/+; UAS-HM-Chmp1-1/+).  
 
118 
 
CHAPTER 5 
 DISCUSSION 
Many cell signaling pathways share a common cascade structure in which activation is 
initiated by the binding of a ligand to a transmembrane receptor. The activated receptor then 
transmits the signal to signaling components in the cellular cytoplasm. This usually leads to a 
change in gene expression, which alters the activity of the cell. Down-regulation of cellular 
signaling pathways is crucial for proper function of a cell and persistent signaling can result in 
severe problems, such as deregulated growth. One method of down-regulating cell signaling 
pathways is degradation of activated transmembrane receptors through the multivesicular body 
(MVB) pathway. The ESCRT (Endosomal Sorting Complexes Required for Transport) -0, -I, -II, 
and –III complexes mediate MVB generation, by which receptors are sequestered from the 
cytoplasm into intralumenal vesicles (ILVs) of the MVB, thereby silencing the signal. ESCRT 
function during MVB generation is required for the down-regulation of many signaling 
pathways, including EGFR and Notch [58-61]. This study investigated the function of the 
Chmp1 protein, a component of ESCRT-III. The ESCRT-III protein complex provides the core 
function of ESCRT activity: the scission of the neck of the ILV, completing MVB formation.  
Previous studies in a variety of organisms have implicated Chmp1 in MVB biogenesis, 
protein sorting, mitosis, and both positive and negative regulation of growth [69, 81, 86-89, 91, 
92, 100]. As most studies on Chmp1 have been performed in single cell culture, Drosophila 
provided a useful model for investigating Chmp1 function in developing tissues. The research 
presented in this dissertation suggests that Chmp1 negatively regulates DER signaling and wing 
vein cell fate in the Drosophila wing. This is likely a result of the role of Chmp1 in the ESCRT-
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III complex, which mediates the down-regulation of activated DERs via the MVB pathway and 
lysosomal degradation. 
I. Chmp1 is essential 
This is the first published investigation of Chmp1 function in invertebrates. Drosophila 
provides a useful model for investigating Chmp1 function as it expresses a single Chmp1 protein 
that shares all the functional domains identified in the vertebrate Chmp1 protein. Also, the well-
established genetic tools available in Drosophila allow the fine control of Chmp1 expression 
during tissue development. Fly lines expressing RNAi targeted at the Chmp1 transcript were 
used to investigate the effect of loss of Chmp1 on survival. Ubiquitous knockdown of Chmp1 
during fly development was lethal, suggesting that Chmp1 is an essential gene for Drosophila 
development. This is consistent with the finding that Chmp1 is essential in Arabidopsis thaliana, 
but contrasts with studies in Nicotiana benthamiana, and Aspergillus nidulans, in which Chmp1 
was not essential for survival [85-87]. It appears, therefore, that loss of Chmp1 is not necessarily 
cell or tissue lethal. However, the deregulation of cell signaling resultant from loss of Chmp1 
activity can cause inviability in some organisms. This suggests that, although Chmp1 activity, 
e.g., its molecular interactions and functional domains, appears to be conserved, the downstream 
consequences of Chmp1 loss differs between species. When compared in a dendrogram showing 
the evolutionary relationships between Chmp1 proteins, Drosophila Chmp1 is more closely 
related to mammalian Chmp1 than to Chmp1 in plants or yeast [92]. So, like most Drosophila 
proteins, it appears that Chmp1 function is better conserved between flies and humans, than 
between flies and plants.  
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II. Chmp1 regulates the wing vein cell fate decision 
The UAS-Gal4 system provided a way to limit Chmp1 knockdown to a specific tissue, 
avoiding the lethality associated with ubiquitous Chmp1 knockdown. Thus, Chmp1 was knocked 
down in the wing, one of the best characterized adult structures of the fly and a non-essential 
tissue for survival. When Chmp1 knockdown was limited to the wing, thickened wing veins 
resulted. Ideally, the strength of the knockdown, i.e., the difference in protein levels between 
wild-type and Chmp1 knockdown flies, would have been measured. As no antibody has been 
generated against Drosophila Chmp1, Chmp1 protein levels could not be detected via 
immunoblot. Additionally, as RT-PCR would assay mRNA levels, it would not necessarily give 
a valid indication of protein levels. However, expression of RNAi against Chmp1 caused a 
reproducible and specific wing phenotype using multiple drivers and two independent RNAi 
lines, strongly suggesting that the thickened wing veins were caused by reduced Chmp1 
expression. 
Thickened wing veins are classically associated with a cell fate change from intervein to 
vein in the wing [14]. Therefore, the thickened wing veins observed with Chmp1 knockdown 
were likely caused by a change in wing cell fate, rather than increased proliferation of wing vein 
cells, suggesting that Chmp1 promotes intervein cell fate over vein cell fate. Supporting this 
conclusion, the number of intervein cells between the thickened veins on a Chmp1 knockdown 
wing appeared reduced, suggesting a change in cell fate, rather than over-growth of vein cells. A 
cell fate change associated with loss of Chmp1 has not been reported previously in animal 
studies, although in Zea mays loss of Chmp1 caused extra layers of aleurone cells to form [92]. 
This phenotype was likely caused by increased specification of aleurone cells from endosperm, 
driven by failure to down-regulate transmembrane receptors through the MVB pathway [92, 93]. 
121 
 
The finding that Chmp1 regulates cell fate in plants is consistent with the finding that Chmp1 
regulates wing vein cell fate in flies, and suggests a conserved role for Chmp1 in regulating cell 
fate decisions.  
III. Chmp1 and DER signaling 
DER signaling is required to promote wing vein development. Loss of DER signaling 
causes loss of wing veins and gain of DER signaling causes wing vein thickening and formation 
of extra wing veins [17, 36]. So it was possible that the thick veins observed with Chmp1 
knockdown could be caused by a gain of DER signaling. This would mean that Chmp1 
negatively regulates DER signaling. This is consistent with previous reports showing that other 
ESCRT components are required for down-regulation of DER signaling [59, 137].  
Genetic interactions between Chmp1 and regulators of the DER signaling suggest a role 
for Chmp1 in the regulation of the DER. Reduced activity of negative regulators of DER 
signaling in Chmp1 knockdown wings enhanced the Chmp1 knockdown phenotype. 
Additionally, reducing the expression of Vn, a positive regulator of DER signaling, in Chmp1 
knockdown wings partially suppressed the Chmp1 knockdown phenotype. This finding showed 
that loss of Vn activity caused a loss of DER activation that partially counter-acted the gain in 
DER activation caused by Chmp1 knockdown. Interestingly, the Chmp1 knockdown phenotype 
was not suppressed by decreased activity of Rho, another positive regulator of DER signaling. A 
genetic interaction between Chmp1 and Vn but not Rho is surprising, especially as Vn and Rho 
appear to have synergistic roles in the wing [121, 122, 138]. This may be explained by 
considering the functional roles of Vn and Rho in DER signaling. Vn is a ligand secreted by 
intervein tissue that directly binds and activates the DER, while Rho is a membrane bound 
protease that cleaves and activates the DER ligands, Spitz and Keren. Spitz and Keren act 
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redundantly in the wing and only loss of activity of both alters wing vein patterning [15, 139]. 
Perhaps losing one copy of rho does not affect levels of DER activation even when Chmp1 is 
reduced, as there is still enough Rho protein to cleave and activate the Spitz and Keren ligands. 
Since Rho is an enzyme, it most likely can repeatedly cleave substrate. In contrast Vn is not re-
used. Additionally, it is thought that Vn provides a low, constant activation of the DER, while 
Rho is a strong DER activator [17, 140]. Thus, reducing the activity of Rho would have less 
effect on DER signaling than reducing the activity of Vn. Another possibility is that there is a 
different timing requirement for Vn and Rho during wing development. An interaction between 
Chmp1 knockdown and Vn, rather than Rho could indicate a later requirement for Vn than Rho 
in the final determination of vein fate [15, 138]. However, since Rho is required late into wing 
morphogenesis, this appears unlikely [17]. 
Loss of MAPK activity caused by altered activity of a single regulator of DER signaling 
usually does not result in a vein-less wing. Instead, only portions of veins are lost, suggesting 
that regulation of DER signaling in vein formation differs in different parts of the wing. Over-
expression of the negative DER regulator aos causes loss of the distal portions of the L4 and L5 
wing veins due to loss of DER signaling in these regions. Interestingly, when Chmp1 was 
knocked down dorsally in wings over-expressing aos, the distal L4 and L5 were still lost, but the 
remaining wing veins were thickened. Although Chmp1 knockdown caused thickening of the 
wing veins, it appeared that Chmp1 knockdown could not reverse the loss of vein cell fate 
specification caused by aos over-expression. This finding is consistent with a model in which 
Chmp1 regulates DER signaling downstream of receptor activation and may suggest that Aos 
can no longer inhibit DER signaling in vein cell specification beyond a certain time point during 
development. After this time, loss of Chmp1 could still activate DER signaling, but Aos would 
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no longer be able to down-regulate the DER. The idea of a switch in DER signaling during wing 
development is supported by previous studies. For example, over-expression of aos at different 
times during wing development has different phenotypic effects. Argos over-expression during 
the pupal stage of development causes extra veins to form, while over-expression during larval 
stages causes vein suppression [138]. Similarly, DER signaling promotes vein specification and 
is active in the wing veins throughout most of wing development. However, from about 28 to 33 
hours after pupal formation (hAPF), MAPK activity, an indicator of DER signaling, is lost in the 
veins and increased in the intervein [138, 141, 142]. The importance of this event and its 
implications for wing development are not well understood. It has been proposed that DER 
activation is required to allow for maintenance of Dpp signaling in the vein, which is required for 
wing vein differentiation, but that the late shift of DER signaling to the intervein is required for 
the specification of intervein fates [138, 143].   
To quantify the ability of the regulators of DER to modify the Chmp1 knockdown 
phenotype, wing vein areas were measured. The area of wing veins was much more variable in 
the wings with Chmp1 knockdown and altered DER activity compared to Chmp1 knockdown 
alone. In Chmp1 knockdown wings that were also heterozygous for loss of function alleles of 
DER regulators, small numbers of wings measured had wing vein areas that were comparable to 
those of Chmp1 knockdown alone, while others were well above Chmp1 knockdown 
measurements. This variability may have been caused by fluctuations in temperature during fly 
development. As Chmp1 knockdown was driven with the UAS-Gal4 system, the Chmp1 
knockdown phenotype was sensitive to temperature. In some cases, a developmental temperature 
of two degrees (from 28oC to 30oC) was a difference between wings with slightly wider wing 
veins and wings that were almost entirely wing vein. Minor fluctuations in temperature within 
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the incubator in which the flies were grown could contribute to the differences observed. Also, 
though the wings measured were all from flies of the same known genotype, there may be 
variation in the genetic background between individual flies that results in differences in gene 
expression. Therefore, individual flies may experience different levels of Chmp1 knockdown in 
the wing that was not apparent from the Chmp1 knockdown phenotype, but is amplified in a 
different genetic background. Nevertheless, for each genotype, the mean wing vein area was a 
good representation of the wing vein thickness that was generally observed. Additionally, 
reduction of all DER suppressors tested enhanced the Chmp1 knockdown phenotype, whereas 
reduction of DER enhancers either suppressed or did not significantly alter the Chmp1 
phenotype. The consistent directionality of the interactions between DER regulators and Chmp1 
is good evidence that Chmp1 negatively regulates DER signaling.  
Interestingly, no interaction was detected between Chmp1 and DER regulators when 
Chmp1 was over-expressed in wings heterozygous for loss of function alleles of positive or 
negative regulators of DER signaling. In light of the Chmp1 knockdown studies, this may 
suggest that excessive Chmp1 protein in the cell has little or no effect on DER signaling during 
wing vein development. Chmp1 knockdown, but not Chmp1 over-expression, results in 
phenotypes in the fly, showing that while the cell does require Chmp1 for proper function and 
signaling, an over-abundance of Chmp1 does not significantly alter cellular function. This could 
offer support for Drosophila Chmp1 as a component of the ESCRT complex when regulating 
DER signaling, rather than acting directly as a regulator of gene expression. It also suggests that 
Chmp1 is not a limiting component of ESCRT function. 
Studies in mammalian cell culture show that Chmp1 regulates cell growth [88, 89, 91]. In 
contrast, the studies presented here did not indicate a role for Drosophila Chmp1 regulation of 
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growth, but rather in regulation of DER signaling in cell fate specification. However, human 
pancreatic [89] and renal [88] tumor cells show a loss of Chmp1A activity, and a gain of EGFR 
signaling is often observed in cancerous cells [144-146]. So it is possible that an increase in 
EGFR signaling caused by loss of Chmp1A activity could contribute to tumorigenesis. 
Therefore, the Drosophila wing may provide a good model for assaying the activity of ESCRT 
components to better understand their role in tumor formation. 
IV. Clones of Chmp1 knockdown in the wing 
 Chmp1 interacted genetically with DER signaling components, suggesting that Chmp1 
negatively regulates DER signaling. If Chmp1 negatively regulates DER signaling, downstream 
targets of the DER should be affected by loss of Chmp1 activity. Clones of Chmp1 knockdown 
were generated in the developing wing to assess the effect of Chmp1 knockdown on expression 
of Bs, which is negatively regulated by DER signaling. Unexpectedly, small clones of Chmp1 
knockdown in the third instar wing disc had no effect on Bs expression. However, Bs expression 
was decreased in large clones (>120 cells) that spanned wing vein and intervein regions. Large 
clones of Chmp1 knockdown were rare, which may mean that Chmp1 knockdown clones were 
unhealthy and died or grew slowly when generated early in wing development. If this is the case, 
it would suggest that Chmp1 is required for proper cellular function in Drosophila wings in 
addition to its role in DER signaling. Another possible explanation for seeing few large clones is 
cell competition. In the wing, cells of a specific genotype may not survive as wing clones, even 
though they can make a perfectly formed wing by themselves, as they are “out-competed” by 
surrounding wild-type cells [147]. Chmp1 knockdown clones in the wing may be out-competed 
and thus rare in the developing wing. 
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 Clones of Chmp1 knockdown were also generated for analysis in the adult wing. In the 
majority of Chmp1 knockdown clones located within intervein regions, clusters of cells within 
the clone adopted vein cell fate. On the other hand, some clones within intervein tissue had no 
effect on wing cell fate. When Chmp1 knockdown clones overlapped wing veins, thickening of 
the wing vein occurred, though the wing vein thickness was only increased by a few cells’ width, 
similar to knockdown in the entire wing, and not throughout the entire clone. Thus, not every 
Chmp1 knockdown cell adopts a vein fate. This suggests that other factors, such as the location 
of the clone within the wing, are involved in determining vein or intervein cell fate in Chmp1 
knockdown clones. However, there is still the question of why intervein cells can adopt a vein 
fate in Chmp1 knockdown clones but not when Chmp1 knockdown is driven with MS1096-Gal4 
and other drivers. It could just be a case of stronger knockdown of Chmp1 in the clones than with 
drivers. For example, the FLP/FRT-Gal4 system uses an actin promoter to drive expression of 
Gal4 constantly and at a fairly high rate. In contrast, promoters of developmental genes, such as 
engrailed (en-Gal4) and patched (ptc-Gal4), may have variable expression over time or stop 
expressing early. 
If Chmp1 acted upstream of the DER signaling pathway, by either directly repressing or 
activating the DER or one of its regulators, Chmp1 knockdown clones might have induced vein 
cell fate regardless of their location on the wing. However, this was not the case. Instead, 
receptor deregulation caused by loss of Chmp1 may just alter the balance of signaling between 
pathways involved in vein specification, i.e., the DER signaling pathway, making a cell more 
likely to adopt a vein fate. This is consistent with a role for Chmp1 downstream of the DER, 
suggesting that Chmp1 knockdown does not in itself activate DER signaling. Rather, Chmp1 
regulates the active DER signaling pathway. If the DER is not activated, then presumably loss of 
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Chmp1 can have no effect on the DER signal. However, when the DER is active loss of Chmp1 
might boost the signal to a level that induces vein formation in the wing. 
V. Chmp1 and Notch signaling 
In these studies, experiments using Chmp1 knockdown to investigate Chmp1 regulation 
of Notch signaling were inconclusive. No strong evidence for Chmp1 as a regulator of Notch 
signaling was obtained. However, a possible minor genetic interaction was observed between 
Chmp1 and the Notch regulator, Deltex. When Chmp1 was knocked down in a wing over-
expressing Deltex, a minor but consistent loss of wing bristle was observed in the wing.  
Transgenic fly lines were created that allowed for expression of either a wild-type or 
HM-tagged Chmp1 protein, enabling investigation into the effects of Chmp1 over-expression, as 
well as Chmp1 protein localization. All of these lines expressed an active Chmp1 protein, as they 
were able to partially or fully rescue the Chmp1 knockdown phenotype. Chmp1 over-expression 
in the wing resulted in widening of the distal tip of the wing vein, or deltas, suggesting that 
Chmp1 may regulate Notch signaling. Wing vein deltas are also observed when activity of the 
Notch ligand, Delta, is lost. Although this effect was weak, it is consistent with previous 
literature showing that ESCRT machinery regulates Notch signaling. For example, in a genome-
wide study to identify modifiers of Notch signaling in Drosophila, Chmp1 was identified as a 
possible negative regulator of Notch[115]. Chmp1 knockdown with an RNAi line from the 
VDRC in the thorax caused notum migration malformation, which was likely due to upregulation 
of Notch signaling [115]. Additionally, loss of Drosophila ESCRT-II component Vps25 caused 
endosomal accumulation of the Notch receptor and enhanced Notch signaling [61].  
If Chmp1 negatively regulated Notch signaling in Drosophila, then Chmp1 over-
expression in the wing might cause reduced Notch signaling, which could result in the deltas 
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observed. One possible explanation for this finding is that Chmp1 over-expression caused 
increased processing of Notch into the ILV. This would imply that Notch normally signals after 
it has been endocytosed, which is consistent with previous studies showing that the Notch 
Intracellular Domain is cleaved at the endosome. The deltas observed under Chmp1 over-
expression could also be caused defects in the processing of Delta, rather than Notch. Delta, as 
well as other Notch ligands, requires monoubiquitination and endocytosis, followed by either 
degradation or recycling back to the membrane for proper activity [148].  
If Chmp1 negatively regulates Notch signaling, then loss of Chmp1 activity should 
increase Notch signaling. In the wing, phenotypes associated with increased Notch activity could 
include loss of wing veins, or ectopic wing margin and bristles. These phenotypes were not 
apparent when Chmp1 was knocked down in the wing, suggesting that Notch activity is not 
increased. However, the findings presented here do not rule out a role for Chmp1 in regulation of 
Notch signaling. It is possible that Chmp1 regulates Notch signaling during wing development, 
but Chmp1 knockdown conditions were not sufficient to generate a Notch-related phenotype.  
VI. HM-Chmp1 localization 
In the light of previous literature, it seems likely that the regulation of DER signaling by 
Chmp1 is a result of its activity in MVB generation as a part of the ESCRT-III complex. This 
would place Chmp1 at the endosome, which has been verified in mammalian cultured cells, 
Arabidopsis, and yeast [86, 93, 97]. The HM-tagged version of Drosophila Chmp1 is active and 
localized to the apical plasma membrane. Similar localization was observed in both embryonic 
and imaginal disc epithelial cells, and with several independent UAS-HM-Chmp1 fly lines, 
suggesting that it is the genuine subcellular localization for HM-Chmp1. When comparing the 
subcellular localization of Chmp1 across published studies, it becomes apparent that Chmp1 
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localization varies between cell types [91, 95, 97]. However, the membrane localization observed 
for HM-Chmp1 is similar to the localization observed for Chmp1A observed in mouse acinar 
pancreatic tumor cells (CRL-2151) in a paper published on the effects of all-trans retinoic acid 
(ATRA) and Chmp1A in pancreatic tumor cells [95].  
Co-localization was not observed between HM-Chmp1 and the early endosome marker, 
Rab5. However, HM-Chmp1 did show some co-localization with a late endosomal marker, 
Rab9. This suggests that a proportion of Chmp1 localizes to the late endosome, but not to the 
early endosome in Drosophila. This contrasts with reports that Chmp1 was detected at both early 
and late endosomes in Aspergillus nidulans and mammalian cell culture [86, 97]. However, the 
late endosomal localization of Chmp1 is supported by studies in yeast, showing that ESCRT-III 
components are only present on the endosomal membrane late in MVB biogenesis [72, 73]. The 
localization of Drosophila Chmp1 to the late endosome is compatible with a role for Chmp1 in 
MVB biogenesis, and supports the idea that this is the mechanism for down-regulating the DER.  
There is published evidence supporting a role for ESCRT function in the nucleus. For 
example, in cultured human cells the ESCRT-I component Tsg101 has been reported to repress 
the cyclin-dependent kinase p21 by directly binding its promoter [149]. Tsg101 may also act as a 
cofactor in regulating gene expression in cultured mammalian cells [150, 151]. Several studies 
report a role for Chmp1 in the nucleus, and the few mechanistic studies on Chmp1 pin the effects 
observed under Chmp1 mis-expression to its nuclear function. [90, 91, 95]. Though Chmp1 was 
not detected via immunostaining in the nucleus of the Drosophila tissues investigated here, the 
conservation of the NLS suggests that Drosophila Chmp1 may play a role in the nucleus. Other 
studies in mammalian cultured cells have reported that Chmp1 may not always be present in the 
nucleus, as it is only detectable at specific phases of the cell cycle, or upon certain cell treatments 
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[81, 90, 95]. Thus it is possible that the nuclear localization of Drosophila Chmp1 was not 
detected because it is transient. Chmp1 appears to recruit BMI1 to condensed chromatin in the 
nucleus of cultured human cells [81, 91]. This is interesting because BMI1 can work as a part of 
PRC1, a protein complex which maintains a transcriptional repressive state in many genes by 
mediating monoubiquitination of histone H2A-K119 [152]. As ESCRTs 0-II can recognize 
monoubiquitinated proteins, this may explain the presence of ESCRTs in the nucleus. Despite 
these findings, there is no well established role for ESCRTs in the nucleus. All characterized 
roles for the ESCRT machinery involve the scission of membranes, but this activity does not 
explain the localization of Chmp1 to condensed chromatin or its interaction with BMI1. It is 
possible that the role of Chmp1 in the nucleus is independent of the ESCRT-III complex, or that 
the ESCRT complexes play a role in the nucleus that has not yet been described. As the role of 
Tsg101 in the nucleus has not been linked with other ESCRT components or known functions of 
ESCRTS, it may well be independent from the well-established ESCRT activities.  
Co-immunoprecipitation and mass spectroscopy experiments have identified many 
binding partners for Drosophila Chmp1, several of which are regulators of gene expression at the 
level of translation [2]. In addition, ESCRT-II components interact with ELL proteins, which are 
elongation factors for RNA polymerase II [153]. Chmp1 may also be involved in the 
maintenance of chromosome integrity during mitosis [100]. Together, these results suggest 
diverse functions for ESCRT proteins, many of which are not well characterized. So it remains 
possible that Chmp1 regulates DER signaling in other ways, in addition to receptor down-
regulation through the MVB pathway. 
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VII. Concluding remarks 
When Chmp1 was knocked down in the Drosophila wing, the DER was deregulated, 
causing wing cells to adopt a vein over an intervein fate. A role for Chmp1 determining in cell 
fate specification through receptor down-regulation is consistent with the function of Chmp1 in 
the ESCRT-III complex. Chmp1 binds Vps4, which completes ILV formation at the MVB. If 
loss of Chmp1 function caused incomplete ILV formation, this might result in retention of 
transmembrane receptors in the limiting membrane of the endosome, rather than incorporation 
into the ILV (Figure 5.1). Indeed, in Arabidopsis thaliana, Chmp1 mutation resulted in the 
presence of membrane proteins in the limiting membrane of the MVB and vacuole [87]. 
Additionally, in mammalian cultured cells knockdown of UBPY, a binding partner of Chmp1, 
caused accumulation of the EGFR on endosomes [108]. Loss of ESCRT-III component activity 
in Drosophila also impaired ILV formation [137]. Therefore, the increased DER signaling 
observed in Chmp1 knockdown wings may be a consequence of incomplete ILV formation, 
resulting in a failure to isolate the DER from the cytoplasm and retention of the DER in the 
limiting membrane of the endosome, where it continues to signal. 
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VIII. Possible future studies  
ESCRT components have been shown to regulate several pathways in Drosophila. 
Investigations into Chmp1 regulation of other pathways in other tissues could be informative. 
This could be tested similarly to DER signaling components. For example, Chmp1 could be 
knocked down in wings heterozygous for regulators of other pathways, such as Dpp or Hh. 
Additionally, the work on Chmp1 in the eye could be expanded. Chmp1 knockdown in the eye 
Figure 5.1 Model for Chmp1 regulation of the DER through the MVB pathway. 1. 
Activating ligand binds to the extracellular domain of the DER. This activates the DER, which 
transmits the signal to the cell through the MAPK pathway. The activated DER is 
ubiquitinated. 2. Ubiquitination of the DER signals endocytosis of the activated receptor. 3. The 
ESCRT protein complexes normally mediate incorporation of the DER into ILVs of the MVB. 
4. The ILVs containing the DER are delivered to the lysosome, where the DER is degraded. 
Loss of Chmp1 from the ESCRT-III complex causes incomplete scission of the neck of the ILV 
and causes the DER to accumulate in the limiting membrane of the MVB, so the receptor is still 
able to signal to the cytoplasm. 
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caused loss of photoreceptors. This phenotype could be investigated at earlier stages. For 
example, in the third instar eye imaginal disc immunostaining can be used to identify at what 
stage the specific photoreceptors are lost during eye development. Additionally, genetic 
interactions with DER, Notch, and other pathways in the eye could be investigated. 
Further testing for interactions between Chmp1 and proteins involved in endocytosis, 
such as clathrin, could link Chmp1 to its role in the MVB pathway more firmly. For example, 
Chmp1 could be knocked down in flies carrying loss of function alleles for proteins involved in 
endocytosis that have no wing phenotype in the heterozygous state. If the Chmp1 knockdown 
phenotype is enhanced in these different genetic backgrounds, then a role for Chmp1 in 
endosomal trafficking in the wing would be supported. 
Chmp1 co-localized with Rab9, a marker for the late endosome. This suggests that 
Chmp1 functions at the late endosome, probably as a component of the ESCRT-III complex in 
MVB generation. A next step in Chmp1 research would be tracking the endocytosis of signaling 
receptors, including the DER or Notch receptor, under Chmp1 knockdown or over-expression 
conditions. If Chmp1 knockdown caused accumulation of the DER or Notch in the endosomal 
membrane, as identified by co-localization with an endosomal marker, then a role for Chmp1 in 
regulating these pathways through the MVB pathway would be better supported. 
Though no nuclear Chmp1 localization was detected in epithelial cells of the Drosophila 
embryo or imaginal disc, there have been multiple studies showing a nuclear localization and 
suggesting a nuclear function for Chmp1 [81, 89-91]. In cultured mammalian cells, nuclear 
Chmp1 was detected at specific stages of the cell cycle or upon certain cell treatments [81, 90, 
95]. So it is possible that Chmp1 does localize to the nucleus in Drosophila cells, but that it just 
was not detected. If Chmp1 localizes to the nucleus at specific times during the cell cycle, then it 
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might be detected in the nucleus upon imaging of live cells, or fixed synchronized cells in 
culture. Investigation of Chmp1 localization in live cells, e.g., in a cultured imaginal disc, would 
require the generation of a transgenic fly line that could express fluorescently tagged Chmp1 
protein. This would allow live imaging of Chmp1 localization in Drosophila tissues. 
Unfortunately, fluorescent tags are often large, and there is always the possibility of interference 
of the tag with the function of the protein. Alternatively, Chmp1 localization could be 
investigated cultured S2 cells (Drosophila cell line), which would allow for synchronization of 
the cell cycle and observation of Chmp1 localization in fixed cells using a smaller epitope tag on 
the Chmp1 protein. However, much of the power of using Drosophila in the lab is the ease of 
genetics and the ability to study the tissues of an entire organism. So moving to insect cell 
culture might be considered a step backwards. 
Creation of a Drosophila-specific Chmp1 antibody, along with Chmp1 mutants, would be 
useful in further studies with Chmp1. Different mutations could be generated to investigate 
which functional domains or regions of the Chmp1 protein are required for proper 
function/regulation of DER signaling, and signaling of other pathways in Drosophila. Generation 
of a Chmp1 mutant with the NLS deleted could be informative about any nuclear function for 
Chmp1 in Drosophila. Additionally, it could be interesting to create a transgenic fly line that 
allows for expression of Chmp1 from a different species, such as humans. If human Chmp1A 
could rescue a Chmp1 mutant phenotype, that would imply that the functions are highly 
conserved and the findings in Drosophila are transferrable.  
Clones of Chmp1 knockdown occasionally caused a cell fate change from intervein to 
vein cell in the adult wing. Additionally, clones of Chmp1 knockdown caused an increase in 
DER signaling and a decrease in Bs expression. However, Chmp1 knockdown did not always 
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have an effect on Bs expression. Large clones of Chmp1 knockdown were required to see a 
change in Bs expression in the wing disc, despite the fact that small clones of Chmp1 knockdown 
could generate vein in the adult wing. A more direct readout of DER pathway activation is 
phosphorylation of ERK. Additionally, Rho expression is indicator of DER activation. In the 
developing wing, one of the first markers of wing vein cells is Rho expression. So it would be 
informative to generate clones of Chmp1 knockdown in the wing disc to see if ERK is 
phosphorylated in any of the clone cells, or if Rho expression was activated. This would offer 
more definitive evidence for a role for Chmp1 in regulation of DER signaling. 
The studies presented in this dissertation suggest that the choice of vein or intervein cell 
fate in the Drosophila wing is a good model for investigating the activity of ESCRT components. 
Thus, the activity of other ESCRT components in regulation of cell signaling pathways involved 
in vein patterning could be investigated in the wing. Many of the interactions of ESCRT 
components have only been suggested through biochemical assays. Therefore, genetic interaction 
studies similar to those used in these studies could be used to establish functional interactions 
between these pathways/proteins. Genetic screens involving ESCRT components could identify 
which components are required for ESCRT function in pathways involved in vein development. 
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CHAPTER 6 
PROJECTS INVESTIGATING FRIZZLED (FZ) PLANAR CELL POLARITY (PCP) 
SIGNALING IN DROSOPHILA  
 In addition to DER and Notch signaling, Chmp1 may regulate the Frizzled (Fz) Planar 
Cell Polarity (PCP) pathway. Investigations of Chmp1 in Fz PCP signaling, as well as 
contributions made to other Fz PCP signaling projects, are discussed in this chapter.  
I. Background on PCP  
 Cell polarity is established by an asymmetrical distribution of contents within a cell and 
is critical for cellular specification and diversity. One example of cell polarity is the polarization 
of epithelial tissues on the apical-basal axis, which gives cells a top and a bottom. However, cells 
that make up epithelial tissues are not only polarized on the apical-basal axis, but also within the 
plane of the epithelium. This type of polarity is called PCP. The Fz PCP pathway controls PCP 
and was first identified for its role in patterning the fruit fly cuticle. It is conserved in vertebrates 
where it is referred to as a non-canonical Wnt signaling pathway [154, 155]. The Fz PCP 
pathway is also involved in cell fate specification, as well as cell migration events, including 
convergent extension movements during gastrulation and neurulation in vertebrates [3, 156]. 
Mutations in human Fz PCP pathway genes have been linked to neural tube defects such as 
anencephaly and spina bifida, and also with epileptic seizures [157-161]. Additionally, in 
humans and mice, defects in Fz PCP have been linked to some cystic kidney diseases, likely 
related to defects in ciliogenesis [155, 162-166].   
Despite the importance of the Fz PCP pathway in human development and disease, it is 
still incompletely understood. From studies in Drosophila, it is known that within each epithelial 
cell, six Core Fz PCP pathway proteins, Fz, Dishevelled (Dsh), Diego (Dgo), Flamingo (Fmi, 
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also known as Starry-night, Stan), Strabismus (Stbm, also known as Van-gogh, Vang), and 
Prickle (Pk), must undergo a series of specific interactions and become asymetrically localized in 
order to establish proper PCP. Although much is known about the interactions and subcellular 
localizations of these proteins, there is no consensus on a global signal that initiates Core PCP 
protein localization within the cell, how the Core PCP proteins interpret that signal, or how the 
signal is transduced. The Fz PCP pathway has been best studied in the fruit fly, which provides 
an easily manipulatable system in which to study this pathway. In these studies, the eye and wing 
were used to investigate Fz PCP signaling.  
II. The Fz PCP pathway in the Drosophila wing 
With respect to Fz PCP signaling, the wing is the most widely used and best 
characterized epithilial tissue of the fly (see Chapter 1 section I.B for details on wing 
development and anatomy). The developing fly wing is composed of an epithelial cell layer of 
hexagonally packed cells. Each wing cell produces a single distally-pointing wing hair, resulting 
in an adult wing decorated with a regular array of hairs. Traditionally, the study of PCP in the 
wing focuses on the formation and polarity of these hairs. Determining the initiation site of hair 
formation, as well as the number of hairs produced within a cell, are processes that require the 
proteins of the Fz PCP pathway [167-169]. During the pupal stage of wing development, within 
each epithelial cell the Fz PCP Core proteins localize apically in the adherens junction (AJ) plane 
and asymmetrically to the proximal and distal ends of each epithelial cell [170] (Figure 6.1A). 
Fz, Dsh and Dgo localize to the distal edges of the cell, Stbm and Pk localize to the proximal 
edges, and Fmi localizes to both proximal and distal edges. The apical and lateral localizations 
are both crucial for proper PCP, as failure to appropriately localize all six Core PCP proteins 
results in PCP defects, such as altered hair initiation site, altered hair polarity, and cells carrying 
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multiple hairs [171-176]. There is no consensus on what global signal initiates the asymmetric 
localization of Fz PCP pathway components within wing cells and establishes direction in the 
tissue. One candidate is a group of proteins, including the atypical protocadherins Fat (Ft) and 
Dachsous (Ds), gradients of which have been proposed to provide a global signal for Fz PCP 
protein localization and so direct wing cell polarity. This idea is supported by evidence that Ft 
and Ds play a role in microtubule orientation, and that the subcellular localization of the Core 
proteins depends upon microtubule-based transport of Fz to the distal end of the cell [173, 177].  
Wnts, extracellular proteins that transmit signals into the cell through Frizzled family 
receptors, have also been proposed as a global cue for establishing polarity. In vertebrates, loss 
of Wnts can cause PCP defects suggesting that Wnts are involved in Fz PCP [178-180]. In flies 
evidence for Wnts  as a directional cue for Fz PCP signaling is lacking, though recent work 
suggests Wingless (Wg) and Wnt4 may act redundantly in the wing to establish proper PCP  
[181-183]. In the wing, the localization of Fz PCP pathway components is correlated with 
cytoskeletal reorganization and the distal formation of an actin rich hair. It is thought that the 
position of Fz within the cell is the main determinant of where a wing hair forms, i.e., Fz 
localizes distally and the wing hair forms at the distal end of the cell [174]. However, the 
mechanisms by which this occurs are unknown.   
III. The Fz PCP pathway in the Drosophila eye 
In addition to DER signaling, development of the Drosophila eye also requires Fz PCP 
signaling, but in this case it controls a cell fate specification event that is critical for patterning of 
the eye [3]. The fly eye is a complex structure composed of about 800 ommatidia. The 
organization of photoreceptors within each ommatidia has a chirality, or handedness, which 
differs between ommatidia in the dorsal and ventral halves of the eye. This means that ventral 
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ommatidia are a mirror image of dorsal ommatidia (see Chapter 1 section I.C for eye 
development and anatomy). Fz PCP signaling is involved in the establishment of the chirality, or 
handedness of each ommatidium, by specifying which photoreceptors become the R3 and R4 
cells (Figure 6.1B). Fz PCP signaling also directs the direction of ommatidial rotation, as the 
specification of R3 and R4 photoreceptors largely determines the direction of rotation. The 
R3/R4 precursor cells can differentiate into either R3 or R4. The Fz PCP pathway signals from 
the future R3 photoreceptor through Fz to Stbm in the future R4 photoreceptor. Fz becomes 
active and signals from the R3/R4 precursor closest to the equator, which becomes committed to 
an R3 fate, while the other precursor closer to the pole of the eye adopts the R4 fate. 
Downstream targets of the Fz PCP pathway drive and reinforce the cell fate decision. For 
example, Fz signaling promotes Delta activity in future R3 photoreceptors and results in 
activation of Notch in the future R4 photoreceptors [24, 25]. Thereby the Fz PCP pathway 
establishes the proper chirality of each ommatidium, as well as the correct direction of rotation. 
When Fz PCP signaling is disrupted in the eye, resulting phenotypes may include achiral, or 
symmetric ommatidia, in which the R3 and R4 photoreceptors become either both R3 or both 
R4, misrotation, in which the ommadia do not rotate the full 90o, and opposite chirality, in which 
a ventral ommatidium adopts a dorsal chirality or vice versa. 
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Project 1: Chmp1 may regulate Fz PCP signaling 
Introduction: As a component of the ESCRT-III complex, Chmp1 is involved in the 
regulation of many cellular signaling pathways and processes. Some Fz PCP core proteins 
undergo endocytosis during signaling, so they may require the ESCRT machinery for proper 
regulation of signaling [184]. When Fz PCP signaling is disrupted in the wing, classic PCP 
phenotypes result (i.e., cells carrying multiple hairs, altered hair polarity). Therefore, to 
determine whether Chmp1 regulates Fz PCP signaling, Chmp1 was knocked down and over-
expressed in the wing. Indeed, Chmp1 knockdown and over-expression lead to defects in PCP, 
suggesting that Chmp1 regulates Fz PCP signaling.  
Methods: Fly crosses for Chmp1 knockdown and over-expression are described in 
Chapter 4, Figures 4.3 and 4.18 respectively. To test for interactions between Chmp1 and Fz 
PCP signaling components, Chmp1 was also knocked down in wings heterozygous for loss of 
function alleles of Fz PCP Core genes, fz (fzP21), stbm (Vang1), and pk (pkpk-sple14). Wings from 
Figure 6.1 The Fz PCP pathway polarizes cells of the Drosophila wing and eye. In the wing 
(left panel), Fz PCP core proteins localize to opposite ends of each cell, polarizing the cell. The 
wing hair is produced at the distal end of the cell. In the eye (right panel), Fz PCP core proteins 
localize to the apical membrane bordering the R3 and R4 cell precursors. This leads to the 
specification of R3 and R4 cells and proper ommatidial rotation within each hemisphere of the 
eye.    
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females with Chmp1 knockdown, and Chmp1 knockdown in a background heterozygous for loss 
of function alleles of Fz PCP genes were mounted in GMM onto a glass slide and imaged with a 
light microscope. 
Results and Discussion: Ubiquitous knockdown of Chmp1 in the dorsal wing under the 
control of the MS1096-Gal4 driver caused thickening of dorsal wing veins (Figures 4.3 and 4.7), 
but gave no classical Fz PCP phenotypes, e.g., altered hair polarity or cells carrying multiple 
hairs. However, localized Chmp1 knockdown caused Fz PCP phenotypes at the boundary of 
Chmp1 knockdown and wild-type cells. Chmp1 knockdown in the posterior wing under the 
control of the en-Gal4 driver caused the expected thickening of posterior wing veins (L4 and L5) 
(Figures 4.4 and 6.2B). Additionally, wings cells carrying multiple hairs were observed adjacent 
to the anteroposterior (AP) boundary of these wings, which was also the boundary of Chmp1 
knockdown (Figure 6.2B). The wing hairs in this region adopted an anterior rather than a distal 
hair polarity, while the wing hairs in the rest of the wing remained wild-type (Figure 6.2B). 
When Chmp1 was knocked down with ptc-Gal4, which has both anterior and posterior 
boundaries of expression (Figure 4.4), altered hair polarity and additional hairs were again 
observed at the boundaries of Chmp1 knockdown and wild-type cells (Figure 6.2C). At the 
anterior boundary of ptc-Gal4 expression wing hairs took on an anterior polarity, and at the 
posterior boundary of ptc-Gal4 expression wing hairs adopted a posterior polarity. These results 
indicate that the Fz PCP pathway may have been disrupted, and suggests a possible role for 
Chmp1 in regulation of Fz PCP signaling. It seems that a gradient of Chmp1 activity was 
required to disrupt wing hair patterning, as the phenotypes were only observed at the boundaries 
of Chmp1 knockdown.  
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The Fz PCP signaling pathway involves cell-to-cell signaling of asymmetrically localized 
transmembrane proteins. A gradient of Chmp1 activity may have created a gradient of Fz PCP 
Core protein activity, possibly due to reduced down-regulation of Fz through the MVB pathway, 
which would alter cell-cell signaling of Fz PCP components. This could explain why the wing 
hair defects were only observed at the boundary of knockdown in the wing. A boundary/gradient 
of Chmp1 knockdown would not exist in the remaining wing, which kept a wild-type hair 
polarity. If loss of Chmp1 activity cause retention of Fz PCP Core proteins in the limiting 
membrane of the late endosome/MVB, it is possible that the localizations of Fz PCP Core 
proteins could be changed. 
When Chmp1 was knocked down in a localized pattern, wing hair polarity was reoriented 
away from the Chmp1 knockdown region, suggesting that wing hairs point away from low 
Chmp1 activity (Figure 6.2B and C). Interestingly, wing hairs point away from low Stbm and 
towards low Fz activity, suggesting a possible role for Chmp1 in regulation of these proteins 
[185, 186]. Specifically, Chmp1 knockdown might cause either low Stbm or enhanced Fz 
activity. 
To investigate a role for Chmp1 in Fz PCP further, Chmp1 was knocked down in wings 
heterozygous for loss of function alleles of fz (fzP21), stbm (vangTBS42), and pk (pkpk-sple14). Wings 
heterozygous for these Fz PCP loss of function alleles appear wild-type, apart from weak hair 
polarity changes in the proximal part of the wing in vangTBS42 wings. As previously shown, 
uniform knockdown of Chmp1 with MS1096-Gal4 caused thickened wing veins but no classic Fz 
PCP phenotypes (Figure 4.7B). However, uniform knockdown of Chmp1 with MS1096-Gal4 in 
vangTBS42 heterozygous wings caused hair polarity defects as well as multiple hairs (Figure 
6.2D). In these wings the PCP defects were mostly observed around thickened wing veins, and 
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reoriented hairs pointed away from the thickened wing veins. As wing hairs usually point away 
from low levels of Stbm, this suggests that there is loss of Stbm activity in the thickened wing 
veins compared to the intervein tissue. This effect was specific for Stbm, as uniform Chmp1 
knockdown in fzP21 (MS1096-Gal4/X; UAS-Chmp1RNAi-VDRC/+; fzP21/+) or pkpk-sple14 
(MS1096-Gal4; UAS-Chmp1RNAi-VDRC/pkpk-sple14) heterozygous wings did not cause any 
significant PCP phenotypes.  
An interaction with Stbm and not Fz was surprising, considering that Fz is endocytosed 
and degraded during signaling, a process that should be affected by loss of ESCRT activity 
[184]. The specificity of the phenotype to thickened wing veins could suggest that in a Chmp1 
knockdown wing, vein cells are more sensitive to loss of Stbm activity than the remaining wing. 
However, if loss of Chmp1 in the wing disrupts the role of the ESCRT-III complex in protein 
degradation, then heightened Stbm activity due to decreased down-regulation might be expected. 
Loss of Stbm activity is also possible though, as investigations with ESCRT components have 
shown that the ESCRT complexes may both positively and negatively regulate signaling 
pathways, depending upon the context of signaling [187]. More likely, these results suggest an 
interaction between Stbm and DER signaling in wing development. Results from Chapter 4 
indicated that Chmp1 may negatively regulate DER signaling, which is active in the wing vein. 
Perhaps there is crosstalk between the DER and Fz PCP signaling pathways during wing 
development. In fact, both DER and Notch signaling pathways interact with the Fz PCP 
signaling pathway during eye development [24, 25, 133, 188].  
Over-expression of Chmp1 also caused occasional wing hair phenotypes, including minor 
hair polarity changes and additional wing hairs, which provides further support of a role for 
Chmp1 in regulating Fz PCP signaling. Though a gradient of Chmp1 knockdown was required to 
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cause wing hair defects, uniform Chmp1 over-expression on the dorsal wing with MS1096-Gal4 
was sufficient to cause wing hair phenotypes (Figures 4.18 and 6.2A). The difference in vein 
phenotypes observed from Chmp1 knockdown and over-expression suggest that loss of Chmp1 
activity has different effects on cellular signaling pathways than Chmp1 over-expression. This 
would mean that if Chmp1 knockdown phenotypes are due to faulty ESCRT function and 
incomplete MVB generation, then the Chmp1 over-expression phenotypes may have a different 
cause. Studies in cultured mammalian cells show that Chmp1 over-expression causes an increase 
in phosphorylation, thus activity, of nuclear factors, such as ATM and p53, possibly through 
Chmp1’s nuclear function [89, 90].  If Chmp1 has multiple distinct roles, then it is possible that 
knockdown and over-expression disrupt different cellular processes. So it is possible that the 
function of Drosophila Chmp1 is not limited to the ESCRT’s role in MVB formation, but there 
might also be a nuclear function despite the fact that this study detected no nuclear localization.  
It is also possible that Chmp1 over-expression has the opposite effect to loss of Chmp1, 
in that the ESCRT complex becomes hyper-active when Chmp1 is over-expressed. This could 
lead to different Chmp1 knockdown and over-expression phenotypes associated with its role in 
regulating DER signaling, for example. However, both over-activity and loss of most Core PCP 
proteins results in PCP phenotypes, e.g., extra hairs and altered hair polarity. Therefore the 
opposite effects of Chmp1 knockdown and over-expression on ESCRT activity might result in 
similar PCP phenotypes. 
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Figure 6.2 Chmp1 may regulate Fz PCP signaling. Light micrographs of wings from adult 
Drosophila females. Distal is right, anterior is uppermost. A. MS1096-Gal4/X; UAS-Chmp1-
2/+, raised at 30oC. B. UAS-Chmp1RNAi-VDRC/ptc-Gal4, raised at 28oC. C. en-Gal4/UAS-
Chmp1RNAi-VDRC, raised at 30oC. D. MS1096-Gal4/X; vangTBS42/UAS-Chmp1RNAi-VDRC, 
raised at 28oC. Panels to the right are higher magnification images of the boxed in regions of 
the panels on the left. Red circles around cells carrying additional hairs. Red arrows indicate 
altered hair polarity; blue arrows indicate wild-type hair polarity.  
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Project 2: Expression of pk and sple in pupal wings 
Introduction: One of the Core Fz PCP genes, prickle, encodes two protein isoforms that 
are involved in PCP in the fly, Pk and Sple (Figure 6.3). The two isoforms are active in all 
tissues studied [189]. However, loss of single isoforms affects different epithelial tissues in the 
fly. Loss of Sple activity results in phenotypes in the eye, abdomen, and legs while loss of Pk 
activity causes phenotypes in the thorax and wings [189]. Work from the Collier lab indicates 
that in the wing both Pk and Sple are active but may be required for Fz PCP signaling at different 
times during pupal wing development [190-192]. Specifically, Sple may be required for an early 
signaling event at around 18 hours after pupal formation (hAPF), while Pk may be required for a 
late signaling event at around 32hAPF [191, 193-195].  
 
 
If Pk and Sple are required at different time points during development, then this might 
be reflected in the regulation of their expression, i.e., Sple would be expressed at the 18hAPF 
time point, and Pk would be expressed at the 32hAPF time point. To test this hypothesis, the 
presence of pk and sple mRNA was analyzed at these two time points in the developing fly wing.  
Figure 6.3 Genetic structure of the prickle gene. The pk gene expresses two transcripts 
involved in Fz PCP, pkpk and pksple, which encode for the Pk and Sple protein isoforms, 
respectively. Green boxes represent encoded exons, brown lines indicate splicing of exons. The 
pk and sple transcripts share a large 3’ region, but contain different 5’ exons and have 
independent promoters. Yellow arrows indicate the position of primers used to amplify 
fragments of pk and sple cDNA. 
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Methods: Wild-type flies were grown in large bottles. Developing flies were collected at 
the pre-pupal stage and separated into two groups - one was aged for 18 hours and the other for 
32 hours. At 18 or 32hAPF, the pupae were dissected from their pupal cases and the left and 
right wings were removed. Immediately after dissection, the total mRNA was collected from the 
pupal wings with a Qiagen QIAShredder kit. cDNA from the pupal wing mRNA was generated 
by reverse transcription (RT) using the ImProm-II Reverse Transcription System (Promega) and 
polyT primers (Invitrogen). The RT reaction was run at 37oC for one hour. Pk, Sple, and Actin 
control cDNA generated from RT was PCR amplified using custom primers (Invitrogen) (Table 
6.1 and Figure 6.3). The control RTPCR reaction omitted addition of reverse transcriptase. 
Optimal annealing temperatures for pk, sple, and actin primers were determined by temperature 
gradient PCR reactions using cDNA generated from embryo RNA extractions. The parameters 
for the PCR reactions were as follows: an initial denaturing step at 94oC for 4 minutes, followed 
by 35 cycles of denaturing at 94oC for 30 seconds, annealing at 55oC (pk) or 60oC (sple and 
actin) for 30 seconds, and elongation at 72oC for 1 minute and 30 seconds. Control PCR 
reactions omitted the addition of template. The PCR product was run on a 1.2% agarose gel for 1 
hour at 120V and analyzed on a GelDoc system. PCR reactions were usually successful with as 
little as two pupal wings from a single fly. 
 
 
 Results and Discussion: Though amplification of a pk cDNA fragment was never 
optimized it was detectable at both 18 and 32hAPF, as was sple (Figure 6.4).  This suggested that 
Table 6.1 Primers used to amplify pk, sple, and actin cDNA. Primers listed are 5’ to 3’. 
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the activity of Pk and Sple in Fz PCP signaling in the wing was not controlled by the expression 
of each isoform at the level of mRNA and suggested that further studies (i.e. optimization of Pk 
PCR or qPCR) were unnecessary. So it is likely that the activity of Pk and Sple are controlled in 
ways other than at the level of transcription. For example, it is possible that the Pk and Sple 
proteins are differentially degraded or stabilized at these time points during development. It is 
also possible that there is translational control that differs at different time points. Additionally, it 
is possible that expression of Pk and/or Sple is regulated by microRNAs with incomplete 
complementarity to the mRNA transcripts, which would mean that translation of Pk and Sple 
mRNA transcripts would be stalled and differences in expression may not be reflected in mRNA 
levels [196]. It is also possible that Sple and Pk are both expressed throughout Fz PCP signaling, 
but that the protein structure of Sple and Pk is altered by binding other proteins, or that they are 
modified in a way that activates or deactivates them depending on the requirement for Fz PCP 
signaling. In fact, there is evidence of Drosophila Pk phosphorylation, which is important for 
localization and endosomal trafficking of Pk, as well as its prenylation in vivo, which is 
important for its recruitment to the membrane and proteosomal degradation [197-199].  
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Project 3: Pk and Sple protein isoforms in patterning of the Drosophila eye 
Introduction: Patterning of the fly cuticle requires the Fz PCP pathway. The polarity of 
hairs may be considered as a ‘readout’ of Fz PCP signaling events that occurred during 
development. As mentioned above, the two isoforms of the Prickle protein, Pk and Sple, are 
active in the epithelial tissues of the fly, but loss of Pk causes PCP defects in some epithelial 
tissues, while loss of Sple affects others [189]. This suggests that the Fz PCP pathway has a 
differential requirement for Prickle isoforms depending upon the tissue. Unpublished studies 
from the Collier lab suggest that in the fly cuticle, Pk and Sple actually have opposite effects on 
the direction of (or the hair polarity established by) Fz PCP signaling. In fact, ubiquitous over-
expression of pk or sple in flies mutant for pk and sple (pksple14) results in opposite hair 
polarities over most of the cuticle. Though the eye develops in a different manner from the rest 
of the cuticle, we wondered whether Pk and Sple had opposite effects on eye development as 
Figure 6.4 Amplification of pk, sple, and actin cDNA fragments. PCR products were run on 
a 1.2% gen containing ethidium bromide at 120V for 1 hour alongside a 1kb DNA ladder. A 
and B are from pupal wings at18hAPF. C is from pupal wings at 32hAPF. 
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well. Specifically, that ommatidia in an eye expressing only Pk would have an opposite chirality 
to ommatidia in an eye expressing only Sple.  
Methods:  pk or sple transcripts were over-expressed in a pksple14 background. 
pksple14/pksple14; tub-Gal4/UAS-Sple flies over-express Sple ubiquitously under the control of 
the tub-Gal4 driver in flies lacking active Pk and Sple. pksple14/pksple14, act5c-myc-pk flies 
express myc-tagged Pk ubiquitously under the control of an actin promoter in flies lacking active 
Pk and Sple. myc-Pk can rescue the pk- phenotype, suggesting that the myc tag does not inhibit 
normal Pk activity. Eyes were prepared as described in Chapter 3, Section VIII.  
Results and Discussion: Expression of Sple in pksple14 flies resulted in nearly wild-type 
eyes (Figure 6.5C). The equator was easily identified and most ommatidia were of the correct 
chirality and rotated properly. Occasionally symmetrical, or achiral, ommatidia were present. 
Also, occasional ommatidia had the opposite chirality or misrotation; however these ommatidia 
were uncommon (Figure 6.5C). This shows that the eye can develop almost normally in the 
absence of the Pk isoform and ubiquitous expression of Sple, suggesting that the Sple isoform is 
sufficient for eye development, which is consistent with other published work [189]. It also 
suggests that the spatial or temporal control of Sple expression is not important. 
Expression of Pk in pksple14 flies caused severe defects in eye patterning (Figure 6.5B). 
The site of the equator was uncertain in these eyes. This means that large numbers of ommatidia 
in each hemisphere of the eye had chirality opposite to wild-type, and appear to have rotated in 
the opposite direction as wild-type. Additionally, ommatidia were present with incomplete 
rotation. However, because the position of the equator was unknown in these eyes, making any 
judgment about the numbers of ommatidia with opposite chirality from normal was difficult. In 
order to obtain a more useful result, this experiment needs to be repeated with a marker of the 
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equator. The best way forward may be to study the eye imaginal disc. The position of the equator 
is known in the eye disc. If the developing photoreceptors are labeled, for example with an 
antibody against the neuronal marker Elav, in combination with a marker for the R3 or R4, such 
as the transgene E(spl)mdelta0.5lacZ, which marks the R4 with β–galactosidase expression, the 
chirality and rotation of ommatidia in each half of the eye can be compared more reliably. 
 
 
Project 4: Localization of the Sple isoform in pupal wing cells 
Introduction: In the Drosophila wing, Fz, Dsh, Dgo, and Fmi localize to the distal edge of 
developing wing cells, while Pk, Stan, and Fmi localize to the proximal edge. As previously 
mentioned, the Core Fz PCP protein, Prickle is expressed as two isoforms relevant for PCP, Pk 
and Sple. It is well documented that the localization of Fz PCP Core proteins is crucial for proper 
Fz PCP signaling. However, while the localization of the Pk isoform has been characterized, 
Figure 6.5 Pk and Sple in Fz PCP signaling in the Drosophila eye. Light micrographs of one 
micron thick tangential sections of the Drosophila eye with cartoon interpretation below. 
Dorsal-type ommatidia are indicated in purple, ventral-type ommatidia are indicated in blue, 
achiral ommatidia in red. A. Oregon R. B. act5c-myc-pk, pksple14/pksple14. C. 
pksple14/pksple14; tub-Gal4/UAS-sple. 
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Sple localization remained uninvestigated. Though Sple is known to have some activity in Fz 
PCP signaling in the wing, its function is poorly understood [189].  Work from the Collier lab 
suggests an early requirement for Sple in Fz PCP signaling [190]. Determining the subcellular 
localization of Sple, will provide more information on its function. 
Methods: One problem in visualizing the subcellular localization of membrane proteins is 
that when the protein localizes to a cell-cell boundary, it is not normally possible to know 
whether it is present in just one cell or both. Expression clones can overcome this problem 
because they allow for visualization of all edges (anterior, posterior, proximal, and distal) of 
clone cells that are adjacent to cells that do not express the protein. To investigate the 
localization of Sple, clones expressing Sple tagged with an N-terminal myc epitope (myc-Sple) 
were generated. The myc-Sple protein could rescue loss of Sple activity (sple1), suggesting that it 
was active and the myc tag did not inhibit its function. The localization of myc-Sple was 
investigated in wings lacking Pk activity (a pk30 mutant).   
Clones of myc-Sple were induced in a pk30 background (see Chapter 1 section 2D and 2E 
for information on generating clones). To achieve this, an act>STOP>myc-sple fly line was 
used. This fly line carries a myc-sple transgene that is downstream of an Actin promoter, but 
separated from the promoter by a polyA stop sequence flanked by two FRT sites (>). hs-flp; pk30 
virgin females were crossed to pk30, act>STOP>myc-sple males. The F1 generation was heat 
shocked at 37oC for one hour at 4-5 days (120-144 hours) into development to induce Flippase 
(Flp) expression and removal of the PolyA stop sequence in a subset of cells. First, female 
larvae, identified by their genitalia (hs-flp/X; pk30, act>STOP>myc-sple/pk30), were collected and 
wing imaginal discs were dissected and fixed (for method, see Chapter 3 section VI) to ensure 
that clones were being generated. Clones were identified as small groups of cells within the 
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imaginal disc that exhibited localization of myc-Sple to the membrane as detected with an anti-
myc antibody. Next, female pre-pupa from the same cross were collected and aged for 32 hours. 
After aging, each pupa was removed from its pupal case. The posterior and anterior ends of the 
pupae were cut with forceps to allow for fixative penetration, and the insides of the pupae were 
washed out with 1X PBS. The pupae were then immediately transferred to a fixative solution 
(8% paraformaldehyde, 200mM sodium cacodylate, 100mM sucrose, 40mM potassium acetate, 
10mM EGTA), where the wings were dissected off and the pupal sacs removed. The wings were 
rinsed in 0.01% PBS-TritonX (PBST) and blocked in 5% BSA in 0.01% PBS-TritonX (BSA-
PBST) for 20 minutes. They were then incubated with an anti-c-myc antibody (1:500, diluted in 
BSA-PBST) at 4oC overnight. The primary antibody was removed and the pupal wings were 
rinsed 3 times and washed 3 times for 10 minutes each in PBST.  Wings were blocked again for 
20 minutes in BSA-PBST, followed by incubation with an anti-mouse Alexa-488 antibody 
(1:500, diluted in BSA-PBST) for 3 hours protected from light. The pupal wings were rinsed 3 
times and washed 3 times for 10 minutes each in PBST. The wings were incubated in rhodamine 
phalloidin (1:100, diluted in PBST) for 30 minutes. They were then rinsed 3 times and washed 3 
times for 10 minutes each in PBST at room temperature and finally mounted on a glass 
microscope slide in Vectashield mounting media with DAPI. Wings were imaged on a confocal 
microscope. 
Results and Discussion: myc-Sple localized to the opposite edge of the cell as the wing 
hair. This is likely the same localization as Pk, and opposite of the expected localization of Fz, 
although this has never been tested in these wings [197]. This is consistent with a recent study 
showing that Sple localized to the opposite edge of the cell as the wing hair [197]. The similar 
localizations of Pk and Sple with respect to hair formation show that the difference in Pk and 
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Sple function may not be due to different localizations. sple over-expression reverses hair 
polarity in the wing, i.e., hairs point proximally, rather than distally. It could be that Sple 
localizes proximally like Pk, and so directs hair formation to the proximal edge of the cell. 
Alternatively, a distal Sple localization could drive a proximal site of hair formation. These 
results support the latter, as Sple localized opposite to the site of hair formation. These results 
suggest that the relationship between the site of hair formation and localization is the same for Pk 
and Sple. However, Pk and Sple may very well have different localizations with respect to Fz 
localization.  
The results above (Project 2) showed that pk and sple transcripts are both detected during 
the two Fz signaling events, suggesting that their activity in Fz PCP signaling is not regulated by 
their transcription. Instead, the functional differences may lie in binding partners or 
modifications. The Pk and Sple proteins are identical in amino acid sequence, except in the N-
terminal regions. Pk has 13 N-terminal amino acids that are not critical to its function. On the 
other hand, the Sple protein has a large N-terminal region that appears to be almost entirely 
unique, with the exception of a small (30 amino acid) region that is shared with other arthropods, 
but not with vertebrates. This region may facilitate interaction with proteins with which Pk does 
not interact. Alternatively, it could inhibit interaction with proteins with which Pk binds. Another 
possibility is that Sple is needed to form and localize protein complexes important in controlling 
the direction of Fz PCP signaling. If Sple does bind proteins that Pk does not, these binding 
partners may modify the Sple structure to change its function. A useful future study for 
investigating Sple function would be to identify proteins that the N-terminal region binds in 
Drosophila cells. This would help characterize the function of Sple in Fz PCP signaling. 
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Figure 6.6 Sple localization in the Drosophila pupal wing. A clone expressing myc-Sple in 
the posterior wing of a female of the genotype hs-flp/X; pk30, act>STOP>myc-sple/pk30. Max 
projections of confocal Z-series. A. Detection of myc-Sple (green) with anti-myc. White arrows 
show localization to the edge of the cell. B. The prehairs are composed of Actin, which was 
detected with rhodamine phalloidin. C. Merge of A and B, showing localization of myc-Sple to 
the opposite edge of the cell as the prehair.  
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